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Innovation in United Kingdom (UK) healthcare has in the last decade been 
driven forward through national policy and the development of a national 
innovation infrastructure, underpinned by an imperative to change. An 
increasing number of National Health Service (NHS) provider units, NHS 
trusts, are making ‘innovation’ part of their strategies; however, a paucity 
of published theory, guidance, or information within the sector means how 
and why a trust should invest in, and develop their innovation strategies is 
not well understood.  
 
In these highly complex, dynamic organisations providing 24-hour 
healthcare delivery, assimilation of innovation into core NHS business and 
realisation of the desired impact appears dangerously slow for the needs 
of the sector. Indeed, acceptability by individual healthcare staff within 
these systems of innovation as part of their role, at best appears ad hoc. 
This presents significant challenges for those who lead these organisations 
and those who work within them with specific responsibilities for 
innovation. This case study research explores this holistically and in-depth 
to gain a deep understanding of how innovation is understood and 
presents a theoretical model of how NHS trusts might function as 
innovative organisations.  
 
The case is an NHS Trust, the unit of healthcare delivery within the 
English National Health Service (NHS), contextualised with its 
organisational boundaries as a ‘mesosystem’, with individual ‘actors’ 
embedded within, identified as working within ‘microsystems’. In many 
ways the case can be seen as typical, yet as a case, also unique, both in 
terms of the temporal component explored and the emic perspective 
taken. The researcher in this study is a senior leader within the NHS Trust 
with a responsibility to lead the innovation strategy, she and her 
colleagues in other NHS trusts struggle with these issues on a daily basis. 




Theory from outside the UK healthcare context was used to explore the 
antecedents to an innovative organisation, including the need for strategy, 
the role of leadership, the creation of a supportive innovation 
environment, and the value proposition innovation might bring to this 
complex mesosystem. Data from multiple sources was collected using a 
validated tool for the exploration and measurement of the Culture for 
Innovation (CfI) (Maher, et al. 2010) over a one year period, six months 
after the implementation of an organisation innovation strategy within the 
NHS Trust. A critical realist perspective informed the data analysis and 
triangulation process, to give a rich description of the case, prior to using 
an abduction process to build on the current theory. A model that seeks to 
explain how a healthcare organisation might function as an innovative 
organisation was created. This will be of direct use to the case, as it 
continues to develop its innovation strategy and will be disseminated to a 
wider audience to support the development of NHS innovation theory. 
Thus will provide a useful resource to support other NHS trusts develop as 
innovative organisations. 
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Chapter 1.  Introduction 
This chapter outlines the author’s interest in the topic of enquiry and the 
need for the research, before presenting the research aims and objectives. 
The chapter explains the thesis structure and gives a summary of the 
contribution this research makes, both to theoretical knowledge and 
practical application. It then clearly and transparently places the 
researcher within the context of the research itself. This placement of the 
researcher is considered fundamental to the design, conduct, and analysis 
of the study from the critical realist perspective and therefore is included 
in the introduction of the thesis, as well as addressed in more detail in 
other relevant sections (Thomas, 2016). 
  
1.1 The need for the research 
There is general recognition that innovation is important for ensuring that 
patients across the UK benefit from outstanding modern healthcare (NHS, 
2019). Yet although an ever increasing number of innovations are 
available to healthcare providers, uncertainty remains regarding how to 
either access or implement them (AHSN, 2019). In the UK healthcare 
system, the National Health Service (NHS), barriers to innovation adoption 
and spread are increasingly well documented (Welcome Trust, 2016; 
Collins, 2018), with some suggesting the pace of change is glacial and 
that the pathway for innovation is fragmented (Youth Health Parliament, 
2016). There are calls for changes to the national structure and its 
regional bodies that support innovation in the NHS, the Academic Health 
Science Network (AHSN). The need to ensure that individual clinicians are 
engaged in the innovation process to ensure adoption of useful innovation 
has also been highlighted (Welcome Trust, 2016). Others postulate that 
these changes alone will not address the root cause of the problem, 
suggesting that embedded organisational behaviours and cultures within 
NHS organisations, coupled with silo working are a major barrier (Castle-
Clarke, et al. 2017). 




How to address this issue is the challenge facing those working within the 
NHS tasked with the remit to promote innovation at organisation level. 
How should NHS organisations work with the AHSN, engage their staff, or 
strategically develop their behaviours and cultures to participate in 
innovation in order that it can be adopted, adapted, or assimilated for the 
benefit of their patients? Given that there are over 200 NHS provider 
units, ‘trusts’, in England alone, (NHS confederation, 2017), with most 
NHS staff employed by these units, developing the evidence-base to 
support these organisations in delivering their innovation strategies would 
seem fundamental. There is however, little organisational literature to 
support managers in this endeavour (Williams, 2011). This is the issue 
faced every day by the researcher and her colleagues who lead innovation 
strategies in other NHS trusts. It is this evidence gap that this research 
aims to address. 
 
1.2 Research aims and objectives  
Research is conducted for two purposes, the development of theoretical 
knowledge and to solve problems (Thomas, 2016). The purpose of this 
research is to address both of these criterions, articulated through the 
following research aims and objectives.  
 
This research had two aims: 
 
1. To develop conceptual clarity and theoretical knowledge on how NHS 
trusts function as innovative organisations 
2. To provide a solution to the problems faced within NHS trusts 








The objectives are to analyse empirically within an NHS Trust 
 
1. How is innovation conceptualised? 
2. How are the antecedents of innovativeness understood? 
3. How can organisational innovativeness be developed?  
 
As a single case study it is not intended that this research will produce 
statistically generalisable results, as such it will not be possible for direct 
inferences to be made from this research to other NHS trusts. In 
developing the underlying theoretical propositions of how NHS trusts 
function as innovative organisations and how innovation strategies could 
be developed, however, it might be possible for analytical inferences to be 
made from this case that are relevant to other similar organisations (Yin, 
2014). In this way the research will be useful beyond the specific case 
involved. 
 
1.3 Summary of thesis structure 
Chapter one provides an introduction and summary of the thesis, why it 
was undertaken, and the knowledge gap it addressed. It describes how 
the thesis is structured, with the positionality of the researcher clearly 
presented. Chapter two follows to present a systematic review and critical 
analysis of the literature. Through this process the context for the 
research, the healthcare ecosystem, is defined along with what is 
currently known of the requirement to innovate within this setting. This 
chapter, then explores the conceptualisation of innovation from within the 
business community (Baregheh, et al. 2009) and then presents a 
framework to support measurement and the development of a Culture for 
Innovation validated within NHS trusts (Maher, et al. 2010). Through its 
product, the literature review presents theoretical concepts or propositions 
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from innovation theory which are synthesised to form the focus of this 
research enquiry.  
 
Chapter three lays out the rationale for using a case study approach to 
explore these theoretical propositions within one NHS Trust and the 
ontological lens through which the research was conducted. This chapter 
outlines the specific methods utilised within the research for data 
collection, and gives a full explanation of how the research was conducted 
and the findings analysed. The main findings from the research are 
presented in three parts in Chapters four, five, and six. Each of these 
chapters explores through rich description the case, as an entity, but also 
sequentially addresses the three identified research objectives by 
conceptualising innovation, describing the receptive context, and 
reflecting on the organisational readiness for change within the case.  
 
In the final section, Chapter seven, the research undertaken is reflected 
upon and the findings synthesised through a process of creative 
retroduction to present as a conclusion a theoretical model of the how 
NHS trusts might be presented as innovative organisations. This chapter 
outlines how this model might be useful to practice and further developed 
through research. In doing so the chapter identified how the aims of this 
research were addressed, bringing the research together as a conclusive 
whole.  
 
1.4 Original contribution to knowledge  
Innovation has been identified as critically important to the future of the 
NHS, (NHS 2019), there is evidence that at the national level 
(macrosystem), strategic development of the systems and structures to 
support innovation are being developed. This extends to a regional 
network of organisations (exosystem) that support innovation within 
healthcare and NHS trusts (mesosystems), who are responding to this by 
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assimilating innovation into their strategic plans. Yet, how innovation is 
conceptualised, understood or should be developed within NHS trusts is 
poorly evidenced (Williams, 2011). It has been suggested that NHS trusts 
(mesosystem) are considered a context for innovation, rather than 
partners in innovation (Thune, et al. 2016). Most importantly it is 
postulated that this lack of understanding might be one cause of the 
identified barriers of adoption and spread (Collins, 2018; Greenhalgh, et 
al. 2005).  
 
This research addresses this evidence gap by first undertaking a critical 
and wide-ranging exploration of the literature, drawing not only from 
healthcare and public sector theory, but also from organisational, and 
private sector innovation theory, to identify what is currently known of 
organisational innovativeness. The literature review provides several 
theoretical frameworks that might usefully support the conceptualisation 
of innovation within an NHS trust, including a definition for innovation 
(Baregheh, et al. 2009) and a valid model for exploration of the Culture 
for Innovation (Maher, et al. 2010). The CfI model was published in 2010, 
however, no published evidence of its use has to date been identified, this 
research explores the ease and usefulness of using this model tool within 
the setting.    
 
The findings of the research were then used to provide a unique rich 
description of innovation and innovativeness within an NHS Trust. The 
current research then builds on this descriptor to present both a novel 
theoretical model of the ‘essence of organisational innovativeness’ that 
has the potential to be useful to the case and describes a plan of action 
for organisational development within NHS trusts. No other examples of 
published reports of this type have been identified, it is therefore 
suggested that this might also be of use to other innovation leads working 
within NHS organisations, within the healthcare mesosystem.  
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1.5 Positionality of researcher 
 Reflective Journal 15 December 2018 
 
‘Having written my proposal and gained permission, I launched into 
the field with desperate gusto, determined to progress at pace. I 
have analytical skills, so felt confident that I could manage the 
analytical stage, when I had the data. However, having collected 
data, done some analysis, here I stop. I have some interesting 
concepts, yet I realised now that I am working the data in parallel, 
there is no ‘convergence of evidence’. I have no idea how to 
proceed! Yin states that the analytical strategy should be written in 
the protocol, I re-read my protocol, I refer to his ‘five general 
strategies’, so this doesn’t help.’ 
 
This paucity of detail in my original analytical framework led not only to a 
revisit of the methodological literature, but also to deeper reflection on the 
concept of ‘self’ as an instrument of this research and the impact of this 
on my thesis. To undertake a competent analysis and therefore write a 
defensible thesis, two things were required; first, transparency as to the 
positionality of the researcher; and second, a clearly identified lens 
through which the research was being conducted and subsequently 
analysed (Thomas, 2016). Thomas (2016) further suggests that these 
should be stated from the outset from the personal perspective of the 
researcher; this section is therefore written in the first person. 
 
I am by profession a nurse, and have worked in the NHS my entire 34 
year career, spending the last 22 years in innovation and research. In the 
time I have worked in innovation and research, I have been in a number 
of roles, worked across all healthcare settings, held positions on an NHS 
Research Ethics Committee, and supported the research governance 
process. I have undertaken, been involved in, or supported an eclectic mix 
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of research projects from randomised controlled trials (RCT) to qualitative 
phenomenological research. I do not value one type of research over 
another; I believe that the right methodology should be used to answer 
the research question posed in order to produce useful outcomes for 
patients, staff, and the NHS. I am currently employed as a senior 
manager within ‘the NHS Trust’, the case, with responsibility for leading 
the Trust’s key strategic theme, ‘To Innovate’ and grappling with the real 
life challenges this presents. This research is the thesis module of a 
Doctorate of Professional Practice (D. Prof. Prac) undertaken part time 
around this full time position. This brief description affords several 
assumptions to be made, which for clarity are summarised here.  
 
My personal aim is to produce a defensible thesis; however, professionally 
I believe I also have an ethical responsibility to produce an outcome 
useful not only to my employer, who has supported my studies, but also 
to individual staff members who committed their time to my studies. In 
addition, I feel a commitment to the wider NHS and also believe this will 
ultimately benefit our patients. This is commensurate with my rationale in 
undertaking a D. Prof. Prac. rather than a traditional PhD. Secondly, as a 
researcher, my time and resources are limited; pragmatic choices had to 
be made including the choice of a single case, my own Trust, which not 
only satisfied ease of access to the field, but also my desire for impact.  
 
Lastly, the case study, has been used across many disciplines, including 
healthcare, underpinned with a variety of theoretical stances, from post-
positivism (Yin, 2014) to more interpretative approaches (Stake, 1995). I 
openly embrace my emic perspective, working with the case using both 
my expert knowledge within the field of study and the tacit knowledge 
gained over many years. I am actively involved in this research; I 
acknowledge the subjectivity of myself in this respect. I identify my 
ontological beliefs as being based within critical realism (appendix 5). I 
acknowledge both the opportunity and challenge this presents, and have 
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utilised reflexivity to both support the process and production of 
knowledge, and to manage the ethical dimensions of this research. This 
then is the personal lens through which I have undertaken this research; 
it forms a connective thread from the initial concept, through to the final 
report writing. 
 
I acknowledge from the outset the specific ethical issues of this approach 
and the particular challenge this presents. Every effort has been made to 
conduct this research to the highest possible ethical standard and in 
particular to protect the anonymity of individual participants. To achieve 
this, the name of the Trust is not directly referenced within this thesis, 
however, I acknowledge that for the inquisitive it would be possible to 
identify the case as an NHS trust from some unique information contained 
within the data. This has been discussed in depth; as it was felt that the 
removal of this data would compromise the richness of the case 
descriptor, so specific permission has been sought from the Trust 
accepting this compromise in anonymity within this thesis (Appendix 
2.III).  
 
1.6 Chapter summary  
This research has been undertaken by the researcher for the thesis model 
for D. Prof. Prac. The research has been approved and supported by the 
University of Northampton and a supervisory team. The intended audience 
for this research is primarily academic and as such this research is 
presented in a linear-analytical structure suitable for this academic 
purpose (Yin, 2014). The researcher is also employed within the NHS 
organisation that is the subject of the case study, there is a moral and 
ethical argument that the research must be conducted to a high standard 
no only to fulfil its academic purpose, but also in order that the findings 
can be shared with and be useful to the host, the NHS Trust where the 
research took place. To achieve this, the research needs to build on what 
The Case to Innovate: understanding organisational innovativeness in one NHS Trust 
9 
 
is already known; this is outlined in chapter two, the literature review that 
follows next. 
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Chapter 2.  Literature review 
This chapter presents the literature review; an essential element of the 
research process which serves two functions. The first, to illuminate the 
broad context of the enquiry and identify what is currently known within 
the subject area (the process). The second is the analytical contribution to 
the thesis argument itself (the product) (Murray, 2002). This chapter 
presents the range of options that could be explored, which by necessity 
have been refined to achieve the focus of interest and specific questions 
that are both possible to investigate and important to answer.  
 
This literature review was developed in several stages; a first-stage 
literature search was undertaken for the protocol development, this 
explicitly used the search terms: ‘NHS’, ‘innovation’ and ‘organisational 
culture’ (Appendix 2.I). After data collection and transformation, a 
second-stage literature review was undertaken to inform further analytical 
stages. This included a formal protocol driven database search of four 
databases, BNI, CINAHL; EMBASE and MedLine, using the search terms 
‘innovation’, ‘NHS’ and ‘purpose, value, reason’ this was supported by a 
specialist (Appendix 4.I). As this yielded only a small number of relevant 
publications this was augmented by a third-stage of purposive searching 
using strategies such as ‘snowballing’ and ‘personal knowledge’ of the 
subject matter (Greenhalgh, et al. 2005a). New theory and publications 
are constantly emerging, not everything could be captured within this 
review; the literature reviewed hereon-in reflects back over several 
decades, up to the present. 
 
Understanding ‘innovation’ and ‘innovativeness’ is problematic; the 
concept is broad and has been assigned multiple meanings, definitions, or 
conceptualised as a multi-stage process (Rye, et al. 2007). In addition to 
this lack of concrete definition, innovation literature is highly 
heterogeneous, drawing from a variety of disciplines, taking a variety of 
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forms and although contributions stretch back many decades, one piece of 
evidence does not necessarily replace another (De Vries, et al. 2016; 
Robert, et al. 2009; Ling, 2002; Greenhalgh, et al. 2005). Undertaking a 
comprehensive literature review of such a nebulous concept presents the 
researcher with an exceptional challenge (Robert, et al. 2009, Ling, 2002). 
Through iterative cycles of critical analysis, key themes were identified 
from the literature and drawn together into a body of knowledge that 
forms a theoretical framework for this research. This review is structured 
into three sections, the first two, the healthcare ecosystem and the policy 
imperative for healthcare innovation, together address the process of the 
literature review. The third section addresses the product, the 
conceptualisation of innovation, and an exploration of the antecedents to 
organisational innovativeness. 
 
2.1 The healthcare ecosystem  
Bronfenbrenner (1979) presented childhood development theory within 
complex interrelated environments, which he categorised as an 
‘ecosystem’. The ecosystem has a series of levels, which can be arranged 
in hierarchical order, with level 4 the ‘macrosystem’, the highest order, 
defining the belief system where the culture, ethics and law provides 
structure for all other systems. Level 3 the ‘exosystem’ is a level in which 
individuals are not perceived as active participants; level 2 provides the 
‘mesosystem’ where individuals actively participate; whilst level 1, the 
‘microsystem’, is where individual ‘actors’ directly engage (Onwuegbuzie,  
et al. 2013). It has been suggested that ecological systems theory 
provides a useful conceptual model for research (Onwuegbuzie, et al. 
2013), and is an approach utilised within healthcare literature (Waring, et 
al. 2014), social entrepreneurship (Hazenberg, et al. 2016) and the case 
study (Pope, et al. 2006; Caldwell, et al. 2012). This conceptual 
framework of the ecosystem is therefore used to describe the UK 
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healthcare system and to place the subject of this study, an NHS trust, 
within its context. 
 
2.1.1 The national system  
The National Health Service (NHS) was established in 1948 and is funded 
from general taxation raised by the government; political oversight, top-
level distribution of funds and national priority setting is managed through 
the Department of Health and Social Care (DHSC). This inevitably means 
a political nuance to healthcare, with funding interdependent with a well-
performing UK economy (Farchi, et al. 2017). The DHSC is however, not 
responsible for the delivery of healthcare, this is delegated to the NHS. 
The NHS has as a core founding principal that the provision of healthcare 
is free at the point of need (Rivett, 2018). The NHS has grown to be one 
of the largest healthcare providers in the world (Grosios, et al. 2010) and 
is often referred to as a ‘national treasure’ 1 (The Guardian, 2013). In the 
context of this study, these two national components of the system are 
considered the ‘macrosystem’.  
 
The NHS, however, is not a single entity, but a brand (NHS England, 
2019), a diverse and complex collection of interlocking agencies and 
public bodies (NAO, 2017). This plethora of organisations, work in a 
crowded space, collectively setting the national strategy, delivering 







1 The NHS is popularly seen as a ‘National Treasure’ however, this emotive language 
means that the public and staff see it as a constant, any proposed changes are fiercely 
fought out in the press with the potential to hamper innovation  
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controlled central budget, often with overlapping responsibilities, which 
can lead to a lack of coherent messaging (Kings Fund, 2019). This is the 
‘exosystem’ of this research, and is subject to almost constant change. 
The last major reorganisation (DH, 2012) saw the establishment of NHS 
England (NHSE), an independent body mandated by the DHSC, but 
subject to ministerial direction like other NHS bodies (NOA, 2017) tasked 
with setting the priorities and direction of the NHS in England and the 
largest recipient of DHSC funding. NHSE through a complex layered 
commission system is responsible for service provision (NAO, 2017). In 
each county of England, NHSE contracts with local Clinical Commissioning 
Groups (CCGs), who are then tasked with commissioning the locality 
based services and the drive towards whole-system integration (McKenna, 
et al. 2016). 
 
2.1.2 Healthcare providers  
The main operational units of local healthcare delivery is the NHS provider 
trust, legal entities approved by order of the Secretary of State to deliver 
healthcare, contextualised here as the ‘mesosystem’. NHS trusts as 
individual organisations are highly heterogeneous, varying contractually in 
size and service provision; however, their primary function is to deliver 
specific, high-quality healthcare services, to a geographical population, 
within their fiscal envelope (NHS Dictionary, 2019). NHS trusts are bound 
by the policies set within the macrosystem, for which they are accountable 
directly to DHSC, but also by tight contractual arrangements to their 
commissioners within the exosystem, NHSE and the CCGs, where key 
performance indicators are reported. Additionally, trusts are subject to 
annual quality reviews by a regulatory body, the Care Quality Commission 
(CQC), with resulting quality ratings published. This complex reporting 
web has led to the accusation of a poorly understood, increasingly 
impenetrable system of bureaucracy (Oliver, 2017). 
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Healthcare provision within the mesosystem is dynamic and constantly 
changing, increasingly documented as an interconnected network of 
activity (Greenhalgh, et al. 2016; Waring, et al. 2014). Here, the focus is 
on continuous delivery of high quality, value for money, patient care, 
often in very challenging circumstances (Shaw, et al. 2011). In the 
mesosystem a constant stream of competing priorities jostle for position, 
compounded by increasing public expectation, raising demand, financial 
pressures (Robertson, et al. 2017) and staff shortages (Addicott, et al. 
2015), contributing to a high pressured environment. Add local history 
and transformational change to the mix and individual, unexpected, 
unique microsystems develop, often at odds with national policy (Waring, 
et al. 2014; Bienkowska-Gibbs, et al. 2016). This has led to criticism that 
the NHS as an ecosystem has a dysfunctional culture (Pope, 2019). 
 
2.1.3 The NHS workforce  
These mesosystems employ the NHS workforce, an estimated 1.4 million 
individuals: doctors, nurses, allied healthcare professionals, managers and 
others, delivering healthcare on the frontline (Addicott, et al. 2015). These 
individuals commonly work within small teams, representing the 
‘microsystem’ for this research. Here, staff deliver increasingly complex 
clinical care, in tightly managed services with limited resources 
(Robertson, et al. 2017). Each individual is bound by their contract of 
employment to the trust, however, as healthcare professionals many also 
have allegiances and obligations to national professional bodies. Add to 
this the directive from quality monitoring bodies that high performing 
organisations must have correspondingly high levels of appraisal, 
supervision, and mandatory training; then it is clear that the workload 
pressures within the microsystem are immense. Increased levels of 
workplace stress are leading to staff burn-out and significant sickness 
rates (4.48% in 2015) within the NHS are now recognised (Paton, 2015; 
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Wilkinson, 2015; George, 2016). There is a demand for immediate action 
by NHS employers (NHSE, 2017). 
 
The science of workforce management has developed over the last decade 
(Hurst, 2003; The Shelford Group, 2013) and as more NHS trusts buy in 
commercially available software packages, ‘big data’2 analysis has allowed 
sophisticated calculation of overall staff unavailability within a trust’s 
budget known as ‘headroom’ (Allocate, 2017). Increasingly, this is being 
used by trusts to model, refine, and manage safe, cost-effective staffing 
of services at point of delivery (Allocate, 2017). Organisational 
management tools however, have limitations; social systems do not 
function in predictable ways, this, and the changing demographic of 
healthcare professionals, presents an acknowledged challenge around the 
long-term sustainability of the NHS workforce. Indeed, recruitment and 
retention of staff is now high on all NHS trust agendas (Addicott, et al. 
2015). 
 
2.1.4 Dynamic and complex interactions  
The UK healthcare system has been described here within four hierarchical 
levels: the macrosystem, where national policy and strategy are 
developed; the exosystem, where multiple organisations provide the 
systems and structures to deliver these policies and commission care 
delivery; the mesosystem, where the healthcare providers, the NHS 







2 Big data is a term used to describe enormous data sets gathered across multiple sites, 
analysed to reveal trends and associations. 
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teams of individuals working on the frontline deliver healthcare. Each level 
has its own specific purpose, function, and structure, thus its own place in 
the ecosystem. They are also tightly bound by a common brand with a 
shared founding principal, providing free healthcare at the point of need 
and by policy, funding, and structure. As such, one part cannot exist 
without the other, so all must function together as a highly complex, 
dynamic and interrelated, if dysfunctional ecosystem.  
 
2.2 The imperative to innovate  
In 2008, the UK, in common with much of the world, went into the 
deepest recession since data collection commenced (Allen, 2010). As a 
tax-funded system, the impact of this, coupled with increasing demand, 
placed the NHS under extreme pressure (Bienkowska-Gibbs, et al. 2016). 
It is considered no longer possible to continue to provide high-quality care 
through existing mechanisms and fiscal envelope; change must happen 
(NHS England, 2014; Sood, et al. 2014). At times of economic crisis, 
seeking novel solutions and problem solving approaches to facilitate 
economic growth and improved performance are common (Hogan, et al. 
2014; Efrat, 2013; Martins, et al. 2003). This imperative to change and 
transform is widely cited within NHS policy, often associated with the buzz 
word ‘innovation’ (Osborne, et al. 2011).  
 
2.2.1 The policy context 
The most recent national strategy, The NHS Long Term Plan (NHS, 2019) 
confirms this ambition to reform the NHS over the next 10 years; 
innovation is a key word in this document, cited 41 times, in association 
with product, technology, research, and transformation change. Such 
clear messaging highlights innovation’s essential role to the future of the 
NHS (Farchi, et al. 2017). The prevalence of a concept, however, does not 
necessarily infer a shared understanding (Osborne, et al. 2011). 
‘Innovation, Health and Wealth’ (DH, 2011 p9) defines an innovation as: 




 ‘An idea, service, or product new to the NHS or applied in a way 
that is new to the NHS which significantly improves the quality of 
health and care when it is applied’ 
 
This definition is not universally applied within national healthcare policy 
documents, indeed in a review of public sector literature the lack of 
innovation definition was identified as the most noticeable feature (De 
Vries, et al. 2016). Indeed, generally there appears to be multiple ways of 
describing an innovation within the literature, with no unifying definition 
(Rowley, et al. 2011). As innovation is so widely quoted within UK 
healthcare literature, this merits exploration of how the word is being used 
within the policy context. 
 
Farchi, et al. (2017) explores the conceptual scope of ‘innovation’ within 
DHSC policies and identified that the use of the word innovation has 
changed over time. They describe three distinct phases of interpretation:  
phase-one (pre 2001), an early narrow focused meaning linked directly to 
clinical research; phase-two (2001-2006), an interim phase embracing 
innovation as a collective endeavour of researchers and NHS staff and 
hence closely associated; phase-three, (2006-present), where the 
meaning has changed to become axiomatic and accepted as everybody’s 
responsibility. It is in phase-three that the links are made to the economic 
climate, with the focus on benefit realisation, quality improvement, and 
efficiencies. One phase however does not replace another, the meanings 
of successive phases are additive, with additional new inferences 
incorporating the previous meaning. Thus, the current inference from 
‘innovation’ within the policy context is a high-level concept, removed 
from the scientific community (Farchi, et al. 2017), with little critical 
analysis of the operational meaning (Osborne, et al. 2011). 
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2.2.2 National Innovation System (NIS) 
Innovation as conceptualised within the first two phases has had a clear 
pathway of support through successive national research strategies, most 
recently ‘Best research for best health’ (DH, 2006). This was driven 
forward through strong clinical leadership from the Chief Medical Officer 
within the DHSC and supported by the establishment of the National 
Institute of Health Research (NIHR). The expressed ambition of the 
strategy was to ‘improve the health and wealth of the nation through 
research’ (NIHR 2019). This was augmented by the NHS Constitution, 
which ensured that patients have a constitutional right to know about and 
participate in research from which they might benefit (DHSC, 2015) and 
by every NHS provider contracted to deliver this obligation. The NIHR has 
continued to grow and develop over the last decade, delivering a focused 
national research agenda. It has developed a systematic process from 
prioritisation of need, to the rapid set up and delivery of research and to 
the adoption of results through the National Institute of Health and Care 
Excellence (NICE). The NIHR has built an evidence-base around the 
positive impact research has for patients, staff and the NHS (Boaz, et al. 
2015; Jonker, et al. 2018) and in doing so it has sustained political 
support and funding. 
 
Innovation, however, has had a more fluid existence. In 2005, a newly 
created Special Health Authority, the NHS Institute for Innovation and 
Improvement was created. Although the publication of the national 
strategy ‘Innovation Health and Wealth’ (DH, 2011), supported by the 
NHS Chief Executive highlighted innovation as a priority, the institute was 
disbanded in 2013, with its responsibilities divided between NHS 
Improvements (NHSI) and the Academic Health Science Network (AHSN). 
The aim of the AHSN was explicitly to spread innovation at pace and scale 
within the NHS (AHSN, 2019). The AHSN is only one of a large number of 
confusing opportunities that support innovation in the NHS (Kelly & 
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Young, 2017). In addition, how research and innovation and all these 
mechanisms work together within the macrosystem is poorly articulated 
(Cresswell, et al. 2016). 
 
It is perhaps no coincidence that the NIHR and the AHSN have been 
established (Young Foundation 2011). In April 2017, NHSE merged its 
internal research and innovation teams and presented its new research 
plan. This articulates how NHSE will work as a system leader in 
partnership with other bodies in the macro and exosystems, such as the 
DHSC, NIHR, and AHSNs to ensure that not only does the NHS  
 
‘supports and harnesses the best research and innovations to 
improve patient outcomes, transform services and ensure value for 
money’  
 
but also, that this will form NHSE’s  
 
‘strategic approach to research including the research and 
innovation architecture and how this links with work ongoing across 
Government, such as the Industrial Strategy’ (NHS England, 2017 
p4).  
 
The NHS has a long history of world-leading innovation, yet retaining this 
position is increasingly challenging (Kelly & Young, 2017); perhaps this 
signals the development of a new fourth phase, the development of the 
healthcare ‘Innovation Systems’ (IS). The conceptual models of IS has 
been around for over three decades within the technology sector 
(Watkins, et al. 2014); networks of public bodies, academic institutions 
and commercial enterprises working together to provide funding for 
research, and develop outputs into innovations ready for market adoption 
(Efrat, 2013). IS work at multiple co-existing levels (Meuer, et al. 2015), 
as the world market place becomes increasingly accessible, dynamic 
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sectors, such as the technology industry, are recognising the value of 
understanding their position within the Global Innovation System (GIS). 
This understanding then allows policy-makers to identify leverage points 
for enhancing innovative performance and improve competitiveness 
(OECD, 1997) and then to configure their National Innovation Systems 
(NIS) to yield maximum competitive advantage (Binz, et al. 2017).  
 
It appears that within the macrosystem a fourth stage of innovation is 
developing, with increasing recognition of the potential to develop the UK 
healthcare as a recognised GIS (Bienkowska-Gibbs, et al. 2016). To 
achieve this, a NIS is being developed within the exosystem, with NHSE 
linking its innovation and research units and closer working between the 
NIHR and AHSNs. Then through regional support hubs and local centres of 
research excellence, Regional Innovation Systems (RIS), provide direct 
support to the mesosystem. This then would place the UK in a good 
position for any global opportunity (Meuer, et al. 2015). National policy 
focus is significant; it has real and far reaching impact across all other 
parts of an ecosystem (Farchi, et al. 2017), including the mesosystem, 
however, how it translates must be explored. 
 
2.2.3 Mesosystem delivery  
Clinical research has a long history in NHS trusts (Bhatt, 2010), with 
Evidenced Based Medicine (EBM) established conceptually since the 1980’s 
(Wieringa, et al. 2017). Since 2014 all NHS trusts have been contractually 
required to support patients in their right to access research (NHS 
England, 2019), so must have a relationship with the regional delivery 
arms of the NIHR, the local Clinical Research Networks (CRN). Research is 
considered to have high associated clinical risk; it is therefore clearly 
defined and managed through strict national governance processes (HRA, 
2017), with responsibility usually allocated to the Medical Director. In 
addition, the requirement to report research activity both regionally and 
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nationally via a central platform is well established, with payment 
following activity managed by the regional CRN. This means the majority 
of NHS trusts now have clear research leadership, process and support 
structures. The interplay between the ecosystem is clearly demonstrated 
(Thune, et al. 2016). 
 
Innovation appeared as a separate and independent concept in the 
mesosystem, introduced through the Commissioning for Quality and 
Innovation (CQUIN) payment framework (DH, 2008) and the NHS Quality, 
Innovation, Productivity and Prevention (QIPP) Challenge (DH, 2010). In 
these documents, innovation is less clearly defined, has no specific 
governance framework presented and is linked directly to quality 
improvement and efficiency savings (DH, 2011a; Young Foundation, 
2011). CQUIN and QIPP in many trusts are the responsibility of the 
Directors of Nursing who lead on the quality improvement agenda and 
Director of Finance, who lead on efficiencies and cost improvement 
programmes. CQUIN and QIPP are agreed between NHS trusts and their 
local commissioners (CCGs), targets and outcomes are set, and these 
must be achieved for any associated payments to be awarded. The 
interface of innovation is primarily within the mesosystem following a 
more localised route (Thune, et al. 2016). 
 
It would appear that systems and processes that support innovation 
within the mesosystem directly replicates the policy phases of the 
macrosystem; the early phase concepts of innovation closely aligned with 
well-established clinical research, with a subsequent more axiomatic 
conceptualisation developing more generally in recent years. Indeed, the 
national shift that brought innovation and research together under one 
directorate in NHSE (NHS England, 2017), is now being echoed amongst 
other organisational elites, such as university teaching hospitals, who 
were the first to change their Research and Development departments to 
Research and Innovation teams. In addition, NHS organisations in line 
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with national policy are increasingly identifying innovation as a priority 
within their strategy plans (Maher, et al. 2010), this is especially 
important as all NHS trusts are now required to articulate their 
contribution to the innovation agenda through annual monitoring systems 
(CQC, 2014), perhaps reflecting the fourth national phase of innovation 
and seeking to develop Organisational Innovation Systems (Meuer, et al. 
2015).  
 
This however, assumes a linear translation of high-level policy concepts 
across the ecosystem, and is perhaps not a reflection of the messy 
process of assimilation that actually happens (Foster, et al. 2016). 
Although there is a huge amount of healthcare literature that pertains to 
innovation, the vast majority is focused on an innovation, or 
implementation and adoption of technologies, with limited representation 
in the literature of the NHS trust, as an organisational innovation system 
(Thune, et al. 2016). Given this lack of understanding, it is perhaps not 
surprising that evidence is emerging of the barriers to innovation adoption 
and spread (Collins, 2018), significant delays in the adoption of change 
(Castle-Clarke, et al. 2017), leading to a systematic failure of benefit 
realisation (Wellcome Trust, 2016). 
 
2.2.4 Organisational identify 
Organisational theory makes the distinction between the organisation’s 
‘image’, how organisational elites would like their organisation to be seen, 
and its ‘identity’, how the members understand their organisation 
(Caldwell, et al. 2012). Although the mesosystem can be seen to mirror 
the national policy directive, addressing the image, it is suggested that the 
wider engagement of frontline staff in delivery of an innovative 
environment, the identity, has been neglected (Creswell, et al. 2016). This 
interconnection between different levels of understanding within the 
complex ecosystem needs to be properly explored, including the 
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perceptions of its members working with the microsystems, if an 
understanding of why pace, direction and impact of innovation and change 
within NHS trusts remains slow is to be gained (Pope, et al. 2006).  
 
Empirical evidence of the understanding of innovation at healthcare 
practitioner level is scarce, however, in June 2018 ‘The Evidence Centre’, 
an independent organisation, was commissioned by the Kings Fund to 
survey a random stratified sample of NHS frontline staff and managers 
(n=1,002) regarding how well equipped they felt to adopt innovation (De 
Silva, 2018). The findings were presented at a national conference of 
experts and received no challenge (Kings Fund, 2019). The survey found 
that 79% of frontline staff said they did not feel confident about what 
‘innovation’ meant, confirming the proposition that within NHS trusts 
confusion exists about the very term ‘innovation’ (Page, 2014; De Vries, 
et al. 2016; Youth Health Parliament, 2016). In addition, 99% of 
respondents said they did not feel well equipped to adopt innovation, 
citing multiple barriers including risk-adverse management, time, and 
space to think, lack of role models, lack of partnership between patients 
and financial pressures amongst others. This is corroborated by two other 
publications; Maher, et al. (2010) survey of NHS staff which found two-
thirds of respondents were not supported in undertaking innovation and 
Page (2014), who found that senior managers questioned did not know 
the processes for implementing innovations. 
 
Innovation in the private sector is acknowledged to be hard, taking both 
focus and energy (Pisano, 2019). Modern healthcare is an increasingly 
complex and challenging environment, particularly on the front-line where 
individual healthcare practitioners operate (Waring, et al. 2014), here the 
focus is on continuous delivery of high quality, value for money, patient 
care, with the environment described as a ‘culture of busyness’ 
(Nevalainena, et al. 2018 p27) and often very challenging (Shaw, et al. 
2011). These microsystems are also environments of constant change, 
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where innovation is not seen as part of the day job (Sheard, et al. 2017). 
In such environments, it can be postulated that innovation is not only the 
first element to go  (Kelly, et al. 2017), but that organisation instability 
often causes staff to take a defensive position that is resistive to change 
(Mueller, et al. 2012; Williams, 2011).  
 
Yet despite this, many staff surveyed commented there was much 
potential within the NHS, they wanted to engage, and gave examples of 
good practice. This is something again echoed within the literature which 
highlights that not only do staff have ideas that could improve healthcare 
(Kelly, et al. 2017), but positive deviant cases can achieve change 
(Sheard, et al. 2017). That said, almost all respondents stated they did 
not think their organisations or their local health and care economy was 
well equipped to support innovation. They highlighted the lack of 
conceptual understanding around innovation, and more generally the NHS 
culture, leadership, and paucity of systems and structures in place as 
barriers to innovation. This corroborates others understanding of the 
barriers and enablers to innovation adoption and spread now emerging 
(Greenhalgh, et al. 2004; Dixon-Woods, et al. 2013; Moullins, et al. 2015; 
Collins, 2018). It is perhaps not surprising that evidence is emerging that 
the UK is now falling behind other high-income countries in relation to 
innovation (Welcome Trust, 2016), with the pace and scale of change is 
dangerously slow with serious repercussions for NHS reforms 
(Bienkowska-Gibbs, et al. 2016). Indeed, it appears something is being 
lost in translation (Youth Health Parliament, 2016). 
 
2.2.5 Lost in translation 
It could be hypothesised that at the macrosystem level policy-makers 
recognise the importance of positioning the UK within the GIS and are 
actively supporting the development of the NIS to maximise the 
advantage this confers (Welcome Trust, 2016). Innovation Health and 
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Wealth (DH, 2011) articulates the ambitious high-level plan to embed this 
in the NHS, although evidence of progress is still weak (Bienkowska-
Gibbs, et al. 2016). In the exosystem, NHSE and AHSNs are committed to 
developing new pathways to market; ensuring patients and healthcare 
practitioners have seamless access to the latest innovations that can 
impact patient care (Welcome Trust, 2016; Marjanovic, et al. 2018). 
Although individual clinicians are without doubt, important as end-users of 
innovation, most work within the microsystem, with limited influence 
beyond their immediate spheres (Moser, 2018). There is developing 
recognition that macrosystem strategy ignores the role of NHS trusts, 
where most innovations are utilised (Williams, 2011). Indeed, even the 
approach is struggling to engage supply-driven, budget focused NHS 
trusts, (Castle-Clarke, et al. 2017). Thune, et al. (2016) suggests that 
NHS trusts are ‘hidden innovation systems’, seen as a context for 
innovation, rather than partners in delivering healthcare reforms.  
 
Innovation diffusion literature suggests that if the barriers to innovation 
adoption and spread are to be addressed, focus needs to shift away from 
individual clinicians, to the organisations themselves (Greenhalgh, et al. 
2005). This concurs with implementation theory, which suggests that 
where individuals work collectively at the organisational level, the impact 
can be greater than the efforts of individuals alone (Weiner, 2009). If the 
role of the mesosystem is identified as crucial to innovation within 
healthcare, it is essential that those tasked with leading innovation within 
healthcare organisations have a conceptual understanding of what 
innovation is within the organisational context, and how innovation-
friendly environments might be created (Marjanovic, et al. 2018). These 
two concepts are explored in the next sections. 
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2.3 Conceptualising innovation  
The definition of innovation has already been identified as a conundrum, 
variously described and defined in healthcare policy as both a specific 
product (DH, 2011), or as an axiomatic concept underpinning policy 
(Farchi, et al. 2016). Exploring dictionary definitions exemplifies the 
problem, where the stem ‘innovat*’ can be used as a noun, verb and 
adjective amongst others (Table 2.1). 
 
Table 2.1 Definition and meaning of innovation 
 
(Collins English Dictionary, 2019) 
Innovation noun (‘The use of’) a new idea or method 
Innovate verb To introduce changes and new ideas 
Innovative adjective Using new methods or ideas  
Innovativeness noun The quality of being innovative  
 
Maher, et al. (2010), suggest that there is little to be gained from 
debating definitions and identify a broad axiomatic definition of 
innovation. 
 
‘Doing things differently and doing different things, to create a step 
change in performance.’ 
(Maher, et al. 2010 p6) 
 
Pragmatically, this simple definition is useful, particularly within an NHS 
trust environment, where in-depth level of conceptual understanding is 
irrelevant. In the research context, however, this lack of specificity is 
problematic, different interpretations of meaning are often associated with 
different underlying methodological assumptions, making any 
generalisations drawn from research unreliable (Rye, et al. 2007; Robert, 
et al. 2009). If the results of research are to be useful, a conceptualisation 
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of ‘innovation’ within the context of the study must be identified (Walker, 
2014).  
 
This poses a challenge, as there is an acknowledged lack of robust 
innovation definition within the public sector literature (De Vries, et al. 
2016), but the healthcare sector is not alone in facing this conundrum. 
Although it is widely agreed that ‘innovation’ is important and necessary, 
its meaning is subject to much academic debate (Skillicorn, 2016), with 
even the use of the word criticised (Berkun, 2013). The business 
community has a vested interest in this area, believing that ambiguity 
over consensual definition for innovation creates confusion for managers 
and researchers, and ultimately impacts on business itself (Baregheh, et 
al. 2009). In a literature review on definitions of innovation, Baregheh, et 
al. (2009) present a multidisciplinary definition of the ‘essence of 
innovation’, a multi-faceted, non-linear, and non-hierarchical process that 
incorporated six key attributes (Figure 2.1). 
 
Figure 2.1 The process of innovation 
 
 
(Baregheh, et al. 2009 p1334) 
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This is augmented by a textual definition 
 
‘Innovation is the multi-stage process whereby organisations 
transfer ideas into new/improved products, services, or processes, 
in order to advance, compete, and differentiate themselves 
successfully into their market place.’   
(Baregheh, et al. 2009 p1334) 
 
Even when a definition is agreed, debate exists as to whether it may be 
transferable between disciplines (Baregheh, et al. 2009). Although this 
integrative textual definition is designed to provide a definition that can 
support transfer of knowledge across disciplinary boundaries, the authors 
caveat this with the notion that their model is conceptual, developed from 
within the business literature, thus further context specific refinement 
may be required if used outside this sector. To support this, they suggest 
exploration of the six key attributes and their descriptors (Table 2.2). 
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Table 2.2 The six key attributes of the innovation process 
 
(Baregheh, et al. 2009 p331-1332) 
Stages of innovation all the steps taken during an innovation process 
which usually starts from idea generation and 
ends with commercialisation 
Social context any social entity, system or group of people 
involved in the innovation process or 
environmental factors affecting it 
Means of innovation the necessary resources e.g. technical, creative, 
financial) that need to be in place for innovation 
Nature of innovation the form of innovation being something new or 
improved 
Type of innovation the kind of innovation as in the type of output or 
the result of the innovation (e.g. product or 
service) 
Aim of innovation the overall result that organisations want to 
achieve through innovation 
 
Although less succinct, this resonates within high-level healthcare policy 
where there is recognition that innovation is a ‘process’ (textual 
definition), that it might be ‘an idea, services or products’ (type), ‘new to’ 
or ‘applied in a new way that is new’ (nature), with ‘three important 
stages’ (stages) important for improving patient outcomes, quality and 
productivity and economic growth (market place) (DH, 2011 p9). The 
conceptual definition and the six key attributes therefore appear to be 
useful for exploring innovation within the context of healthcare literature. 
 
2.3.1 The creativity process: nature, type and stage 
The three attributes, nature, type and stage can be link together directly 
through the creativity process (Martins, et al. 2003), where idea 
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generation, development and implementation can be described through a 
simple linear model (Efrat, 2013) (Table 2.3). 
 
Table 2.3 The creativity process 
 
(Efrat, 2013) 
1 Ideation Invention, idea generation, tested within research and 
development, which may or may not proceed.  
2 Innovation Development of proven inventions for 
commercialisation, either internal or external to 
research and development. 
3 Adoption Taking a novel innovation out to the market, which to be 
successful requires support from a wider network, NIS  
 
In the NHS context there does not seem to be any shortage of ideas, with 
recognition that there are ‘brilliant people with brilliant ideas’ working 
amongst its ranks (DH, 2011). There are barriers to ideation, however, 
with recognition that ideas require time, capacity, and energy (Maher, et 
al. 2010a), creating a workforce capability to support innovation is 
essential (DH, 2011). Yet, identifying problems and creating solutions is 
rarely built into clinicians roles (Castle-Clarke, et al. 2017), and given the 
‘busyness’ culture, this subsequently impacts on the innovation pipeline 
(NHS, 2019). But, if innovation is seen as a process, ideation refers to the 
invention stage and represents newness (Robert, et al. 2009). The nature 
of innovation is therefore considered as a new idea, new to or applied in a 
new way to the NHS (DH, 2011). 
 
If nature can be understood, innovation type is more problematic. Thune, 
et al. (2016) states that some view innovation as medical objects, others 
as medical practices, and others again as medical problems. Other authors 
note that national policies use terms such as ‘incremental, radical, and 
transformative’ to distinguish innovation typologies (Osborne, et al. 2011 
p1339). De Vries, et al. (2016 p153) categorises public sector innovation 
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into four themes: Process (sub-divided into administrative and 
technological); product or service innovation; governance innovation and 
conceptual. This does not though cover all innovation types; a fifth 
category ‘other’ was required to include such innovation types as 
behavioural components (De Vries, et al. 2016). 
 
It could be postulated that incremental innovation could be included within 
this ‘other’ category. Small-scale, often unrecognised micro-innovations 
take place every day within the workplace, recognised within business 
literature as capable of generating huge economic worth (Pisano, 2019). 
As continuous incremental innovation is understood within the ethos of the 
healthcare system (Maher, et el. 2010), this perhaps explains the policy 
focus on this area of innovation with some hypothesising that managing 
the two concepts of innovation and quality improvement together might 
be a way to optimise impact (Marjanovic, et al. 2018). Indeed, some 
might wonder if there is a difference when published definitions of quality 
improvement include a ‘systematic approach’ though ‘iterative change, 
continuous testing, and measurement’ (Jabbal, 2017).  
 
This is not without controversy though, although healthcare policy and 
literature might conflate incremental innovation and incremental 
improvement, to convey a general meaning of positive progression 
(Osborne, et al. 2011) there are important differences. Quality is defined 
through three concepts; safety, effective care, and patient experience 
(Taylor, et al. 2017). If care is known to be safe and effective, logically 
there must be an underpinning evidence-base, one that can be 
benchmarked and audited against. Osborne, et al. (2011) stress that 
innovation is about newness, and as such is inherently risky; if an 
innovation is tried and found to be unsuccessful, it must cease; conversely 
if successful, discontinuation of current practice would be required. This 
fundamentally makes the management of an incremental innovation a 
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different proposition from the management of a quality improvement, thus 
conflation of these concepts is conceptually flawed (Osborne, et al. 2011).  
 
It appears there is no one ‘type’ of innovation within healthcare, with 
conceptual definitions differing or even intertwined to create ‘hybrid’ forms 
(De Vries, et al. 2016). This is not necessarily detrimental and there may 
be market advantages to engaging in innovation in this wide-ranging way 
(Rowley, et al. 2011). In this thesis, ‘type’, will be considered within the 
common categories identified within public sector literature: process 
(administrative and technological); product or service innovation; 
governance innovation and conceptual, with recognition of ‘other’, which 
includes continuous or incremental innovation.  
 
In a similar vein, innovation stage is problematic, with criticism levelled at 
public sector policy for utilising a simple linear model adopted from the 
manufacturing sector (Osborne, et al. 2011). Even if the first and second 
stages of process are considered to be clearly defined and supported by 
the NIS, there is recognition that existing health research paradigms 
remove innovation from the real-world NHS context, delivering evidence 
that both fails to translate across into practice or deliver in a timely 
fashion (Castle-Clarke, et al. 2017). This concept is corroborated by the 
growing body of empirical evidence around the barriers to adoption and 
spread (Collins, 2018; Horton, et al. 2018). This second translation gap is 
a long-established concept (Cooksey, 2006), and a whole work stream of 
the NIHR has been dedicated to implementation research, with a varied 
degree of success (Caldwell, et al. 2012). Thune, et al. (2016 p1546) 
describe how hospitals act as ‘central nodes’ in the process, undertaking 
key roles and engage at all stages of the innovation, but highlight the 
iterative cyclical nature of this process, with multiple feedback loops and 
redevelopment (Figure 2.2). This notion of complex process is supported 
by other authors (Greenhalgh, et al. 2016; Robert, et al. 2009) and so is 
adopted for this research. 




Figure 2.2 Hospitals as central nodes for innovation 
 
  
(Thune, et al. 2016 p1546) 
 
The healthcare literature regarding the nature, type, or stage of 
innovation is highly heterogeneous; there appears to be no uniformly 
agreed definitions (Greenhalgh, et al. 2005). They have been 
conceptualised here for this research and are now acknowledged as 
important for a number of reasons. Not only are these concepts often 
used in lieu of a formal definition of innovation (De Vries, et al. 2016), but 
conceptualising innovation is essential for identifying the risk involved and 
the management support required (Osborne, et al. 2011).  
 
It could be hypothesised that having a conceptual understanding of 
innovation as this creative process, and knowledge of how an innovation is 
conceived and might be described is fundamentally essential to developing 
an understanding of organisational innovativeness and thus a key 
objective of this this research. In addition, all innovation requires 
resources, conceptualisation of nature, type and stage is essential to 
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understanding the organisational resource required to develop an 
innovation (Pisano, 2019). Baregheh, et al. (2009) explore this in more 
depth via the key attribute of means, discussed next. 
 
2.4 Means  
The ‘means of innovation’ describes the resources required for innovation, 
technical, creative, and financial (Baregheh, et al. 2009). Robert, et al. 
(2009) however, describe the means as an organisation’s physical 
structure, the hard antecedents that support innovation, such as 
organisational size, and complexity, this is explored in more detail.  
 
Historically an unwritten law that large organisations cannot be innovative 
is recognised, possibly because as organisations grow in size and 
maturity, they become more structured, less spontaneous and more risk-
averse; as a result their culture changes, with a profound effect on 
innovation (Pisano, 2019). Size is typically measured using number of 
employees as a proxy (Walker, 2014); NHS trusts, employing thousands 
of staff, are by definition large organisations, a factor that might then 
explain the healthcare barriers to innovation. There is however growing 
recognition from the private sector that this rule does not apply in the 
modern world, (Pisano, 2019), coupled with evidence within healthcare 
literature of a small, but positive correlation between organisational size 
and innovativeness (Robert, et al. 2009).  
 
One proposition that accounts for this phenomenon is the notion that 
larger organisations have more ‘organisational slack’, the opportunity to 
flex budget surplus, engage larger numbers of talented employees and to 
spread new ideas (Walker, 2014 p32). This is coupled with a positive 
association to organisational complexity, defined by numbers of 
specialisms and units (Greenhalgh, et al. 2005), thought to support 
opportunities for the cross-fertilisation of ideas (De Vries, et al. 2016). 
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Organisational slack has also been positively associated with 
administrative capacity, the processes, and systems required for the 
adoption of innovation (Walker, 2014). This has to be considered 
cautiously; it has also been identified that organisations with a large 
number of homogenous employees may not always have an advantage in 
innovation and indeed professionalism has been negatively associated 
with the adoption of innovation technology in a healthcare setting (Robert, 
et al. 2009). Castle-Clarke, et al. (2017) linked this to several factors 
including a perceived threat of autonomy, professional judgement or the 
lack of an entrepreneurial culture.   
 
There are two other important points to note; the first is the criticism of 
the methodological rigour of the research in this area, which limits 
generalizability; second, that the structural determinants of innovation are 
largely explored as independent variables, meaning any joint effects or 
non-linear effects are not fully explored or understood (Walker, 2014). 
Indeed, as cash-strapped healthcare organisations can exert no control 
over factors such as size, funding or professionalism these influences are 
acknowledged as important to conceptualisation of understanding 
innovation, but provide little support for how the innovation-friendly 
environment can be developed.  Baregheh, et al. (2009) descriptor of the 
‘social attribute’ includes the organisational environmental factors that 
support innovation. 
 
2.5 The social attribute 
Innovation is ‘an intensely and uniquely human activity’ (Pisano, 2019 
p.223), a key element is the creativity of individual actors and their 
interactions within their social environments (Greenhalgh, et al. 2005). 
The healthcare ecosystem has been described as a complex network with 
indistinct boundaries, filled with individual autonomous actors 
(Greenhalgh, et al. 2005), whose actions impact within and change the 
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context of the whole. Such systems have porous boundaries, are adaptive, 
with multiple feedback loops, responding to external pressures, organised 
around competing internal demands (Robert, et al. 2009). In these 
environments, rational controlled planning models may not always work 
(Plsek, 2003) and progress might be dependent on the social context 
(Greenhalgh, et al. 2005).  
 
Robert, et al. (2009) in their comprehensive review of organsiational 
factors that influence technology adoption, identified six broad themes 
that work together within this complex social ecosystem that affect 
technology adoption (Table 2.4).  
 
Table 2.4 Factors that affect technology adoption 
 
1 The innovation itself 
2 The adoption process 
3 Communication and influence (incuding social networks, opinion 
leaders and change agents) 
4 The ‘inner (organisation) context’ 
5 The outer (inter-organisational) context 
6 The implementation/sustainability process 
(Robert, et al. 2009 p22) 
 
Three of these elements are the innovation, and its stages (adoption, 
implementation) which have already been discussed in the creativity 
process (section 2.3.1). The third factor, communication and influence 
might be considered integral to complex systems and thus is implicitly 
addressed.  The fourth and fifth factors of the the inner and outer context 
however, warrants further exploration when considering the social 
attribute,  particularly their influence on developing organsiational 
innovation, also described in the literature as the anteceedents for 
innovation.   
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Antecedents of innovation can be described as context specific features 
known to positively or negatively influence the innovation process and 
have been defined within four levels: environment, organisation, 
individual, and the innovation itself, with little difference between stages 
of innovation (De Vries, et al. 2016; Fleuren, et al. 2004). The 
environmental antecedents are associated with the outer context  
described by Robert, et al. (2009), although the focus of this thesis is 
organisational innovativeness, Greenhalgh, et al. (2005) points out that 
the outer context appears to have a large effect on decision-making within 
the inner context, and therefore merits some discussion. 
 
2.5.1 Outer context 
Features of the outer contact or environmental antecedent include: 
external pressures; networks and inter-organisational relationships; 
regulatory aspects and market competition (De Vries, et al. 2016), with 
external pressures applied from political, media, and public demands. The 
political element strongly resonates with the policy imperative already 
described (section 2.2.1). The National Innovation Systems expectation of 
organisational engagement has already been identified and might explain 
why NHS trusts are assimilating innovation into their strategies. There is 
also increasing recognition of the importance that the media and public 
play as ‘powerful stimulants for innovation’ in healthcare (West, et al. 
2017 p13), which until recently were unrecognised within public sector 
innovation strategy (Marjanovic, et al. 2018). As healthcare moves 
towards an age of personalisation, collaboration with patients and their 
representatives is now seen as fundamental to achieving success 
(Welcome Trust, 2016). Businesses invest heavily in understanding both 
their customer base and their experiences; this is identified as a key 
lesson public sector innovation could learn from industry (Ling, 2002). It 
is accepted that all these elements have a direct impact on the inner 
context. 




2.5.2 The inner context 
The fourth theme, ‘the inner context’ pertains to organisational level 
(Greenhalgh, et al. 2005); understanding this is essential, as the 
mesosystem exerts more pressure than its external counterparts (Walker, 
2014). The ‘organisational climate’ is an umbrella term that brings 
together eight components of organisational nature that support 
organisational innovativeness including the informal organisation and its 
routines, the environments for receiving innovations, and knowledge 
management capacity (Greenhalgh, et al. 2005 p150). Robert, et al. 
(2009 p87), synthesise this into a conceptual model, which demonstrates 
the complex relationship between this organisational climate and the 
creativity process (Figure 2.3). There is conceptual similarity between this 
model and features of Baregheh, et al’s. (2009) definition of innovation as 
a process, such as the creativity process and resources, it is therefore 
considered a useful tool for this research.  
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Figure 2.3 Conceptual model of the determinants of innovations 
 
 
(Robert, et al. 2009 p87) 
 
Specifically, this model identifies the system antecedents for innovation 
describing them as either the ‘hard’ visible structures or means already 
discussed (Section 2.4) or the ‘soft’ mediums of the culture and ways of 
working (Robert, et al. 2009 p24). The soft antecedents are summarised 
into two concepts; ‘absorptive capacity for new knowledge’ and the 
‘receptive context for change’. Although these are explored separately, it 
is accepted that concepts are broad and overlapping (Robert, et al. 2009).  
 
2.5.3 Absorptive Capacity (AC) 
Cohen, et al. (1990) described absorptive capacity (AC) as a firm’s ability 
to recognise and adopt new knowledge to bring value to the organisation. 
As most innovations are ‘borrowed’ from other organisations, 
understanding the known, and recognising the new and being able to 
assimilate it, is therefore essential to organisational innovativeness 
(Easterby-Smith, et al. 2008). This ability to adapt, in addition to adopt, is 
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also gaining momentum in the healthcare sector (Horton, et al. 2018; 
Castle-Clarke, et al. 2017). Robert, et al. (2009) summarised AC into four 
central components for technology adoption (Table 2.5).  
 
Table 2.5 Components of absorptive capacity 
 
(Robert, et al. 2009 p84) 
existing knowledge and skills base 
pre-existing related technologies 
a ‘learning organisational’ culture 
proactive leadership to enable the sharing of knowledge 
both internally and externally  
 
A comprehensive citation base on AC within healthcare does not exist, 
perhaps because as Cohen, et al. (1990) discuss, AC is intangible and the 
benefits indirect. Several other authors, however, reference the concept, 
identifying it as an essential element of knowledge management and 
learning organisations (Williams, 2011; Castle-Clarke, et al. 2017; De 
Vries, et al. 2016; Walker, 2014).  
 
Knowledge itself is a nebulous concept, with a wide variety of types 
utilised within the professional healthcare context including scientific, 
experiential, and tacit knowledge (Barnfather, 2013). Production, 
management and transference of knowledge is acknowledged as 
problematic in large organisations, particularly so within busy complex 
ecosystems, or in relation to tacit or unspoken knowledge often associated 
with healthcare professionals and technology (Barnfather, 2013). Sackett, 
et al. (2000) hypothesised that doctors develop routines for the 
management of frequently encountered clinical conditions; first in medical 
school, but then repeated as postgraduate trainees under the supervision 
of consultants. Later as the clinician develops, knowledge may be modified 
based on experience, but it’s far less common for clinicians to seek 
support from guidelines, created on best evidence of others. Williams, 
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(2011) corroborates this, adding that clinicians distrust sources that are 
unfamiliar or distant; perhaps one reason for this is professionals feel their 
clinical judgement is challenged when asked to change and adopt new 
practices developed elsewhere (Castle-Clarke, et al. 2017). This makes 
the adoption of innovative practices problematic. 
 
Innovation has been identified as a socially constructed human activity; 
communication is an essential component of this process. Rye, et al. 
(2007 p247) refers to this as ‘connectedness’, embedded social 
communication networks that facilitate the swift transfer of information 
from individuals across systems supporting innovation adoption. The NHS 
however, is acknowledged to work in silos (Castle-Clarke, et al. 2017), 
proactive initiatives are required by organisations to improve their 
knowledge management, including the development of internal, and 
external communication networks (Cohen, et al. 1990). Internally,  
publishing case studies, creating clinical groups, or sharing forums with 
identified individuals as ‘boundary spanners’ (Castle-Clarke, et al. 2017 
p7), working across groups, and spreading innovation prevents this silo 
working and is suggested to open up the organisational learning culture 
(Williams, 2011). Externally organisations need to look to the RIS, 
supported by the AHSNs, who lead on the development of networks and 
communities of practice (Marjanovic, et al. 2018). 
 
Organisational stability is positively associated with the development of 
organisational AC (Williams, 2011); conversely organisational change is 
identified as having a negative influence (Castle-Clarke, et al. 2017). The 
frequently changing healthcare ecosystem has already been noted, and as 
Williams (2011) points out, experience and memory are powerful and 
long-lasting forces, that can destabilise progress. This is harder to address 
and slow to change, and impacts directly on developing an organisational 
receptive context for change. Robert, et al. (2009) present two core 
elements for the receptive context for change, leadership and culture, 
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both concepts are recognised within other healthcare innovation literature 
(Maher, et al. 2010; West, at al. 2017) and within other sectors, such as 
the educational (Dearnley, et al. 2013) and business environments 
(Pisano, 2019). Their impacts are considered significant in the context of 
an innovative organisation and are explored further. 
 
2.5.4 Leadership  
The importance of leadership within the NHS is well understood, the NHS 
Leadership Academy promotes the idea that better leadership delivers 
better care (NHS Leadership academy 2017). Leadership for innovation is 
much discussed within the healthcare literature (Maher, et al. 2010; 
Walker, 2014). Innovation, as a human activity, requires creative 
individuals that break through the risk-averse environments of public 
sector administration, empowered autonomous employees is a significant 
aspect of this process (De Vries, et al. 2016); leaders have significant 
roles to play (Greenhalgh, et al. 2004). How this might be achieved, 
however, has only recently been presented (West, et al. 2017). West, et 
al. (2017) highlights the shift within healthcare from hierarchical 
leadership models to a collective approach and the beneficial 
consequences that has for empowering innovation. The role of the 
‘compassionate leader’ is clearly articulated, through four key elements: 
attending, understanding, empathising and helping.  
 
Although human factors can be managed and supported by compassionate 
leaders, change carries an element of risk and NHS organisations are 
known to be risk adverse (Albury, 2005). Psychological safety is identified 
as an essential cultural requirement for innovation (Pisano, 2019), so 
leaders who can infer this to staff and support safe risk-taking, are 
essential to the process (Williams, 2011). Likewise, failure is a recognised 
component of innovation, an empathetic leader will understand staff 
frustrations, support learning from the process and encourage the next 
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steps in innovating (West, et al. 2017). Achieving this is acknowledged as 
problematic; the NHS is under constant political, economic and social 
pressure, contributing to claims that its culture is ‘institutionally deaf, 
bullying, defensive and dishonest’ (Pope, 2019 p45).  
 
Another key issue in the public sector are the resources necessary for 
innovation; this might be time or financial resources, leaders are not only 
in a position to agree the necessary time, but also to identify routes to 
achieve the other necessary resources (Maher, et al. 2010). NHS 
organisations are high-pressure environments, the relationship between 
environmental pressure and creativity is non-linear, typically described as 
an inverted ‘u-shape’; although a certain amount of pressure is necessary 
to develop the need to problem solve and change, if pressure is excessive, 
innovation is stifled and activity drops (Walker, 2014). Healthcare 
managers need to be attuned to this and have the ability to flex with and 
control the situation (West, et al. 2017). They also have a significant role 
in maintaining the motivation of staff and embedding innovation as the 
norm within these environments (Greenhalgh, et al. 2004). 
 
Leaders operate as both a collective and as individuals within 
organisations, and have a disproportionate influence in the development 
of the organisation’s innovation culture (Maher, et al. 2010). Business 
theory has recognised the important role of the ‘creative constructive 
leader’ in innovation (Pisano, 2019 p222), further identifying that leaders 
need to be ‘Culture Warriors’, vigilantes who guard their organisation’s 
innovation culture, keenly aware of both its importance and how quickly it 
can be destroyed.  
 
2.5.5 Organisational culture for innovation (CfI) 
Organisational culture has been described as powerful force that must be 
recognised and understood (Schein, 2004), having a greater impact on 
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desired outcomes than both structure and strategy (Hogan, et al. 2014). 
First associated with scientific inquiry by Pettigrew, (1979), organisational 
culture is a popular concept within behavioural and management science 
(Hogan, et al. 2014) with emergent theory of organisation culture drawing 
from psychology, social psychology and anthropology roots and describes 
a wide range of social phenomena. Organisational culture identifies shared 
language, behaviours, values, and beliefs as an expression of an 
organisation’s character, with individual actors supporting diffusion 
through social interactions (Scahill, et al. 2009; Scott, et al. 2003).  
 
The term ‘organisational culture’ is nebulous and complex; definitions 
range from ‘the way we do things around here’ (Scahill, et al. 2009; 
Davies, et al. 2000) to ‘an anthropological metaphor used to inform 
research and consultancy to explain organisational environments’ 
(Parmelli, et al. 2011). A popular definition appears to be the ‘essence of 
culture’ defined by Schein (2004) (Scahill, et al. 2009; Mannion, et al. 
2008; Scott, et al. 2003; Parmelli, et al. 2011).  
 
‘a pattern of shared basic assumptions that was learned by a group 
as it solved its problems of external adaption and internal 
integration, that has worked well enough to be considered valid 
and, therefore, to be taught to new members as the correct way to 
perceive, think, and feel in relation to those problems’  
(Schein, 2004 p17) 
 
This is a widely recognised definition within healthcare literature, but 
usefully it identifies both group and individual member’s behaviour. In 
doing so this recognises of both the mesosystem and microsystem. This 
definition also acknowledges the relationship between external adoption 
and internal integration, and thus the relationship between the inner and 
outer context. It is therefore considered useful to support 
conceptualisation of organisational culture within this thesis. 




The link between organisational culture and creativity is well established 
(Efrat, 2013; Hogan, 2014; Martins, et al. 2003; Harrington, et al. 2005). 
Pisano, (2019 p181) describes an organisation’s culture as its ‘software’, 
becoming a ‘shadow system’ shaping how the ‘hardware’, formal systems, 
run. There is evidence that organisational culture is linked to performance, 
the risk adverse nature of NHS culture does not lend itself to creativity 
(Albury, 2005), however, changing an organisation’s culture, could 
achieve positive benefits (Mannion, et al. 2008). There is, however, a 
paucity of evidence regarding both the measurment of culture,  or 
effective change stratgies (Parmelli, et al. 2011). One reason for this is 
that the understading of culture is implicit, predicated on the tacit 
knowledge of the experts within that system, rather then explict (Plsek, et 
al. 2007). Greenhalgh, et al. (2004) reflects on the importance of the 
culture for innovation (CfI) and the difficulties of creating this in NHS 
organisations, stating that there are no magic ingredients for success. 
 
Addressing this and developing an understanding of what makes 
innovation-friendly environments, and how they might be grown within 
healthcare organisations remains problematic (Fleuren, et al. 2004). 
Maher, et al. (2010), acknowledging that the healthcare evidence in this 
area was poor, drew from a much broader literature base from outside the 
healthcare sector, then using a pragmatic ‘design science’ approach, 
identified 27 constructs, organised into seven dimensions of supportive 
factors of the CfI (Figure 2.4).  




Figure 2.4 Dimensions of culture for innovation (CfI) 
 
 
(Maher, et al. 2010 p9) 
 
These dimensions can then be considered the characteristics of the 
‘culture for innovation’ within NHS organisations summarised as: risk-
taking; resources; knowledge; goals; rewards; tools; relationships. Each 
is then explored in detail, presenting its evidence-base and activities that 
can be undertaken to support development and measure impact (Maher, 
et al. 2010), thus providing a useful theoretical framework for exploring 
and measuring CfI within NHS organisations. Although the tool was 
successfully piloted and validated within NHS trusts, no subsequent 
publications have been identified to provide any benchmark data. 
 
2.5.6 Individuals within the system 
The social attribute also acknowledged the role of individuals within these 
social systems, the groups or collectives they form and the culture they 
create (Baregheh, et al. 2011). Robert, et al.’s (2009) conceptual model 
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(Figure 2.3) identifies as key elements within the inner context both the 
organisation and individual, and highlights the interactional relationship 
between them. In the discussion on leadership and culture the role of both 
the organisational and individual is implicit, it is now made explicit. De 
Vries, et al. (2016) identify nine individual level antecedents of innovation 
(Table 2.6), acknowledging the role of ‘creative individual entrepreneurs’, 
empowered to break through the organisational norms. 
 















(De Vries, et al. 2016 p158) 
Employee autonomy (empowerment) 
Organisational position (tenure, mobility) 
Job related knowledge and skills (professionalism) 
Creativity (risk-taking, solving of problems) 
Demographic aspects (age, gender) 
Commitment/satisfaction with the job 




These soft antecedents all work together within the inner context, 
identified as having influence on the likelihood of innovation being 
undertaken and assimilation into business as usual (De Vries, et al. 2016). 
Change will not occur however, if the system is not willing and able to 
change, a concept recognised as ‘Organisational Readiness for Change’ 
(Robert, et al. 2009). 
 
2.5.7 Organisational Readiness for Change (ORC) 
The literature on innovation has much in common with that of change 
management (Ling, 2002), which identifies Organisational Readiness for 
Change (ORC) as an essential element for successful change 
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implementation within complex healthcare systems (Weiner, 2009). There 
is a growing citation network that ORC is an important antecedent of 
innovative behaviour in healthcare (Kelly, et al. 2017; Williams, 2011). 
ORC has been theorised as multi-level and multi-faceted organisational 
level construct, that can be described as a psychological state, where 
organisational members’ share a collective determination to implement a 
change (change valance), and a belief in their collective capacity to deliver 
(change efficacy) (Weiner, 2009). This supports two notions previously 
postulated, that innovative organisations can achieve more impact, than 
individuals working alone (Weiner, 2009; Ling, 2002), and that the 
antecedents of innovation may make an organisation amenable to an 
innovation, but not ready or willing to assimilate it into routine practice 
(Greenhalgh, et al. 2004).  Baregheh, et al. (2009) links this to the 
importance of an organisation sharing a collective aim for innovation, 
including articulating market value, advantage and success. This is the 
final attribute of their model and explored in more detail next.  
 
2.6 The aims of innovating 
Baregheh, et al.’s (2009) definition of innovation postulates that the aim 
of innovation is what an organisation wants to achieve through innovating. 
Pisano, (2019) states that it is not good enough to articulate a general 
desire to be good at innovation and believe that this positive message will 
achieve impact, to add value the purpose behind innovating must be 
clearly described and understood, and supported (Pisano, 2019). Yet, 
even within the business literature it seems little written in this regard, 
Baregheh, et al. (2009) conclude that the aim of innovation maybe a 
taken for granted assumption.  
 
Greenhalgh, et al. (2004) concur that a clear strategic vision for 
innovation within the health sector is required, supported by Maher, et al 
(2010) who identify ‘goals’ as a key dimension of the CfI (Figure 2.4), yet, 
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whilst there is a lot of rhetoric referring to the need for innovation in 
macrosystem policy, a clear statement regarding why NHS trusts should 
innovate has not been identified. Indeed, De Vries, et al. (2016) report 
from their literature review of 267 papers on public sector innovation, that 
identification of innovation goals was absent in over a third (35%) of the 
those that did state a goal, the most common equated to improving 
performance denoted by effectiveness (18%), or efficiency (15%), 
especially within the UK heath sector. This relates directly to the policy 
imperative for innovation in order to deliver economic and service benefits 
(section 2.2.1). Pisano, (2015) whist agreeing with the need for a goal 
focused innovation strategy acknowledges the connectivity of this to an 
organisations business model. Although the policy definition for innovation 
(DH, 2011) was previously linked to the marketplace (section 2.3), this 
macrosystem policy has been criticised for the suitability of applying 
innovation theory from outside the healthcare sector (Osborne, et al. 
2011), with the suggestion that as NHS trusts are public sector 
organisations, these goals may not be directly relevant, and other models 
should be explored. 
 
2.6.1 Social innovation 
In the years since the economic recession, there has been a decline in the 
welfare state, with reforms in the public sector driven by the need to 
create the most cost effective models of service provision (Hazenberg, et 
al. 2016a). This has allowed public sector employees to ‘spin-out’ from 
public sector control becoming employee-owned ‘mutual’ organisations 
(Hazenberg, et al. 2016a). These hybrid organisations are often referred 
to as social enterprises and have merged boundaries within the healthcare 
sector, (Millar, et al. 2012). Encouraged and developed through national 
policy directives, social enterprises can be considered as organisations 
that provide public sector services, such as healthcare, that are not within 
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the public sector and where stakeholder control, public and employee, 
play a significant role (Hazenberg, et al. 2014).  
 
As these organisations do not fall under the control of the public sector, 
they have more decision-making freedoms, a particular distinguishing 
difference from their public sector counterparts; one aspect of which is 
how surplus income generated can be used, including supporting 
innovation (Shaw, et al. 2013). Social enterprises have been categorised 
as ‘hybrid organisations’, organisations which span institutional boundaries 
(Doherty, et al. 2014) and are suggested as being more innovative and 
responsive organisations from their conceptualisation providing a real 
alternative for service users and healthcare staff (Millar, et al. 2012). In 
these social enterprises, there is a developing dissatisfaction with 
mainstream definitions and models of innovation; the term ‘social 
innovation’ is postulated as a solution (Vickers, et al. 2017 p1756). Social 
innovation is a holistic innovation model, which draws on the positionality 
of social enterprise as hybrid organisations that are able to mobilise 
resources creatively for mutual benefit. Although theory in this area is still 
emergent this conceptualisation could have major benefits, not just within 
the emerging world of social enterprise, but also for NHS organisations 
(Shaw, et al. 2013). Indeed, maybe it is time that the NHS starts thinking 
like a ‘start-up’ (Youth Health Parliament, 2016); developing an innovation 
strategy that can respond to its mesosystem might be an appropriate 
place to start. 
 
2.7 Chapter summary 
This research acknowledges the problems faced by those within NHS 
trusts tasked with leading the development of innovation. It aims to 
contribute to the theory base of how ‘innovation’ is perceived and 
‘organisational innovativeness’ is understood within healthcare, as well as 
how it can be developed. Scrutiny of the literature concurs with previous 
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findings, reaffirming the heterogeneous nature of the evidence-base 
around innovation (Greenhalgh, et al. 2005). Although a large quantity of 
texts were identified referring to innovation within the public sector or 
healthcare context, there is no prevailing citation body (De Vries, et al. 
2016). The number of empirical research publications in this cohort was 
small; a significant number of texts either discussed a specific innovation 
or reiterated the policy rhetoric that innovation is necessary to meet the 
future demands of healthcare, with limited contribution to theory 
development. There are a few seminal and widely quoted literature 
reviews specific to innovation in the UK healthcare context, most notably 
Greenhalgh, et al. (2005) and Robert, et al. (2009). Whilst useful, these 
focus on a single stage of the innovation process, adoption, rather than a 
holistic organisational understanding of innovation or innovativeness.  
 
The literature review also noted that authors are generally critical of the 
methodological rigour of public sector innovation research, highlighting 
the lack of a consistent definition of concepts and confusion over 
constructs within publications (Fleuren, et al. 2004; Walker, 2014). This 
lack of parity between concepts leads to a significant challenge in 
aggregating a cogent body of knowledge to support development in this 
field (Rye, et al. 2007; Fleuren, at al. 2004). The lack of clarity around 
innovation definition and the paucity of theory regarding innovativeness in 
NHS organisations are apparent, and the researcher postulates that this is 
perhaps one reason NHS trusts are not systematically or strategically 
articulating their organisational approaches to innovation (Thune, et al. 
2016, Williams, 2011).  
 
This literature review explores organisational innovativeness presenting 
the results in three sections, the first describes the healthcare ecosystem 
(section 2.1); this serves to place the ‘subject’ of this research, ‘the 
Trust’, within its contextual frame (Thomas, 2016). The second section, 
presents the policy requirement to innovate within this context (section 
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2.2) provides the analytical frame or the ‘object’ of this research (Thomas, 
2016). The final section (section 2.3-2.6) explores theoretical propositions 
(Yin, 2014) around innovation and innovative organisations. Two theories 
dominate this exploration; Baregheh, et al. 2009 conceptual definition of 
innovation and Maher, et al. 2010 Culture for Innovation model. 
 
Baregheh, et al. (2009) conceptual definition of innovation from the 
business literature, describes innovation as a context specific, multi-stage 
process, identified by six key attributes. These six key attributes are 
explored in depth with reference to healthcare through the 
conceptualisation of innovation (section 2.3), which discusses the nature, 
type and stage of innovation, the means (section 2.4), the social attribute 
(section 2.5), before exploring the final attribute of aims (section 2.6). 
 
These theoretical propositions raise questions regarding how ‘innovation’ 
is understood, what is the relationship between the antecedents of 
innovation within an NHS trust, and if these were identified and 
understood, how could organisational innovativeness be developed? 
Answering these questions has been identified as the objective of the 
research (section 1.2). The review also presented a model for the 
measurement and development of a Culture for Innovation (section 
2.5.5), validated within the healthcare sector (Mayer, et al. 2010). This 
evidenced based model highlights seven interrelated dimensions required 
to develop innovation at an organisational level, which collectively cover 
many of the complex elements of the social attribute (section 2.5), it is 
therefore identified as a key underpinning theory to address the questions 
postulated within this research.   The next chapter outlines the 
methodology through which these questions were then explored and this 
model used. 
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Chapter 3.  Methodology  
The methodology chapter of a research thesis follows logically from the 
propositions articulated in the preceding literature review. This section is 
designed to clearly articulate the methodological approach taken, in order 
that the reader can understand how the research was conducted, 
ultimately allowing an appreciation of how results were conceived, and 
conclusions drawn. Robert, et al. (2009) stated that future research 
regarding organisational innovation in the NHS should utilise a holistic in-
depth approach and acknowledge the complex multi-level systems of the 
NHS trust. The approach should include the role of formal and informal 
structures, politics, and policy, teams, and individuals, to take into 
account the unique environment of an NHS trust. Thomas, (2016 p23) 
states that a case study is about ‘seeing something in its completeness’, 
and identified this approach as particularly good for developing analytical 
insights, thus used for this research.  
 
This research is an instrumental mixed-method, single case study, with 
two embedded units of analysis undertaken from a critical realist 
perspective. The design is a correlation of methodological approaches 
presented primarily by Yin, (2014), Thomas, (2016) and Carolan, et al. 
(2015), augmented with other literature. To support methodological rigour 
this chapter first presents an overview of the approach used, before 
providing a more detailed description of the individual stages of the case 
study design: the situation of the research and researcher; determining 
the components of the case study design, the choice and delivery of the 
research methods employed and how the data was analysed (Carolan, et 
al. 2015). The final section then explores how the issue of quality was 
addressed. 
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3.0 The case study approach 
The case study has a long history of use across a range of disciplines, 
which establishes its usefulness as an approach for research (Yin, 2014). 
The approach is increasingly popular within healthcare where it is 
purported to accommodate multi-level, complex system research 
(Harrison, et al. 2017). A concise methodological description of the 
approach is essential to underpin any research, however, Carolan, et al. 
(2015) highlight that within healthcare the case study has a variety of 
descriptors, varying by the unit of analysis (case), the process (design) or 
indeed the product itself (the study), with the only uniting factor being the 
utilisation of mixed methods of data collection. In their review of 
healthcare case studies they identified the most commonly cited 
methodology  authors were  Yin, (2014) and Stake, (1995), further 
identifying Yin’s definition as more frequently cited (Carolan, et al. 2015).  
  
‘A case study is an empirical enquiry that  
• investigates a contemporary phenomenon (the ‘’case’’) in 
depth and within its real-world context especially when 
• the boundaries between the phenomenon and the context 
many not be clearly evident  
(Yin, 2014 p16) 
Healthcare organisations are situated within a real-world context and the 
complexity of the area of study has already been described (section 2.1), 
this definition thus presents an appealing approach. Although offering a 
useful, high-level conceptualisation of a case study, alone it confers no 
particular philosophy, methodology, or method (Carolan, et al. 2015). This 
adaptability can lead the unwary researcher to confusion and academic 
criticism (Yazan, 2015). The antidote to this is clarity regarding the 
ontological and epistemological lens through which the study was 
conducted (Harrison, et al. 2017). Carolan, et al. (2015) notes that this is 
often poorly described within the healthcare literature and suggests that a 
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structured framework (the ‘DESCARTE’ - DESign in Case Research in 
healThcarE model) is used to support articulation of the design, conduct 
and reporting of case studies, suggesting three sequential phases are 
addressed (Table 3.1). This has been used to inform the methodology 
section of this thesis. 
 
Table 3.1 Stages of the DESCARTE model 
 
Stage  1 The situation of the research and researcher 
Stage  2 Determining the components of the case study design 
Stage  3 Data analysis – adopting the three stances 
(Carolan, et al. 2015 p5) 
 
3.1 Stage one: Situating the research and the researcher 
Three areas to be discussed are laid out by Carolan, et al. (2015) in this 
component; the ontological frame, the situation of self, and the ethical 
dimensions of the research. Careful consideration of these elements 
ensures that the research aligns with the researcher’s world view and 
addresses the aims of the study (Harrison, et al. 2017). The ontological 
frame of critical realism and the emic position of the researcher was 
outlined in Chapter 1 (section 1.5), further exploration is included in 
Appendix 5.  
 
This emic provides a unique opportunity for the researcher to be 
immersed within the research itself (Hammersley, 2006), as such it is 
impossible for the researcher to be seen as a passive recipient of the 
research, by necessity they must embrace the notion of active 
participation (Thomas, 2016). As such the researcher brings into the 
enquiry their prior knowledge, beliefs, and values, this researcher-self 
must be recognised and understood, in order to ensure a cogent 
understanding of its impact on knowledge creation (Carolan, et al. 2015). 
Thomas, (2016 p148) identifies this position as a ‘Participant Observer’ 
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and highlights this as a fundamental concept within the ‘interpretive’ case 
study approach.  
 
3.1.1 Ethical tensions 
This emic perspective has other advantages including an in-depth 
knowledge of the local context, a shared language with participants, 
knowledge of the right questions to ask as well as easy access to the field 
(Silverman, 1998). Such positionality also presents ethical tensions that 
must be acknowledged and managed (Simmons, 2012). These were 
identified prior to the research and discussed within the protocol and 
ethical approval process, (Appendix 2.II); however, they remained under 
review throughout the study (Pillow, 2003; Riley, et al. 2003).  
 
Fraser (1997) identified five ethical concerns the emic researcher needed 
to be aware of: personal values and their potential for bias; the 
researcher’s role within the organisation; role conflict; confidentiality and 
anonymity; and time constraints. The researcher’s professional role has 
been explicitly stated within the introduction of this thesis, transparently 
identifying her position. In addition, the previous section acknowledges 
the researcher’s values thus addressing Fraser’s, (1997) first two 
concerns. Role conflict pertains to the conduct of the researcher in the 
field, an issue carefully considered and monitored throughout the study, 
so as not to exceed the rights afforded to the researcher by her position. 
Through the approval and data collection stage of this study the 
researcher was cognisant of her senior post within the organisation and 
the bi-dimensional power dynamic that interviewing both very senior and 
very junior staff presented. This impacted the research practically in 
several different ways described next. 
 
This research went through the same organisational scrutiny processes 
through which all other student projects are assessed, including review at 
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the Trust’s research committee3. The researcher neither attended this 
meeting nor engaged in the approval process. Care was then taken to 
maintain mutual respect within the workplace (Fraser, 1997); practically, 
this included ensuring that all staff had the Participant Information Sheet 
well in advance, they (or their administration staff) controlled the 
interview time, date, and chose the location of the interviews so they felt 
comfortable. This was particularly important for junior staff, who were 
invited to participate by a third party, such as their ward manager and 
interviewed within their place of work. This was underpinned by the 
informed consent process.  
 
The anonymity challenge required practical consideration throughout the 
study, particularly as interviews took place with a small cohort of very 
senior managers. Thus to preserve anonymity all personal identifiers were  
removed, rather than assigning pseudonyms which might infer gender, a 
unique alphanumerical code was created for each participant, based on 
staff group, interview order and a random letter, so no hierarchy was 
conferred. This anonymity was extended throughout and included light 
editing of ‘in-vivo’ quotes so as not identifying the Trust within the thesis. 
Once the research was completed, formal permission was obtained from 
the Trust before submission, dissemination, or publication (Appendix 
2.III). 
 
People’s time to participating in the research and the impact it might have 







3 . The Trust holds a monthly research review committee which reviews all student 
research 
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groups were not represented within the interviews; one group not 
included were estates staff (cleaners, catering and maintenance staff). 
Additionally, if a staff member had volunteered and made time for an 
interview, the interview was undertaken. As more interviews than required 
were booked to allow for clinical pressures, this meant a slightly larger 
number of interviews (n=28) were conducted than originally planned 
(n=24). All interviews in the clinical area were done at the convenience of 
clinical staff, did not exceed the forty minutes allocated, and interruptions 
for clinical care duties were accepted. Post-interview, all interviewees 
were followed up by email and thanked for their participation, which also 
provided an opportunity to share their interview transcripts within them 
for validation.  
 
The impact of these decisions on data collection and analysis needs to be 
reflected upon and understood (Carolan, et al. 2015). In this study, the 
researcher noted in her journal that when interviewing very senior staff, 
the interviews were  
 
‘controlled by the agenda they [very senior managers] wanted to 
share and by the time allocation they had available, thus very short 
and professional’ (PO:09/07/18).  
 
Care was also taken with the interviewees to make them feel comfortable, 
reassurance was given by the researcher that there were ‘no right or 
wrong answers’, and that it was ‘their understanding that was of interest’. 
This was particularly important when junior staff did not understand words 
used, such as ‘innovation’ itself. Indeed, in these instances ‘ideas’ was 
substituted. All staff appeared happy and comfortable to discuss the 
subject matter with no concerns raised.  
 
Reflexivity has been described as a critical component of the interpretive 
research process through which a researcher confronts their ontological 
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and epistemological position and acknowledges the impact this has on 
knowledge generation (Ribbens, et al. 1998). Day, (2002) proposes that 
through the reflexivity process the unspoken is spoken and the invisible 
made visible. A view supported by Carolan, et al. (2015) who identifies 
the importance of reflexivity within the case study, as the process which 
moves beyond methodological rigour to become a management tool that 
continues to assess ethical considerations of the research, balancing the 
needs of study design and the needs of the participants. Reflexivity is thus 
considered an essential element of this study, in relation to the ethical 
dimensions of this research. The analytical impact is discussed in section 
3.3.1. 
 
3.2 Stage two: determining the components of the case study 
design 
A study’s design addresses the logical issues of how the research aims will 
be answered, not the logistical issues associated with the method (Yin, 
2014). Although this principle is noted, the logistical aspects required for 
the purposes of academia are also understood; therefore both are 
described so that a judgement regarding the quality of this investigation 
can be assessed. Carolan, et al. (2015) in stage two of the DESCARTE 
model identify four interrelated components of case study design; the 
case, the purpose, the sampling approach, and the conceptual framework, 
presented within a conceptual model (Figure 3.1 DESCARTE  model). 




Figure 3.1 DESCARTE  model 
(Carolan, et al. 2015 ) 
 
Carolan, et al. (2015) acknowledges the interaction of the design with the 
context and states the importance of addressing all of these four 
components, before responding to the rationale behind the data source 
chosen. To support this, the researcher is challenged to respond to six 
non-sequential questions (Table 3.2).  




Table 3.2 The components of case study design 
 
How is the case defined? 
How is the context defined? 
What is the purpose of the case study? 
What is the conceptual/theoretical framework for the case study? 
What is my sampling approach? 
What is the rationale for my choice of data sources?  
(Carolan, et al. 2015 p6) 
 
Carolan, et al. (2015 p8) groups the first two components together as the 
‘case-purpose dyad’, addressed by three questions. Although articulated 
differently, other authors concur with the importance of defining these 
components within a case study. Yin, (2014) identifies these as 
‘propositions’ that outline the purpose of the research and the ‘unit of 
analysis’ the case to be explored. Thomas, (2016 p15) states a case study 
is made of two halves, ‘a subject’ and ‘an analytical frame or object’. 
Describing the case-purpose dyad is important as this exemplifies two 
points; the connectedness of these components and the uniqueness of 
each case (Carolan, et al. 2015). Identifying uniqueness is crucial, as this 
in turn delineates the case boundaries (Yin, 2014; Thomas, 2016). These 
boundaries not only articulate the nature of the case, but crucially also 
include elements such as social groups, organisational context, 
geography, and temporal dimensions (Crowe, et al. 2011). These 
propositions are presented next.  
 
3.2.1 The case 
The case is the subject of the case study (Thomas, 2016) and as such 
selection is a crucial decision for the research, requiring careful 
consideration in relation to the research questions and study purpose (Yin, 
2014). Yin, (2014) identifies the first decision is whether a single or multi-
The Case to Innovate: understanding organisational innovativeness in one NHS Trust 
62 
 
case design is required, acknowledging that single cases may be the only 
option in cases of uniqueness, but comparators between multiple cases 
lends robustness to the findings. Once this decision is made, a bewildering 
array of descriptors abound, varying by author and their epistemological 
commitments, making comparisons problematic (Yazan, 2015). 
Additionally, some texts identify a case as a phenomenon or an entity 
(Carolan, et al. 2015), whilst others require it to be an entity (Yin, 2014), 
compounding the issue. Thomas, (2016 p98) provides a simple solution, 
stating that selection of a case may be based on a researcher’s familiarity 
with it, highlighting this as a practical option for students where time and 
resources are limited, terming this a ‘local knowledge case’. The 
advantages and disadvantages of this approach and the strategies 
through which they were managed have been discussed in section 3.1.1. 
  
Once case selection is made, consideration needs to be given to the level 
of exploration required to answer the research questions (Thomas, 2016). 
A single case study design undertaken holistically without enough detail 
might produce an abstract conceptualisation, this can be mitigated with 
embedded units of analysis, which position the study and prevent 
theoretical slippage (Yin, 2014). If too much attention is placed on the 
embedded units there might be limited contribution to the contextual 
theory, thus a careful balance is required throughout the enquiry (Yin, 
2014). It is recognised that people’s perception differ with organisational 
positionality, variation between managers and frontline staff are 
recognised within healthcare literature (Plsek, et al. 2007). To provide the 
rich detail necessary for the integrity of this research, not only was the 
organisational level perspective explored, but granular detail was 
developed through two ‘embedded’ units (Yin, 2014 p50). These were 
classed as ‘Senior Leadership Team’, (SLT) representing the management 
position and ‘Front-Line Staff’ (FLS) representing clinical roles, although 
some overlap was noted between these two notations. This research is a 
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local knowledge single site case study, with two embedded units of 
analysis. 
 
3.2.2 The context 
The subject of this research is an NHS trust, identified as ‘the Trust’ here-
on-in to protect anonymity. The Trust is located within the mesosystem of 
the UK healthcare ecosystem described in section 2.1.2. The Trust is a 
legal entity in its own right working strategically as a bounded 
organisation, but constrained by the policies and reporting structures of 
the macrosystem. It is also a highly complex system, functioning at 
multiple levels, employing the individuals who work in teams 
(microsystems), to provide healthcare to its population. Whilst 
acknowledging the relationship and influence of the macrosystem and 
exosystem, the focus of this research is the mesosystem, the Trust itself, 
as a unique entity.  
 
Innovation has been part of the Trust’s strategy since 2014; however, the 
current Innovation Strategy was only launched in June 2017. This 
research retrospectively explores the Trust’s early documentation and 
strategy development from 2014 onwards with data collection primarily 
taking place from January to December 2018. This is therefore considered 
the temporal bounds of the study (Thomas, 2016), with the main element 
of the research considered a ‘snapshot’ of the organisation. 
 
The Trust could be described as a ‘common’ case (Yin, 2014 p51), it, like 
many other trusts, delivers healthcare services to an identified geography. 
It could also be described as an ‘unusual’ case (Yin 2014 p51), as it was 
rated as ‘outstanding’ by CQC in August 2018, one of only a few providers 
in England to achieve this accolade. The Trust is also unusual in having a 
designated strategic theme ‘To Innovate’ and a senior manager, the 
researcher, tasked with delivering and developing this theme. Thomas 
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(2016 p114) alternatively refers to common cases as ‘key’ cases and 
unusual cases as ‘outlier’ cases, however, recognises that these states can 
be allowed to coexist, as they provide conceptual options that support the 
development of the research. In this research, no specific proposition as 
to whether it is a key case or outlier has been made.  
 
3.2.3 The purpose 
The purpose of the case study defines what will actually be examined 
within a particular study and why (Yin 2014). Stake (1995 p445) identifies 
the case study’s purpose as ‘intrinsic’, a study of interest with no specified 
outcome in mind or ‘instrumental’, which provides insight and the 
necessary evidence to support change. In instrumental studies the case 
becomes less important with the focus shifting to purpose and its 
analytical frame (Crowe, et al. 2011). Alternatively, case studies might be 
described as evaluative, explanatory or exploratory, the most common 
being explanatory, where connections are made and explained even if 
only within the limited context of the case. In this way, a single case study 
can be used to confirm or challenge a theory (Thomas, 2016).  
 
Thomas (2016 p15) defines the ‘analytical frame’, as the unique element 
of a case study that binds the subject, the context and the research aims 
and objectives. This makes it difficult, but also necessary to define. The 
subject and context are defined in section 3.2.1 and 3.2.2, the aims, and 
objectives of this research are identified in section 1.2. The analytical 
frame might be described as the policy imperative to innovate in order to 
meet the future demands of the healthcare ecosystem, described within in 
section 2.2. The purpose of this research is to both develop theory and 
provide solutions for NHS trusts in addressing how innovation is 
understood, identifying the innovation environment and how it might be 
developed. This case study can thus be described as an instrumental or 
explanatory case study. 




Carolan, et al. (2015) proposes that if the case-purpose dyad is clearly 
conceptualised, complex typology descriptors become redundant. 
Practically, however, typologies provide clarification and summary, thus 
have been included in the case-purpose dyad description. In summary this 
research could be described as an instrumental or explanatory, local 
knowledge, single case study with two embedded units of analysis.  
 
Texts differ on whether the case-purpose dyad should precede (Carolan, 
et al. 2015; Thomas, 2016) or follow the research questions (Yin, 2014). 
Carolan, et al. (2015) states that where the research questions are placed 
first, a pragmatic paradigm is established regardless of whether this 
changes later within the research, they promote that the case-purpose 
dyad is central and thus should come first, with the research questions 
logically following it. This research is required to meet the standards of an 
academic thesis, and thus the research aims and objectives were stated at 
the outset; however, specific research questions follow in section 3.2.6 
thus placing it in the critical paradigm.  
 
3.2.4 Theoretical framework 
Yin’s (2014 p37) focus for the design phase of the research is on the 
development of logical models, linking this to ‘theoretical propositions’, or 
theories that are to be tested within the research. Yin, (2014 p41) 
acknowledged the difficulties in this, stating that it must be informed by 
an in-depth analysis of the literature to identify all available theories to be 
tested, noting that some of these may be ‘rivals’ that must then be 
explored within the study. He postulates that this theory testing approach 
is a key difference between the case study methodology and other 
qualitative forms of enquiry (Yin, 2014). 
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The literature review undertook a pragmatic, recursive approach to distil 
key elements from the evidence-base regarding what is currently known 
of organisational innovativeness in the context of NHS trusts, augmented 
with theory drawn from the business literature to create a theoretical 
framework. This recognises innovation within the complexity of the NHS 
mesosystem, the NHS trusts, and their porous boundaries to the wider 
healthcare exosystem and macrosystem. Thomas (2016 p38) suggests 
distilling these key propositions into a ‘storyboard’ to provide clarity for 
the research design; this is presented in Figure 3.2 . 
 




The critical realists perspective accepts that the world is theory-laden, not 
theory driven. In this instance, ‘theory’ is conceptualised as a ‘temporary 
conceptual framework’ that can be used for the purposes of the study, 
‘discarded’ or retained’ depending on the outcome of the research 
(Thomas, 2016 p150). In addition to the propositions of the literature 
review, three other theories inform the design and analysis of the 
research, these are described next. 
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Complex and general system theory  
NHS trusts have been described throughout as complex, dynamic 
systems, with multiple individuals, undertaking different functions, at the 
same time. As units of analysis, they have been described as ‘open 
systems’, with no possibility for a researcher to exert control (Edgley, et 
al. 2016). Complex and general system theory recognises this, and 
describes how within each level of the ecosystem, individuals have 
autonomy and a freedom to act in ways that are not always totally 
predictable. Each action impacts on other interconnected elements within 
the system and as the levels within the systems have ‘fuzzy’ boundaries 
unpredictable consequences can occur (Greenhalgh, et al. 2005 p79). 
These systems are dynamic and constantly changing, with important 
implications for how information is understood and transferred throughout 
the ecosystem (Greenhalgh, et al. 2005). Exploring complex systems 
holistically, to ensure an understanding of the interactions between 
components and between all parts of the system is essential (Greenhalgh, 
et al. 2005), thus making the case study approach an ideal 
methodological choice. 
 
Design Science Approach (DSA) 
Chapter one identified the purpose of research as two-fold; knowledge 
development and problem solving; the researcher has stated her own 
positionality in relation to these concepts. Van Aken (2007 p68) makes a 
distinction between two types of knowledge, linking the ‘knowledge 
problem’ to the understanding of the present reality and ‘field problem’ to 
designing a better reality. He elucidates that the explanatory sciences are 
concerned with knowledge that uncover truths, whereas design science is 
the underpinning theory through which research is linked to problem 
solving (Van Aken 2007). It is suggested that design science is the 
process through which experts and professionals think, using their tacit 
knowledge to create solutions to field problems (Bevan, et al. 2007).  




The approach is characterised by an underpinning holistic stance and is 
strongly customer and outcome focused (Van Aken 2007). In addition, it 
focuses on establishing the right specifications and uses deliberate 
procedure, thus distinguishing it from the lay approach. Bevan, et al. 
(2007) identifies four sequential phases to the design science approach, 
described in Table 3.3. 
 
Table 3.3 Four stages of the design science approach 
 
1 Reflection, analysis, diagnosis and description: looking back, 
harvesting, establishing and codifying what we know  
2 Imagining and visualising: looking forward, hypothesis formulation, 
imagining what might be possible 
3 Modelling, planning and prototyping: knowledge exploitation, 
though prototyping and testing coming up with something that 
might work  
4 Action and implementation: intervention, building and testing 
(Bevan, et al. 2007 p139) 
 
Design science does not seek to find statistical truths; instead the focus is 
on converting the implicit, tacit knowledge of experts into explicit, 
actionable knowledge to present the possibility for change. It postulated 
that if you want to achieve a goal, within a specific context then actions 
such as ‘X’ might help (Plsek, et al. 2007). Four practical methods have 
been associated with design science; reviewing documentation, convening 
groups of experts, listening to stories and posing hypothetical scenarios 
(Plsek, et al. 2007). This approach has been successfully used within the 
NHS to create large scale transformation change (Bevan, et al. 2007). It is 
therefore considered a useful theoretical framework to support the second 
aim of this research and the data collection methods.  
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Soft System Methodology (SSM) 
Thomas, (2016 p214) suggests that case study analysis can be usefully 
informed by ‘systems thinking’. This approach, sometimes called ‘Soft 
System Methodology’ (SSM) was conceived by Checkland (1981), and has 
developed over 30 years to become widely recognised within the private 
sector (University of Cambridge, 2019). SSM is situated with the design 
science paradigm (Van Aken, 2007) and uses a similar logic model to 
provide a purposive solution focused approach within integrated social 
systems, to address complex problems.  
 
Thomas (2016) presents a six-stage approach to SSM, the first two of 
which, outlining the problem, and organising and describing it. Stage-
three, the system thinking stage, attempts to identify the root cause of 
the issues, characterised by appreciation of the situation from varying 
perspectives, customers, actors, transformation, Weltanschauung, owners 
and environment, exemplified by the acronym ‘CATWOE’ (Thomas, 2016 
p215). Table 3.4 presents how CATWOE has been interpreted for the Trust 
in this research.  
 




Table 3.4 Six features of situation as a system 'CATWOE' 
 
Thomas 2016 Interpretation at the Trust 
a Customers Those who benefit 
from the system 
Patients, service users, 
carers and staff 
b Actors People who 
transform inputs 
into outputs  
All Trust staff(SLT and 
FLS) 
c Transformation  From this to that, 
a to b, inputs to 
outputs 
Findings and analysis 







e Owners  People who ‘own’ 
the problem and 
want to solve it 
Trust senior managers 
(SLT) and Innovation leads 




Hard antecedents, social 
context  
(adapted from Thomas, 2016 p215) 
 
This variation then informs stages four and five, speculate how things 
might be different, and how they could be changed, before a final stage 
identifies the differences between the actual and the desired and proposed 
actions to bridge the gap (Thomas, 2016; Checkland 1981). These stages 
loosely mapped to the four DS stages, with CATWOE providing a tool to 
support the consideration of the variation of perspectives within the 
system. 
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Thomas, (2016 p219) describes theories as  ‘tools’ for analysis and as 
‘glue’ that binds understanding, holding it together, rather than the end 
point of an enquiry. If theory is considered in this context, then these 
three frameworks bind this research ontological perspective, design, and 
analysis. They acknowledge the complexity of the social system under 
investigation and problems this infers for empirical research. They support 
the need to explore complex systems holistically and from a variety of 
levels and perspectives. They accept the temporary nature of reality 
coterminous with a critical realist’s perspective, where the transient 
nature of knowledge is accepted (Scott, 2007; Edgley, et al. 2016). In 
addition, these frameworks provide useful structure and tools for data 
collection, analysis, and presentation of complex research findings.  
 
3.2.5 The sampling approach 
Carolan, et al.’s (2015) fourth component of the research design is the 
sampling approach; however, this is poorly described within their model, 
referring the reader to other texts, so it is unclear how they intended it to 
be discussed. Thomas, (2016) rejects completely the notion of sampling 
within the case study, stating the term lies within the positivist paradigm 
and has no place when seeking to understand the holist nature of a 
specific case, with case selection paramount. Yin, (2014) who represents 
the post-positive perspective, states that both qualitative and quantitative 
methods are of equal importance within the case study methodology, but 
also rebuts the use of sampling logic, stating that any power calculation 
for sample size is irrelevant for case study research. Indeed, Yin, (2014 
p61) dismisses commonly reported confidence levels as ‘discretionary 
judgements’, following that in his opinion, discussions about sampling are 
to be avoided if possible.  
 
As case identification has already been addressed (section 3.2.1), by 
default sampling here must refer to the data collection methods. In this 
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research, all sampling should be considered purposive (Yin, 2014), and no 
attempt at statistical generalisation from the case itself made. To support 
an understanding of investigation size, however, numerical values are 
presented for specific data collection methods and summarised in Table 
3.8. 
 
3.2.6 Choice of research methods  
In the DESCARTE model the final question of stage-two (Table 3.2) 
requires an exploration on choice of data sources (Carolan, et al. 2015). 
Data in its simplest concept is information, however, Thomas (2016 p187) 
makes the distinction that ‘evidence’ is data that supports some 
proposition. Yin, (2014), concurs stating that the theoretical propositions 
should lead naturally to the development of the research questions, these 
then narrow the focus to what specifically will be examined within the 
research (Creswell, 2005). Unlike other methods, case study questions are 
therefore posed to the researcher as a tool that helps define the evidence 
sources required to address the study aims, with each question linking to 
a ‘likely’ sources of evidence (Yin, 2014). Theoretical propositions from 
the literature review were summarised into a storyboard (Figure 3.2) and 
further distilled into five specific research questions (Table 3.5). 
 
Table 3.5 Research Questions (RQs) 
 
RQ1 How was innovation understood? 
RQ2 How was innovation leadership articulated? 
RQ3 How was the innovation culture perceived? 
RQ4 What were the shared belief, values, and behaviours around 
innovation?  
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As there are no prescribed data collection methods within a case study 
approach (Harrison, et al. 2017) critical decisions need to be taken 
regarding data sources that will yield the right evidence for the enquiry, 
with the evidence sources multiple and various to support triangulation. 
Differing methodologies lean towards differing methods depending on 
their ontological leanings, (Yazan 2015), where Yin (2014) states these 
may be qualitative, or quantitative, with no hierarchy of methods implied, 
Stake (1995) however, focuses only on qualitative approaches. A 
summary of potential data sources is presented by Thomas (2016), this 
has been augmented by other authors to give an overview of the choice 
on offer to the researcher, although this is not considered definitive (Table 
3.6).   
 




Table 3.6 Common data types in case study method (authors own) 
 
  Authors 
Commonly used data collection 
method 









Interviews/stories/accounts Qualitative       
Diaries  Qualitative      
Expert group interviews/focus groups  Qualitative      
Document/record interrogation  Qualitative      
       
Questionnaires/Surveys  Mixed methods      
Participant observation Mixed methods      
Direct observation Mixed methods      
Photographs/image based methods Mixed methods      
Physical artefact Mixed methods      
       
Measures/Tests scores  Quantitative       
Audits Quantitative      
Accounts Quantitative      








Of necessity, pragmatic but informed decisions on research methods must 
be made. Particularly relevant to this research was the Culture for 
Innovation Framework (Maher, et al. 2010) (section 2.5.5), as this offered 
a context specific, validated framework. The framework provided two data 
collection methods; a structure for convening groups of experts and a 
structured questionnaire, both identified as primary data collection tools 
for case study research (Table 3.6). These two primary methods were 
augmented by a third primary data collection method, semi-structured 
interviews, described in more detail next.    
 
Collaborative Enquiry Workshop (CEW) 
On 8 January 2018 the Trust held a conference for approximately 120 
staff members, including but not limited to Senior Leadership Team (SLT) 
on the topic of  ‘Innovation and Creativity’. The conference saw the public 
launch of the Trust’s strategic innovate theme and the supporting 
‘Innovation Pathway’ (TD5). It also introduced staff to the idea of 
‘embracing change’, by becoming leaders of innovation, presented tools to 
support creative thinking and a real-life case study from within the Trust 
(TD6). The day commenced with an external motivational speaker 
presenting ‘The Leader’s Mindset in The Age of Disruption’, taking 
concepts of innovation from the business world, in particular, creativity, 
and catapulting them into this NHS arena. At this event a ninety minute 
Collaborative Enquiry Workshop (CEW) was held with all participants. The 
methodology was adapted from Maher, et al. (2010 p132) and Parkes, et 
al. 2013 and summarised in Table 3.7.  





















(Adapted from Maher, et al. 2010 and Parkes, et al. 2013)  
 
1 Whole conference  
15 minutes 
Presentation of purpose: overview of CEW, culture for innovation tool, summary dimensions of innovation,  
actions to be undertaken  
2 Individual session 
5 minutes 
Individual consideration of seven domains of culture for innovation (participants, n=120) 
3 Individuals scores Individual Scores on A4 size portal charts (CEWi, n=90) 
4 Table top discussions 
20 minutes 
Scores shared and discussed in small table groups of 8-10 participants. Summary of Dimensions of 
Innovation available on each table 
5 Table scores Table groups scored A3 portal charts to produce a consensus rating for the table group (CEWg, n=22) 
6 Table discussions 
20 minutes 
One or two dimensions of the portal chart identified as priority, ideas, and actions discussed on how to 
improve the scores, captured on flip charts. 
7 Whole conference 
feedback session 
15 minutes  
Groups presented scores (n=1) and ideas to the whole group, convergence/divergent noted. 
8 Scoring of ideas 
Over lunch session 
Flip chart pages placed on walls, individual participants given three voting sticky dots. Voted on top three 
ideas using sticky dots (Dotmocracy, 2019) (Appendix 4.III) 
9  Summary presented at 
end of conference 
Summary portal chart created from CEWg Mean Dimension Score scores. List of most highly ranked ideas 
tabulated presented back to the participants at the end of the conference 
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The data outputs from this session included quantitative scores for each of 
the seven dimensions plotted on portal graphs for CEW individuals (CEWi; 
n=90), CEW group (CEWg; n=22). These scores represented discrete 
interval data, scaled from, -5, negative behaviours and practices 
associated with innovation, to +5, positive behaviours and practices 
associated with innovation. The strength of positive or negative 
association was represented by number size, with 0 representing 
neutrality. Mean Dimension Scores were calculated for both the CEWi and 
CEWg scores and plotted on a portal chart.  
 
A secondary data output from the CEW was the qualitative data generated 
from the discussions regarding actions that could be taken by the Trust to 
develop the CfI, these actions were also assigned an ordinal rank through 
the Dotmocracy process. Dotmocracy is a novel process designed as a fun 
way to quickly assess group preferences when limited options are 
available (Dotmocracy, 2019). This approach has a developing evidence 
base within healthcare where it has been used in lieu of a survey to 
achieve effective stakeholder involvement in hard to reach groups 
(Parkes, 2013) or as an abbreviated Delphi to address significant, complex 
issues and in a meaningful way quickly (McGarath, et al. 2018). In this 
research CEW participants were given the opportunity to vote on their top 
three actions identified in the discussions.  
 
Maher, et al. (2010) identify that this activity provides a quick assessment 
and develops a rich understanding of the current situation and supports 
idea generation. These results therefore, are a snapshot that cannot be 
seen as representative of the whole organisation or replicated, for this 
they suggest a survey (Maher, et al. 2010).  
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Trust Survey (TS) 
A validated survey tool is presented within the Culture for Innovation 
framework which Maher, et al. (2010) suggest has several advantages 
including the ability to reach a larger population, develops a deeper level 
of understanding, and can be repeated over time. The questionnaire had 
29 items, presented as a group of four questions for each of the seven 
dimensions of CfI, the fourth question in this group addresses 
management support, in this way making the connection with 
organisational leadership (Appendix 1.0). This framework thus provided a 
useful method tool to quantitatively measure RQ2, and RQ3.  
 
The survey (Maher, et al. 2010 p142-143), was formatted verbatim within 
an online tool, Survey Monkey (Survey Monkey, 2019) augmented by a 
question regarding staff group and a free-text response box. The 
questionnaire used an implied consent model, all responses were 
anonymous and took approximately ten minutes to complete. This was 
promoted widely through the Trust’s normal communication routes, 
supported by SLT, from 1 to 30 April 2018. The TS provided quantitative 
data for analysis similar to the CEW quantitative data, discrete interval 
data scored from -5 to +5 bit for all 29 items. The results were exported 
via an excel spread sheet directly into SPSS (n=159 responses; 5% 
response rate). 
 
Semi-structured Staff Interviews (SI)  
Plsek, et al. (2007) identified in their design science approach that the 
advantages of engaging with groups of experts were that they readily 
understood the concepts and engaged in the discussions, however, they 
also noted that participants tended to describe what they would like to 
happen and genuinely struggled to think explicitly in terms of actions that 
could be captured. It was suggested this was due to the complexity of 
thinking required to both recall what was done and why, whilst 
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simultaneously conceptualising what could be taken forward (Plsek, et al. 
2007). To address this issue the DSA suggests augmentation data 
collection using qualitative methods, getting both operational managers 
and frontline staff to tell their stories in semi-structured interviews (Plsek, 
et al., 2007).  
 
In this research, although the CEW discussions were tasked to identify 
actions, the results concurred with Plsek, et al.’s (2007) findings, and so 
augmentation with 28 semi-structured interviews took place, drawn from 
the two embedded units (SLT, n=12; FLS, n=16). Participants were 
purposively drawn from a wide range of disciplines, ethnic backgrounds, 
and pay grades within the Trust. The most junior was pay band 2 the 
most senior on very senior managers pay scales (Appendix 3.IV). Formal 
consent was taken from each interviewee and the interviews were 
supported by an interview schedule (Appendix 2.IV) that addressed all the 
research questions directly. In keeping with the DSA, the summary portal 
chart from the CEWg (Appendix 3.III) was used as a physical artefact 
(Yin, 2014) and shown to participants to support hypothetical discussions 
regarding how culture for innovation was understood and might be 
developed. The interview length varied between 13.56 to 41.14 minutes 
(mean=22 minutes approx.). Each interview was recorded and transcribed 
verbatim.  
 
These three primary data collection methods were augmented throughout 
by other secondary data including Trust Documents (TDs), outputs of 
Trust events, such as Sli.do poll (Appendix 4.vi) and the participant 
observation conducted by the researcher (PO). At the Innovation and 
Creativity event, 92 people responded to a direct online poll (sli.do, 2019) 
to the question ‘In 1 word describe what innovation means to you?’ 
(Appendix 4.VI). Practically, this research produced a lot of data that 
required careful and meticulous management, a database of evidence was 
kept (Appendix 4). Flexibility and adaptability was supported through a 
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research journal and also by regular meetings with the researcher’s 
supervisory team, using a critically reflexive approach. Data collection 
methods are summarised in Table 3.8. 
 
 




Table 3.8 Research Question with primary and secondary data sources identified  
 
RQ Activity  Sample size  Analytical methods  Outputs  
ALL Understanding of current knowledge and 
theory  
Secondary data sources 
Literature review: database searches; grey 
literature; conference  
Participant observation and Reflexivity 
N/A Qualitative document analysis, 
interpretation and synthesis  
Active participation of 
researcher 
Conceptualisation of subject, 
analytical frame and conceptual 
framework and current theories, 
emergent theories  
RQ1 How was innovation understood? 
Primary data source 
Semi-structured interviews (SI) with purposive 
sample very senior leaders and senior leaders  
Semi-structured interviews (SI) with purposive 
sample of frontline clinical staff  






Constant comparison analysis 
using NVivo 11 
 
 
Thematic analysis of 
understanding of innovation  
RQ2 How was innovation leadership articulated? 
Primary data source 
Semi-structured interviews as per RQ1 




Constant comparison analysis 
using NVivo 11 
 
Thematic analysis of 
understanding of leadership 
behaviours 
RQ3 How was the innovation culture perceived?  
Primary data source 




Analysis of ‘Portal Charts’ 
individuals and groups, 
Dotmocracy data using 
Thematic analysis of 
organisational innovation culture 
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(Parkes, 2013) ‘Culture for Innovation’ portal 
charts (Maher, et al. 2010) using and  
Secondary data source 
Dotmocracy approach (Dotmocracy, 2019)  
Sli-DO poll (sli.do, 2019) 
Primary data sources 
Questionnaire trust survey (TS) Culture of 
Innovation  using Survey Monkey (4 weeks 
April 2018) 







qualitative methods  
Constant comparison analysis 
using NVivo 11 
Statically analysis SPSS 22 
RQ4 What were the shared belief, values, and 
behaviours around innovation?  
Primary data source 
Semi-structured interviews (SI) as per RQ1 
 
See above 
Constant comparison analysis 
using NVivo 11 
Thematic analysis of 
understanding of belief, values 
and behaviours 
RQ5 How has strategy and policy impacted on the 
development of the innovation? 
Primary data source 
Semi-structured interviews (SI) as per RQ1 
Secondary data source 
Document analysis 
See above Constant comparison analysis 
using NVivo 11 
Thematic analysis of 
understanding strategy and 
policy  
ALL Synthesis of finding and lessons for practice  
All data sources 
 Triangulation of CEW, survey 
data, staff interviews, 
document review (TD) and 
Participant Observation (PO), 
Distillation of results to case 
report and theory development  
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Key Informant Feedback (KIF) 
thought critical reflexivity, 
phronesis and abduction  
ALL Outputs and dissemination Post viva   Publically available thesis in UoN 
library  
Journal publications: target 
Qualitative Health Research and 
Health Service Journal 
 
The Case to Innovate: understanding organisational innovativeness in one NHS Trust 
84 
 
3.3 Stage three: data analysis and adopting the three stances 
Analysis is the process of giving meaning to data (Yazan, 2011), yet, this 
stage of case study methodology is poorly described with no ready-made 
conventions; thus presenting a challenge to researchers (Yin, 2014). 
Thomas, (2016) postulated that the analytical framework is shaped by the 
first two stages of the study design already described, with a focus on the 
study object. This is corroborated by other authors; Carolan, et al. (2015 
p9) stress the overlapping nature of this process, but state the need for 
three specific stances to be described; ‘philosophical, strategic and 
integrative’. Although much of the philosophical approach has already 
been addressed in this chapter, the element of reflexivity and the other 
stances require further development. 
 
3.3.1 Philosophical stance  
The philosophical stance pertained to the ontological and epistemological 
assumptions that underpin the research analysis supported by the 
reflexivity process (Carolan, et al. 2015). The researcher’s ontological 
stance has been openly described as one of critical realism; however, little 
attention has been given to date to reflexivity and its purpose within this 
research, and so is addressed in more detail next. 
 
Critical realism acknowledges that empirical research explores what can 
actually be observed of the real world from a position of the researcher’s 
current knowledge. Throughout the research process, empirical study of 
data collected is interpreted into the study findings, and abducted into 
new theories relevant at that particular point in time; to apply these 
theories to the real world, a process of retroduction must occur (Tsang, 
2014). To achieve this, the researcher must both immerse themselves in 
the research process and engage in critical recursive thinking throughout 
the analysis (Thomas, 2016). This process of continuous internal 
analytical deliberation recognises the role of the researcher, both within 
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the researching process and as an instrument of the research 
interpretation, which is often termed ‘reflexivity’ (Berger, 2015). 
Reflexivity by necessity is particularly important to the emic researcher 
and the critical realist, where the researcher brings their knowledge and 
understanding into the research.  
 
Pillow, (2003 p176) describes reflexivity as a ‘methodological tool’ 
common within qualitative research practice that can support legitimacy 
and validity within the interpretive process. The frequency of its citation 
however, means its definition is often implied rather than explicitly stated, 
this has led to criticism and challenge regarding how reflexivity 
contributes to better research (Pillow, 2003). In order to address this, the 
researcher must explain how and why reflexivity is being used for their 
research. Pillow, (2003) suggests four co-dependent reflexivity strategies 
to achieve this; the first is awareness of self. Berger, (2015) articulates 
the impact of self in three ways: access to the field and its impact; field 
relationships; and the knowledge the researcher brings with them. The 
emic positioning of the researcher and the ontological positionality have 
already been discussed (Section Error! Reference source not found.). 
 
The three other reflexivity strategies then need to be considered 
throughout analysis these are: the ‘other’, ‘truth’ and ‘transcendence’ 
(Pillow, 2003). If these concepts are expounded, the ‘other’ refers to ‘how 
well does the research allow the voice of the participants to be heard’? 
‘truth’, asks ‘is this right?’ (Pillow, 2003); and ‘transcendence’ then 
encourages the researcher to transcend their own subjectivity and cultural 
context in a way that produces an honest interpretation, acknowledging 
the uncomfortableness of this process (Pillow, 2003). In doing this the real 
value and meaning of the research is produced. If this reflexive journey is 
then understood as one of many versions of the possible, this then 
becomes a new text of a reality, which can be interrogated as evidence, 
as opposed to being a mere reflection of what has transpired (Riley, et al. 
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2003). This responds to the philosophical concepts postulated as critical 
realism (Edgley, et al. 2016) and thus considered the philosophical stance 
of the analysis and is strived for throughout this research process. This 
was managed and supported throughout the study by the use of a 
reflective journal (section Error! Reference source not found.) and the 
supervisory process.  
 
3.3.2 Integrative stance  
The strategic stance is relevant for multiple case study designs where the 
analytical approach might be variable-based or case-based (Carolan, et al. 
2015), as a single case study by default the strategic approach is case-
based. The integrative stance is therefore the last component requiring 
description in Carolan, et al.’s (2015) DESCARTE model, although there is 
recognition that this is the least well described and the most problematic. 
Multiple data sources must converge through a non-hierarchical 
triangulation process to describe the phenomenon as a case (Yin, 2009; 
Reeves, et al. 2008; Scott, et al. 2003). The researcher must explicitly 
state how each stage of the analysis was conducted so that a judgement 
about the quality of the research can be made (Carolan, et al. 2015). 
 
Yin, (2014 p135) agrees that a strategy is required for data analysis, 
suggesting a starting-point as ‘playing with your data’, before using four 
general strategies and five specific analytical techniques. Outside of the 
case study methodology, however, mixed-methodologists have developed 
logic frameworks to support the triangulation of mixed-data 
(Onwuegbuzie, et al. 2006). In their framework, Onwuegbuzie, et al. 
(2006) describe a cyclical analytical process, linking the research aims, to 
research questions, design, data collection and the analysis phase, using 
this to re-define the research questions where necessary. They suggest 
within their logic framework a researcher utilises at least some elements 
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of seven sequential, but non-linear, processes in their analysis 
(Onwuegbuzie, et al. 2006) (Figure 3.3)  
 
Figure 3.3 Seven stage process of analysis 
 
 
(adapted from Onwuegbuzie, et al. 2006 p476)  
 
Case-study research produces a lot of data that requires preliminary 
management. Onwuegbuzie, et al. (2006) describes this process as 
reduction and primary display, using descriptive statistics and exploratory 
thematic analysis. Field (2013) also suggests that first phase of 
quantitative data analysis is visualising the data using frequency 
distributions and assessing the properties of the data through exploring 
the central tendencies. The quantitative data collected from the 
Collaborative Enquiry Workshop individuals (CEWi) and groups (CEWg) 
were tabulated in Excel, frequency distribution graphs analysed and mean 
dimension scores (mDS) calculated. The Trust Survey (TS) was first 
tabulated in Excel, then frequency distribution graphs and mean survey 
question scores (mSQS) were calculated for each of the 29-items for the 
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TS. Each group of questions pertaining to the dimensions of CfI were then 
combined to give a grand mean (Field, 2013) dimension score (mDS) and 
again frequency distributions assessed.  
 
All quantitative data was then imported into IBM® SPSS® Statistics v22.0 
(SPSS) where a more formal process of assessment of frequencies and 
measures of central tendency were undertaken, exploring normality, 
dispersion, and dimensions for each data set. Portal charts were plotted 
using Excel, histograms and bar charts were plotted in SPSS (Appendix 
4.IV). Throughout the analysis process, attention was paid to the type of 
question being interrogated by the data, if a question is a simple 
descriptive question, then descriptive techniques were used within the 
analysis; as the analysis progressed the questions asked of the data 
developed in complexity, thus different analytical strategies were required 
(Onwuegbuzie, et al. 2006). Maher, et al. (2010) acknowledges the 
statistical limitations of their CfI tool, predicated on a DS model, although 
this was scale data it was found to be non-parametric, hence a non-
parametric test, a one-way ANOVA (Kruskal-Wallis test4) was used to 
compare means between different data sets.  
 
Saldaňa, (2016 p20-21) suggests making and reading a ‘hard copy’ of all 
qualitative data as it is generated in a processes of ‘pre-coding’ and 







4 The Kruskal-Wallis test is the non-parametric version of a one-way independent ANOVA 
and is used to test the hypothesis that data from multiple independent groups comes 
from different populations by using ranking. The test can be used when the size of 
sample differs greatly or data has been assessed as not having a normal distribution. 
Both factors applied in this case (Field 2013).    
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level-one coding is undertaken. Thomas, (2016 p205) terms these 
‘temporary constructs’. Qualitative data was generated from staff 
interviews (SI), all data was transcribed verbatim, formatted in Microsoft 
Word, and a hard copy printed, before an electronic version was uploaded 
into NVivo 11. Each hard copy transcript was read, significant quotes 
highlighted and notes made to give a visual presentation of data and to 
develop temporary constructs. Textual data from the CEW feedback 
session and qualitative comments from the TS were also tabulated and 
manually reviewed before being formatted and uploaded into NVivo. Other 
data sources were captured and logged on the database of evidence 
(Appendix 3.I). 
 
Level-one coding was undertaken using the constant comparative method 
(CCM). Although CCM is commonly associated with a grounded theory 
approach (Glaser, et al. 1967), this research did not take this 
underpinning philosophical approach, recognising the implications of the 
emic researcher and the prior knowledge in this field. Instead this 
research acknowledging CCM as described by Thomas, (2016 p204) as 
‘the basic method of interpretive enquiry’ , following the principle of 
repetitive cycles (constant) of exploring data against known concepts 
(comparison) to elicit ‘themes’, in an iterative process. A primary coding 
cycle was undertaken by comparing the data to the ‘temporary constructs’ 
(Saldaňa, 2016). This was followed by a transitional reflexive phase 
(Saldaňa, 2016), before a second-level coding cycle was undertaken, 
comparing the data to the primary codes and refining the themes. This 
was repeated until points of data convergence and themes evolved 
(Thomas, 2016 p204) (see Appendix 4.V). Yin, (2014 p136) identifies 
‘four general strategies’ that support this process, the first three concur 
with CCM; ‘relying on theoretical proposition’; ‘working your data from the 
ground up’ and ‘examining rival proposition’ all of which were used in this 
process. 
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The third stage transformation is optional, where quantitative data are 
converted into narrative data that can be analysed qualitatively and/or 
qualitative data are converted into numerical codes. This was not 
undertaken in this study. Stages four, five and six involve correlation, 
consolidation, and comparison of the qualitative and quantitative data 
sources in parallel (Onwuegbuzie, et al. 2006). Although CCM supports the 
development of descriptive themes, alone it cannot demonstrate the 
connectivity, relationships, or differences between the themes required to 
develop a holistic picture, other analytical techniques are required to 
augment this process of ‘theme mapping’ (Thomas 2016 p206). Yin, 
(2014 p143) recommends five specific analytical techniques that support 
data triangulation, three of which, pattern matching, explanation building, 
and logic model development were utilised at this stage of the analysis.   
 
Data integration is the final stage, whereby both quantitative and 
qualitative data are integrated into one coherent whole. Yin (2014) 
describes this as ‘developing a case descriptor’, which for a descriptive 
case study might be the end of the analytical stage. The case is presented 
as a ‘thick-description’, a vivid picture through which the reader can 
understand the case within its context, augmented by in-vivo quotes and 
visual material (Yin, 2014; Thomas, 2016). The results of integration are 
coterminous with stage one of the DS approach; reflection, analysis, 
diagnosis and description (Bevan, et al. 2007). 
 
3.3.3 Interpretation 
The single case study can be considered a classic case study; the classic 
approach is often described as ‘interpretative’ (Thomas, 2016 p147). The 
interpretative position has already been implied in the positioning of the 
researcher as a critical realist, this is now explicitly stated, doing so 
acknowledges that this approach can then be utilised to build or test a 
theory depending on the questions posed (Thomas, 2016). This is stage 
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eight of Onwuegbuzie, et al.’s (2006) model, substituted as a third 
analytical stance, and described as a two-stage process, abduction, 
followed by retroduction (Tsang, 2014). 
 
Abduction is the process of developing a theoretical idea from the 
evidence presented within the research (Hammersley, 2006). This process 
changes the level of analysis from thick description of the entity provided 
in the integration stage, to provide theoretical re-description (Fletcher, 
2016). The findings, informed by theoretical propositions are developed 
through the researcher’s ontological beliefs, then abduction through 
critical thinking and the process of phronesis to develop new theoretical 
propositions (Thomas, 2016). Thomas (2014 p214) describes the 
usefulness of ‘systems thinking’ and suggests using SSM to support this 
development. The process is iterative and recursive involving reading, 
coding, CCM, elaboration of emerging themes and re-engaging with wider 
literature (Waring, et al. 2014). The results of the abduction are 
coterminous with stage two of the DS approach; Imagining and visualising 
(Bevan, et al. 2007).  
 
The final stage of analysis is retroduction, the distillation of the concepts 
back to the potential theoretical models of the real domain (Tsang, 2014). 
The results of retroduction are coterminous with stage three of the DS 
approach; modelling, planning and prototyping (Bevan, et al. 2007). The 
interpretation stage of analysis was supported by the second-stage 
literature review, the thick description from the case study, and 
researcher engagement. Throughout the interpretative analysis stage, 
engaging and feedback from key-informants was significant (Yin, 2014). 
 
3.4 Assessment of quality 
The case study methodology has been criticised for lack of scientific rigour 
and limited basis for generalisation (Crowe, et al. 2011). Yin (2014) states 
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that the researcher must be prepared for this criticism and be able to 
defend the quality of their method; however, various authors take 
different approaches on how this should be done. There appears to be a 
general consensus that multiple sources of evidence are required to 
ensure the process of triangulation can be achieved in enough depth to 
give a rich description of the case and that this should be informed by 
theoretical propositions (Yazan, 2015; Haughton, et al. 2012; Yin, 2015; 
Stake, 1995; Thomas, 2016). This principle of multiple data sources was, 
therefore, accepted as the first underpinning principle of quality used for 
this research. Beyond this, opinions diverge depending on epistemological 
perspective (Yazan, 2015).  
 
Yin’s, (2014) realist suggestions include addressing three areas of validity; 
(construct, internal and external) and reliability supported through a 
series of strategies. At the other extreme Thomas, (2016) rejects the 
concept of having to prove a study’s reliability and validity, stating that 
reliability is imported from psychometrics and validity only addresses 
whether the research findings confirmed the aims of the study. Thomas, 
(2016) also rejects traditional interpretivist perspectives of 
trustworthiness, stating instead that a case study is a unique holistic 
study, which in using multiple data sources and rich description presents a 
case that should be accepted as such. Riege, (2003) suggests that in 
mixed-methods research a blended approach incorporating both the 
realist and constructionists paradigm and includes a further four 
principles, alongside those of Yin. This leaves the student researcher in a 
quandary regarding how this element of the thesis should be presented.  
 
The researcher, within her professional role is familiar with all clinical 
research being subjected to external audit to assure its quality and 
therefore felt that attention should be given to this concept. Yin’s (2014 
p45) realist model identifies the study protocol, the development of the 
research database, and the establishment of the chain of evidence as 
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confirmation of an audit trail. Houghton, et al. (2012), whilst rejecting the 
positivist notion of reliability and validity, links the concept of 
dependability and confirmability to having a clear audit trail of decision-
making in order that the reader, who may not share the researcher’s 
ontological perspective, can at least appreciate how analytical decisions 
were taken and conclusions drawn. Indeed, Houghton, et al. (2012) 
identifies that NVivo provides a traceable account of how the qualitative 
analytic decisions were made, which supported by the process of 
reflexivity captured within a reflective diary, can provide a useful audit 
trail.  
 
These principles all appear to have three common factors: firstly, a well-
conceived research enquiry with a properly designed protocol; secondly a 
fully identifiable audit trail of how the research was conducted, data 
collected and managed; finally, evidence of how analytical decisions were 
made so others could assess if these were correct. This description of an 
auditable process then marries the realists and interpretivists approach to 
quality. The researcher accepts the elements described as good research 
practice, thus having a transparent audit trail is identified as the second 
underpinning principle of quality used for this research.  
 
There appears to be a third area where the notions of quality from across 
the paradigms meet. Yin, (2014) presents the need for key informant 
feedback to situate the analysis and make it real;  however, Houghton, et 
al. (2012 p14) identifies ‘peer debriefing’ and ‘member-checking’ in a very 
similar way, where the former uses external experts to assess the 
credibility of findings and the latter allows members to check their 
transcripts for accuracy before analysis. The researcher acknowledges it is 
good practice to check with participants that they feel their transcripts 
have been accurately transcribed and to share preliminary analysis with 
both internal and external witnesses to establish the credibility of the work 
as it developed. The researcher accepts the principle of the feedback loop 
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between data, key informants and analysis as good research practice, this 
is then the third underpinning principle of quality used for this research. In 
this research, the external experts were the supervisory team that 
supported the methodological and analytical process; the internal experts 
were Trust members who commented on the initial findings. These 
approaches to quality are summarised in Table 3.9. 
 





Table 3.9 Approaches to quality 
TEST Case Study Tactic adapted from Yin, 2014 & 
Riege, 2003 
Phase of Research in which 
Tactic Occurs 
Undertaken in this 
research  
Construct Validity –  
Neutrality and objectivity  
Use of multiple data sources of evidence 
Establish chain of evidence  








Internal Validity – 
How spurious effects will be 
managed and how 
inferences will be made   
do pattern matching 
do examination building 
address rival explanations 









External Validity – 
How will you know that 
findings have meaning 
beyond the case 
use theory in single-case studies research design Yes 
Reliability – 
How can the research be 
repeated  
use case study protocol 






Logical and unprejudiced  
Retention of raw data for audit so auditor 
might judge inferences made 
Data collection  Yes 




Are the findings believable  
 
Triangulation techniques using multiple 
sources of evidence 
Peer debriefing – expert review 
Member checking – presentation of findings 








Do findings show analytical 
generalisation 
Creation of thick description  
Cross case where possible 
Use specific procedures for coding and 
analysis 




Stability and consistency of 
process  
Audible design phase  
description of the researchers theoretical 
positioning  
Design stage Yes 
Yes 
(Adapted from Yin 2014 and Riege, 2003) 




3.5 Chapter summary 
This chapter addresses how the research was conducted, working as the 
bridge between the theoretical propositions presented in the literature 
review and the subsequent findings of the research. The literature review 
suggested the need for the case study approach to explore the 
conceptualisation of innovation holistically within the complex multi-level 
systems of NHS trusts (Robert, et al. 2009). This approach allowed the 
containment of the research within identified boundaries whilst 
acknowledging the significant influence of the context (Thomas, 2016). 
Case studies have been criticised within the literature for poorly 
articulated design, to circumvent this, the DESCARTE framework was used 
to explicitly describe the methodological approach, augmented by other 
literature to ensure the quality and rigour (Carolan, et al. 2017; Yin, 
2014; Thomas, 2016).  
 
The research design was underpinned by three supporting theoretical 
frames; complex and general system theory, design science approach and 
soft system methodology. The theoretical propositions from the literature 
framed the research questions and the choice of data collection methods. 
In particular, the Culture for Innovation framework (Maher, et al. 2010) 
was identified as providing a useful tool to support data collection both in 
terms of the collaborative enquiry workshop and the trust survey. The 
data analysis approach is described in detail using Onwuegbuzie, et al. 
(2006) mix-methods model of reduction, presentation, triangulation, and 
integration of data. The results of the integration stage are presented 
through thick description in the next three chapters.  
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Chapter 4.  Conceptualising innovation  
This chapter presents the findings in relation to RQ1 and RQ55. These 
findings have been transformed through triangulation into a rich 
description of the Trust to address the first objective of this research, how 
is innovation understood. The findings are presented in five sections; the 
first section presents the Trust, as a case-descriptor within its context. 
The next three sections conceptualise innovation, including the strategic 
position, definition of innovation, and the creative process, before a final 
section presents the hardware of innovation. 
 
4.1 The Trust  
The Trust is situated within a countywide healthcare system, strategically 
working with multiple other partners to provide healthcare to a diverse 
and growing population of 741,000. It is commissioned, by two local 
Clinical Commissioning Groups (CCG) and Public Health (PH) within the 
local council and is required to report performance via these routes, as 
well as maintaining other national reporting requirements from DHSC and 
NHS E. It has partnership agreements with both the regional AHSN and 
NIHR infrastructures and is inspected annually by the Care Quality 
Commission (CQC). At the outset of the study it was rated ‘good’ by CQC, 
but achieved an ‘outstanding’ rating in August 2018. As a unit of 
operational delivery the Trust is an NHS foundation trust, (DH 2003), as 








RQ1: How was innovation understood?  
RQ5: How has strategy and policy impacted on the development of the innovation? 
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decision making, however, resources are constrained, with the key 
financial imperative year-end break-even.  
 
The Trust’s function is to provide more than 100 healthcare services from 
four main in-patient sites. It also has numerous outpatient units 
throughout the county, and via a field-based workforce directly delivers 
care into patients own homes. A large number of these services are sub-
divided into geographical located teams, where staff work in partnership 
with General Practitioners, and many other services to provide clinical care 
to patients at their time of need. In 2017/18, the Trust had a workforce of 
approximately 4,000 whole-time equivalent staff (including students and 
temporary) provided more than 1.5 million care episodes to patients. Of 
the permanent staff, (n=3,169) 50% are highly trained and educated 
healthcare professionals (n=1530), the largest group of which are nurses 
(n=1130). The non-clinical workforce (n=1639) are a made up of 
mangers, administrators, and estates staff.  
 
These elements inform the means (section 2.4) or hard antecedent of the 
innovative organisation, where individual staff works in highly pressured 
environments, within a culture of ‘busyness’ (Nevalainena, et al. 2018) 
can be clearly demonstrated. These individuals work together in service or 
teams, each of which could be considered a microsystem. The Trust can 
then be identified as a complex mesosystem, managing these teams, but 
situated within the wider healthcare ecosystem.  
 
4.2 The strategic position 
The Trust proudly promotes its mission statement ‘making a difference for 
you with you’ and its ambition ‘to be a leading provider of outstanding, 
compassionate care’ on its website. It also states that it strives to 
‘continually innovate and make a positive difference to our community and 
those working for and with our Trust’. These statements have been 
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supported by the development of a comprehensive Corporate Strategy 
over the last five years, evidenced through publicly available board papers 
and corporate documents. In a review of these papers the Trust first 
presented its current Corporate Strategy in 2016 (TD1), laying out five 
‘Strategic Themes’; Develop, Innovate, Grow, Build and Quality (known 
internally as ‘DIGBQ’), around which it has built a strong brand. These 
strategic themes are supported by other integral elements including a 
‘Communication Strategy’ (TD2) and ‘Leadership Matter’s Strategy’ (TD3).  
 
The Trust has invested in its Leadership Matter’s Strategy, stating its 
ambition to empower all staff as leaders through four leadership 
behaviours: take responsibility; embrace change; work together; and 
being authentic. These behaviours are presented at all trust induction 
programmes and embedded within supervision and appraisal process. The 
Trust augments this with quarterly ‘Leadership Matters’ conferences and a 
programme of internal ‘Leadership Matters’ training. The Trust’s Learning 
and Development Team regularly deliver a one-day Foundation Level 
course ‘Quality performance and innovation’, which 134 members of staff 
accessed in 2018. The CQC report (TD4) contained specific commentary 
regarding the impressive nature of the Trust’s innovation ethos, making 
particular reference to the leadership behaviours, the Innovation and 
Creativity conference (section 3.2.6) and the foundation course. This 
deliberate and exceptional stance to include innovation within the Trust 
Corporate Strategy was reflected on in the interviews by Senior 
Leadership Team (SLT) interviewees. 
 
‘I think we have deliberately put this centre stage, I don’t think 
everybody does that, I think we’ve invested in it, which I don’t 
think everybody does, I think we’ve sought to align our strategic 
aims across the organisation’ (8E:SLT) 
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Although SLT interviewees were fully engaged in the Trust’s Corporate 
Strategy, well versed in DIGBQ and the innovate theme, many of Front-
line Staff (FLS), particularly very junior grades, did not understand these 
concepts. SLT members intrinsically recognised this and reflected within 
their interviews that the Corporate Strategy may not have penetrated to 
all levels of the trust; however, felt that this in itself was not significant, 
as long as staff were embracing the organisational ethos. This embracing 
of the ethos appeared evident, epitomised by a very junior member of 
staff who had been in the Trust only short time, who struggled to respond 
to any questions about the Trust Corporate Strategy, or innovate theme, 
but understood embracing change as part of her role.   
 
‘I think it’s definitely something that the Trust wants members of 
staff, to do, um, when I did my leadership and appraisal training, 
they spoke quite a lot about embracing change and it is 
everybody’s responsibility, and everybody’s, you know, it not just 
for people that are higher up, if you have an idea, its, you speak up 
and voice what you need to say.’ (15Q:FLS) 
 
There was evidence of the Trust commitment to innovation within its 
strategic documentation and to ‘embracing change’ as everybody’s 
business through deliberate communication and training. This directly 
supports the proposition that high-level macrosystem policy has been 
directly assimilated into the mesosystem (Farchi, et al. 2017). In addition, 
by describing innovation as part of everyone’s business the conceptual 
scope can be associated with a broad, umbrella meaning of innovation 
(Osborne, et al. 2011) (sections 2.2). A rival proposition was also noted; 
the Trust’s stance was identified ‘exceptional’ by the CQC, this would 
indicate that not every NHS trust is taking this approach. Although a 
strategy for innovation is important, to be effective it and innovation must 
be clearly understood (Baregheh, et al. 2009) (section 2.6), and this is 
explored next. 




4.3 Conceptualising innovation 
At another leadership event, the researcher was sat next to a Trust 
Governor (PO:22/03/18). The Governor, who had a scholarly knowledge in 
the field of Neuro Linguistic Programming and marketing, remarked on the 
use of the word ‘innovation’ used throughout the Trust’s presentations, 
highlighting the ambiguity of language, explaining ‘to innovate, is a verb, 
thus active, useful within strategy context; an innovation, is a noun, thus 
passive, better used within the context of projects’. This, when explicitly 
stated, appears obvious, (section 2.3) however, in the Trust document 
review inconsistent terminology was identified. 
 
The Trust’s Corporate Strategy was approved by the Board in July 2016 
(TD1); the first page of the document identifies ‘Innovate’ as Strategic 
Theme 2 (Figure. 4.1), however, by page two, this has changed to 
‘innovation’, with the stated outcome firmly associated with quality 
improvement and an objective that linked explicitly to income generation 
(Figure 4.1 and Figure 4.2), how the definition of how innovate or 
innovation was being conceptualised was not expressed within the 
documents.  




















The Innovate Theme has since evolved and now includes an annual 
delivery plan (TD5), it still does not include a definition of how the Trust is 
interpreting innovation conceptually; instead it postulates a simplified 
strategic objective and vision for the future (Table 4.1). 
 




Table 4.1 Trust innovate theme annual delivery plan 
(TD5)   
Strategic Theme 2: 
Innovate to change the future 
Outcome – what will it look/feel like in four years’ time?  
A diverse, contemporary organisation engaged in delivering and sharing 
innovations that are changing the future.  
This ambiguity of the language corroborates the proposition from the 
literature that innovation is a ‘buzzword’ with an axiomatic meaning 
(Osborne, et al. 2016). Although it is noted that some state this 
distinction is unimportant (Maher, et al. 2010), others disagree. Pisano 
(2019 p28) states that if innovation means ‘anything’, then it actually 
means ‘nothing’, adding that a shared understanding of the concept is 
essential within an organisation to prevent different fractions being pulled 
into separate directions and limiting impact (section 2.6). As no 
mesosystem definition was identified, the meaning of innovation was 
explored further with individual actors.  
 
A sli.do poll undertaken at the Leadership Matters conference (section 
3.2.6) was analysed using the word frequency function of NVivo and 
presented as a word-cloud (Appendix 4.VI). This provided a useful visual 
aid to how innovation was understood (Thomas, 2016). Words such as 
new, ideas, service, and improvement appeared most frequently, 
reaffirming the proposition that innovation and improvement are used 
interchangeably (Maher, et al. 2010). This was examined in greater depth 
within the interviews where understanding was questioned directly, the 
majority of SLT interviewees were confident in their responses. 
 
‘innovation is taking a completely differently look at a current or 
emergent problem and providing a solution that has not been tried 
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before um, using disruptive techniques, to be quite honest and um, 
creating a gap between, where you were and where you want to 
be, so the analogy for me would be the difference between cave 
men not having fire and cave men having fire, and the possibilities 
that then emerged as a result of that, in terms of development the 
species, er, er, along with being able to cook your dinner’ 6K:SLT 
 
This might have been anticipated as a large proportion of the SLT were 
engaged in developing the Trust’s strategy, attended Trust events, and 
courses. There was however, no uniformity to these descriptions, and 
many also linked their response directly or indirectly to quality 
improvement. Indeed, only a minority appear to recognise the notion of 
step change or risk. Concerns were raised by some SLT actors that there 
might be even less clarity of this operationally within the trust, perhaps 
resulting in innovation happening within the services unrecognised. 
 
‘people are innovating but not realising that they are innovating, so 
when I do service visits and go round to various parts of the 
organisation and see what people are doing and say to them that 
looks like innovation, they say  oh? Is it? And it is, they don’t 
realise it is, so there’s a lot of innovation going on that nobody 
knows is innovation or they don’t see it as innovation, um they just 
see it as being the sensible way to do things or clinically, we found 
that this worked better, or we went to a conference where 
somebody talked about using this particularly way of doing things 
and we’ve adapted it to [trust], um, so there is I think, potentially 
not so much a lack of innovation, but a lack of understanding of 
what innovation is?’ (2P:SLT) 
 
It was also postulated by SLT actors that communication of a complex 
strategy across the Trust was problematic. It was noted that the majority 
of people who attended Trust Leadership events were team leaders (Band 
The Case to Innovate: understanding organisational innovativeness in one NHS Trust 
106 
 
6)6 or above and that in a large fragmented organisation communication 
routes were challenging and messages did not always translate well, with 
some honest reflections around this. 
 
‘I don’t think we ever, get that bit brilliantly right, in that, you 
know I’ve been a band 5, band 6, band 7, and you, …. might get 
some drop down information about how we’re trying to do things, 
or what’s happening, or what you’re involved in this, it’s very hard 
to always get that at the right level and I don’t think we always 
manage to do that’ 9H:SLT 
 
This was confirmed within FLS interviewees, where actors, including Band 
5 and 6 registered nursing staff, did not recognised the Trust’s DIGBQ 
strategy and described the word innovation as ‘big’ , ‘posh’ or 
‘complicated’, associated with ‘academic study’, that could go ‘over 
people’s heads’, rather than delivering any practical change at their level. 
In the case of very junior unqualified staff (Band 2), several struggled 
with the word ‘innovation’ itself, finding it completely unrecognisable, until 
the Researcher re-phrased questions using ‘new ideas’ and ‘change’, 
whereby they readily re-engaged in conversation, highlighting how ideas 
had been taken forward within their teams to improve quality. In general 
interviews with FLS, and in particular very junior staff appeared much less 
certain, less focused on innovation and more associated with quality 








6 Bands denotes NHS pay grades 
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‘Innovation is basically making improvement of the service, so, 
stuff like, er, an idea in order to improve the quality of service that 
we provide’ 13I:FLS  
 
The connection between innovation and quality improvement was made 
by most interviewees across both cohorts and when prompted to 
differentiate between the two concepts, no clear distinction was 
articulated. At SLT level some felt that actually small changes might be 
‘more useful’ and at FLS level busy clinicians felt the differentiation was 
irrelevant, their focus was on doing the right thing for patients.  
 
‘as long as you’re doing the best you can do, and you’ve got the 
best level of care you can give and whether somebody’s labelled it 
as quality improvement or research and innovation, probably, I’d 
say on the ground level people don’t really care as long as, they 
feel that they’re doing the best they can do.’ (9C:FLS)  
 
The actual conceptualisation of innovation within the trust concurs with 
two findings of the literature review. Firstly, the lack of strategic goal for 
innovation (De Vires, et al. 2016), highlighted as significant because 
innovation requires not only dedicated resources, but to be understood 
and supported by the organisation (Pisano, 2019). Secondly, although 
some SLT members confidently described innovation, no shared definition 
was evident and junior staff were unclear what the concept meant, 
corroborating the proposition that innovation is poorly understood (Page, 
2014; section 2.3). At all levels the term innovation and improvement 
were used interchangeably, confirming the proposition from the literature 
that the parlance of healthcare is more keenly associated with 
improvement (Marjanovic, et al. 2018). Nevertheless, many stated that 
innovation was happening, as such a conceptual understanding of the 
nature, type and stage of innovation is important to both manage risks 
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and identify the resources to support it, this is explored in the next 
section. 
 
4.4 Understanding the creativity process  
The connection between innovation and technology was made by several 
interviewees, and divided opinion. There was, for some, a belief that 
technology brought advantages in terms of safety to patients and 
efficiency within the Trust and embrace with enthusiasm. Others however, 
were more reticent, recognising that not everybody felt confident using 
technology, discussing the fear faced by some staff in relation to the 
recent introduction of new computer systems. 
 
‘[IT system] it’s an innovation that actually improves the skills of 
the, of the staff, but there’s barriers ‘cause, obviously, some of the 
staff, they are not really adept to computers, they haven’t got 
much computer skills, so, although it quite, self, it’s quite simple 
and easy to use, ….…… I don’t know, they kind of, um, scared of 
that thing, you know, computers’ 13I:FLS 
 
This tension around technological innovation is recognised within the 
Trust, staff are supported by an extensive Information Technology team 
and multiple training programmes. This is also recognised within the 
healthcare literature, whilst the need for technological innovation is 
promoted (Welcome Trust, 2016), the barriers around its adoption and 
spread are documented (Roberts, et al. 2019). The NHS digital strategy 
now recognises the need to take all NHS staff on the technology journey 
(Honeyman, et al. 2016), acknowledging that a digitally enabled NHS 
workforce would release time to care (Topol, 2019). Although technology 
innovation is a large focus of NHS innovation (Welcome Trust, 2016), it 
was not the only type of innovation discussed.  
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At the mesosystem level the Trust had been recognised in July 2018 for a 
disruptive innovation technology project, which had won a safety award. 
SLT actors might again be expected to cite these examples of disruptive 
innovations, but more surprising a significant number of FLS across all 
levels presented this information, having heard about the Trust winning 
the award via routine communication channels. Other FLS discussed other 
new initiatives within the Trust that they had personally come into contact 
with, even if they didn’t recognise them as innovations, an example of 
which was the Nurse Associates project  
 
‘there, a new, yeah, the Band 4 thing, that we’re going to have 
Band 4 nurses on the ward, because normally we are work as Band 
7, 6, 5 and then we’ve got Band 3, but the band 4’s will be more 
qualified to even do medication and other things, so they’ll be 
helping the band 5’s a lot more with the works’ 10V:FLS  
 
The majority of FLS, when asked, spoke about ideas they or their teams 
had, or heard of from outside the Trust, projects they had or wanted to 
take forward. They articulated at their level, within the supportive 
structures of their teams, they felt empowered to engage in these, yet, it 
appeared that few FLS had stopped to think about what sort of initiative 
these ideas were. In addition, there was very little knowledge about what 
to do with an idea, beyond discussions within their team, hence, few had 
been shared beyond their own clinical area, despite the fact that other 
areas in the trust might have benefit. 
 
This corroborates the SLT perspective (section 4.3) that innovation was 
happening in the Trust, but not recognised. In addition, it supports the 
prior notion that not only are there no shortage of ideas in the NHS (Kelly 
& Young, 2017), but positive deviant cases can be identified where change 
can be achieved within the workplace (Sheard, et al. 2017). The most 
frequent examples cited were small incremental changes, which could be 
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classified at the level of continuous innovation, synonymous with the 
ethos of the NHS (Maher, et al. 2010), however, even these were not 
being shared, contributing to the barriers to adoption and spread 
internally, as well as external (Collin, 2018; Horton, et al. 2018). This 
presents another challenge, how do large complex organisations, with a 
recognised culture of ‘busyness’, (Nevalainena, et al. 2018) get 
practitioners to stop, and think about their ideas? A small selection of FLS 
references are presented in Table 4.2 showing how some might be 
classified. 
 




Table 4.2 Example of innovations given by interviewees 
 
Potential nature/type Interviewee reference  
Product -Technology  
(Rowley, et al. 2011) 
‘I guess, it’s always good to try something new, and you might, try something that say someone doesn’t 
think may become anything massive and actually it does and it, like for example, the body worn cameras, 
that was obviously just an idea and actually its grown so much now, and, didn’t they win awards for it or 
something, yeah, and it can change things’ (11J:FLS) 
Process – people 
(Rowley, et al. 2011) 
Disruptive 
(Pisano, 2019) 
‘Absolutely, absolutely! Erm, February last year, as a team we were struggling, erm, we felt like we were 
firefighting, with all the patients that we’ve seen and that’s how we’d, we’ve kind of looked at areas of why 
we were seeing certain patients, erm, what call, callouts we were getting, so that’s when we introduce the 
trauma boxes to the care homes, care, um, link nurses to the care homes, because the care homes felt that 
they were, erm, were being isolating, and having lack of continuity, with different nurses coming in all the 
time, um, and areas well, where we felt, if we did some teaching with the care homes and made them take 
a bit more responsibility and a bit more ownership for the care that they’re delivering and that’s why we’ve 
introduced them administering insulin in the care home, with teaching went alongside the diabetes team, 
we’ve also done pressure ulcers prevention, moisture lesion, and we’re doing, um, end of life care a well. 
So.’ 
‘Yes, yeah, rather than just going in and doing things for them we’re empowering them to make really 
important decisions in looking after the, looking after their residences, really. (7N:FLS) 
Process-innovation 
(Rowley, et al. 2011) 
Continuous 
Innovation 
‘There’s a few things that I’ve tried, but they haven’t really worked, when I first started I noticed that there 
was a lot of waste, I still notice that there’s a lot of waste, but it’s just trying to find out how to, fix that 
problem, I did originally email, a charity, that were looking for medical supplies in, I think it was Syria, but 
they wasn’t interested, in what we’d got so back to square one. Yeah, yeah. (14Z:FLS)  





(Baregheh, et al. 
2009)  
Technology 
(Rowley, et al. 2011) 
‘we also have like technology wise, its call a My Life, it’s like a machine that has, like, loads of activities on it 
for patients, um, reminisces, so they can watch like little clips of TV programmes from however long ago, 
and then, that they can use’ (11J:FLS) 
Adoption  




Yes, I mean nothing technology wise but I did an AIMS review and we went to a ward where they 
(Researcher: AIMS?) Sorry, Accreditation in Mental Health, so we have an app, it’s under CQC we have it 
every 3 years and band 6’s are expected to go out and do assessments in other hospitals, so on the back of 
that, we came back and said that, this particular hospital was giving out jelly, every day, very simple idea 
but it helps to improve hydration, it’s been researched and clinically proven, that actually someone might 
say no to a glass of water but they’ll take a jelly, so I brought that back and said I think that’s a really good 
idea, so within a week we went out brought jellies and introduced that onto the ward, which, we’ve seen 
notices asked families to bring things in, so we put those onto the ward, so not always the bigger things, but 
some of the little things, that make a difference. (9C:FLS) 
 




4.5 The hardware of innovation  
There was some thoughtful reflection around ‘innovation’ as a concept 
particularly by healthcare professionals, its relationship to clinical 
research, its role in developing robust evidence to support clinical practice 
along with their professional duty to engage with, keep up to date and 
provide the highest standard of healthcare. There was a view by more 
senior clinical staff that ‘innovation’ was a better term, a broader, and 
more encompassing term than ‘research’ and to many a more engaging 
word.  
 
But, one FLS actor reflected that ‘innovation’ here, was being utilised as a 
new standalone concept in its own right. This added uncertainty, the 
discussion alternatively acknowledging how this could both empower staff 
and impact patient care, but, presented a juxtaposed position of the 
clinical risks innovations might pose, and the need for careful governance. 
The need to stop unsuccessful innovation or discontinue old practice if new 
practices are successful was not fully articulated, although clinical staff 
touched on this through their reference to the traditional research route. 
This was corroborated by another clinical SLT member who commented 
that to innovate was a challenging process and not something that 
everyone might feel that they could do. 
 
‘innovation, you know, in terms of the terminology being used, in, 
in terms of it being a flag of something that we do here, is new to 
me, relatively new to me, ‘cause I think it’s probably just 
something that come under the umbrella of research and 
development before’ 16B:FLS 
 
This nervousness of managing the risk of clinical innovation was 
recognised by clinicians and corroborates finding from the literature that 
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innovation is inherently risky (Osborne, et al. 2011). Although the 
literature connects to the management of innovation through research or 
utilisation of regional innovation systems (Marjanovic, et al. 2019), there 
was limited discussion of this in the interviews. One SLT interviewee 
remarked that in previous roles in the private sector, they had just done 
things, but noted that they didn’t have the associated risks around patient 
care.  
 
‘I’ve not worked in the NHS for ever, so if I compare us [the Trust] 
to a private sector organisation and I think private sector 
organisations are sometimes more free to innovate, um, we were 
always changing things in organisations that I worked, because 
partly we didn’t have the same risks associated with patient safety, 
um, partly because we had more funds, we had no constraints and 
sometimes limited governance, around these things so we could go 
out and kind of go, we’ll just do that, we had, in fact we had a term 
called JDI, ‘Just Do It’, let’s just have a go’ (5G:SLT) 
 
Pisano (2019) presents the organisations formal innovation systems, as 
the ‘hardware’ through which it performs. The Trust, when it launched its 
‘Innovate Theme’ in January 2018, recognising at the time the need to 
accompany the strategic aim with a supportive innovation system, 
processes and structures, including a governance framework that 
supported the innovation pathway (TD6). This is accompanied by an 
operational plan (TD5), progress against which is reported on quarterly to 
the Trust’s Strategic Executive Board. These include specific meetings, 
structures, and processes that support innovation, with information 
available to all staff through the trust’s intranet and widely promoted 
within the Trust’s standard communication routes, yet, despite this there 
was limited recognition within the interviews of this system. 
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4.6 Chapter summary  
This section presents the Trust as a unique entity and the subject of this 
research. The context of its operation is described holistically and in doing 
so the chapter presents the Trust’s means for innovation, its size, 
complexity and professional identity (Section 2.4). The strategic position 
then provides more detailed description of the analytical frame, 
demonstrating how the broad umbrella policy imperative to innovate has 
influenced strategic development (Farchi, et al. 2016), with no clear 
definition of innovation, making its conceptualisation within the 
organisation uncertain (De Vries, et al. 2016).  
 
The ethos of embracing change appeared to be developing throughout the 
organisation, with the Trust engaging in wide variety of innovations 
(Rowley, et al. 2011). Recognition of innovation, however, and its 
typology was poor (Page, 2014) and closely associated by staff with 
quality improvement (Marjanovic, et al. 2018). Despite wide 
communication of the innovation support system, the hardware to support 
innovation, this pathway was unrecognised by the majority of 
interviewees, with FLS not usually sharing ideas beyond their teams. This 
corroborates theories of silo working (Castle-Clarke, et al. 2017) and the 
impact that this could have on adoption (Collins, 2018).  
 
It appeared that the relationship between the organisation’s mesosystem 
innovation strategy and the innovation taking place within the 
microsystem is complex, on some levels aligning yet, on others 
dysfunctional. To understand this better the social attribute was explored 
and is described next in relation to the receptive context for innovation 
within the organisation.                   
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Chapter 5.  The receptive context 
This chapter presents the findings from RQ2 and RQ37. These findings 
have been transformed through the triangulation process into a rich 
description of the Trust’s receptive context for innovation, the ‘software’ 
that shapes how it thinks (Pisano, 2019). This chapter explores the second 
objective of this research, how the antecedents of innovativeness are 
understood and recognised, supported by propositions from the literature 
review (section 2.5). The findings are presented in two sections, 
leadership matters and the culture for innovation.  
 
5.1 Leadership matters 
The Trust’s leadership strategy has already been presented (section 4.2). 
It is however worth exploring this in-depth, as leadership has been 
identified as having a disproportionately large impact on an organisation’s 
innovativeness (Maher, et al. 2010). In 2018 the Trust held four 
conferences, all of which had been attended by the researcher in her 
professional role. The impact of this visible presence was acknowledged by 
members of the SLT, recognising the contribution it made to including 
innovation as core Trust business. These conversations were linked to the 
importance of the Trust’s leadership strategy (TD3), and its leadership 
behaviour of ‘embracing change’ as the mechanism of devolving the 
responsibility for innovation throughout the trust (TD11). There was 








RQ2: How was innovation leadership articulated? 
RQ3: How was the innovation culture perceived? 
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embracing change was everybody’s responsibilities across all levels of the 
workforce. 
 
‘we have got a good team of people, want to embrace change, but 
if we can’t do that then I think we would be in somewhat difficult 
territory and I think that the other things is that, we’re monitoring 
that through appraisals and clearly reinforcing those behaviours, 
which is also important isn’t it, so that people get clarity about 
what that behaviour looks like’ (8E:SLT) 
 
‘it’s everybody’s responsibility you might only do the tiniest little 
thing but you’ve done something’ (5W:FLS) 
 
Differences were observed between two embedded units, Strategic 
Leadership Team (SLT) and Frontline Staff (FLS) regarding how they 
perceived their roles leading innovation. These are presented in two broad 
themes; SLT perceived their role as ‘articulating the vision’ within the 
mesosystem, whereas FLS described ‘leading from the front’ reflecting 
their place within the microsystem. The next sections describe how these 
different levels of leadership had differing foci. 
 
5.1.1 Articulating the vision 
Senior Leaders articulated their leadership role in three ways closely 
associated with the strategic aims of the Trust; leading the Trust’s 
innovation vision, managing the risks, and developing the external 
relationships within the local healthcare ecosystem. SLT members spoke 
about their roles in developing strategic vision for innovation and 
spreading this vision across the whole Trust, acting as conduits of 
communication, champions, and celebrating success. There was 
acknowledgement that this was a dynamic, iterative process, which 
required embedding into all areas as core business. There were 
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suggestions for the next stage of development, particularly linked to 
technology adoption within the organisation.  
 
‘I think we need to position it much more strategically, in the 
organisation and we need to be thinking in terms of the, the, reach 
that it has into, not just services that are maybe open minded and 
looking at technology, but all our services, and how it fits with an 
overall strategy in the Trust. (6K:SLT) 
 
Innovation is externally monitored by CQC as part of the annual ‘Well-Led’ 
inspection, SLT interviewees acknowledged this relationship and the need 
for innovation to be visible if an ‘outstanding’ rating was to be achieved 
and maintained. This was tempered with the role that they might have 
within the organisation, a few interviewees linked innovation to managing 
risk and safety.  
 
‘it’s about quality and safety, so we wouldn’t be innovating to do 
something worse to patients, I need to be assured that any 
innovations that we take forward have a governance structure 
around them to ensure patient safety’ (7X:SLT) 
 
The Trust’s place within the local healthcare ecosystem was also 
recognised, and the role leaders had in developing the right relationships 
with commissioners and other partners, (universities, third sector, NHS 
organisations) for innovation was significant. This positioning reflects the 
national policy developments around system integration articulated within 
the NHS long term plan (DH, 2019). Although the local healthcare 
ecosystem featured in these conversations, there were no references to 
the NIS (section 2.2.2) or its regional bodies available to support the Trust 
to innovate. 
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‘I think if you can get commissioners on board, if you can get 
partner organisations on board right at the start then, you’ve 
already done the work to start the innovation and we’ve got some 
really good working relationships with the thirds sector.’ (9H:SLT) 
 
5.1.2 Leading from the front 
Clinical Leaders saw their role as ‘leading from the front’, remarking that 
this was not easy. Communicating strategic concepts down through the 
established hierarchy within the Trust has been highlighted as 
problematic, coupled with the challenges of change management. Clinical 
leaders recognised this, but accepted their responsibilities as agents of 
change. This was described in four themes; socialising the concept of 
innovation; supporting the innovation environment; evaluating and 
sharing; team work. 
 
‘I say, for the band 6’s, we have to sort of leading from the front, 
and be  seen to be embracing the, if we’re sitting back and saying 
nobody will want to try this, blardy blah, load of old rubbish, then 
everybody else is gonna to follow that lead, whereas if we’re at the 
front saying right we’re going to try this, we think it’s going to be 
really good for the patient and the staff, if it doesn’t work, we’ll 
review it, we need to be seen to be sort of embracing that 
ourselves, because if we don’t embrace it, nobody else is, is going 
to be on board with it’ (9C:FLS) 
 
Clinical Leaders also discussed their roles in creating the right 
environment to support idea development. This included the need to 
encourage and support staff who came to them with ideas, positive 
feedback and praise as well as facilitating how an idea might be taken 
forward, including  identifying any necessary resources. There was an 
acknowledgement that although resources were limited, taking forward 
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smaller ideas was not all about funding, a sound working knowledge of the 
Trust, its systems and relationships within this environment could 
facilitate innovation and mitigate some of the barriers.  
 
More senior FLS recognised the need to evaluate the new ideas that they 
had taken forward to demonstrate impact, but admitted this was not 
something that they were very good at. The lack of evaluation skills and 
time were most commonly blamed for this, with FLS stating that if 
something worked then it continued, if it didn’t work then they just 
stopped it, but did not really take the time to consider this further. There 
was little time or incentive to share what they were doing beyond their 
team, unless more formal support was given by the trust, with more 
imperative to share something that had worked. Within the FLS, the team 
element featured very strongly, very junior staff and staff who were lone 
workers, spoke in the interviews about the value of their immediate 
superiors and the support of the team in developing any ideas and 
empowering staff to implement changes that they might want to take 
forward.  
 
‘it’s all about, supporting each other really, we’re a team, it’s 
irrelevant if you’re a band 2, and band 1 and band 3 or a band 8, 
we are all still part of the same organisation, we’re there to support 
each other.’ (3Y:FLS)  
 
5.1.3 Quantifying innovation leadership  
The Trust was rated outstanding overall by the CQC in August 2018, this 
included achieving an ‘outstanding’ rating in the ‘well-led’ category, which 
includes ‘innovation’. Although the qualitative evidence indicated that staff 
recognised and took an appropriate level of responsibility for innovation 
leadership, this did not provide an objective measurement for 
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benchmarking or replication, this was provided by the Trust Survey (TS) 
(section 3.2.6).  
 
Mean dimension scores (mDS) for leadership were calculated for each 
dimension, each achieving a positive score (Table 5.1). The highest score 
was achieved for the dimension ‘goals’ mDS=2.45 (TS Q16: ‘senior 
leadership has made it clear that innovative new thinking is required to 
achieve some of our organisational goals’). This corroborated the findings 
of the qualitative analysis that embracing change was seen as part of 
everyone’s’ business. The lowest score was achieved for the dimension of 
resource mDS=0.52 (TS Q8: ‘senior leadership makes sure there is both 
the availability of time and of money to support innovation’). This finding 
for the resource dimension corroborates other findings covered in section 
5.2.3.  
 



















2.21 .52 1.73 2.45 1.62 1.64 1.78 
3.00 1.00 2.00 3.00 2.00 2.00 2.00 
Mode 4 0 5 3 3 0 3 
Std. Deviation 2.667 2.667 2.901 2.500 2.760 2.416 2.650 
 
 
A Trust overall innovation leadership score was determined by calculating 
a grand mean of the above (Field, 2013). This demonstrates that the 
Trust was perceived to have a positive overall innovation leadership score 
of +1.71/+5, corroborating the qualitative data (Figure 5.1).  
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There was evidence that the Trusts leadership strategy, leadership 
behaviours and devolved leadership model was embedded and recognised 
at all levels in the Trust, and that this was having a positive impact 
empowering staff to make and sustain change within their teams. These 
findings concur with established propositions from the literature which 
indicate the important relationship between leadership and innovation 
(section 2.5.4). Differences between the two embedded units were 
recognised; with the SLT focused on innovation strategy and vision, whilst 
FLS valued the role of compassionate leadership in supporting innovations 
to be taken forward within teams (West, el al. 2017).  
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These differing leadership roles are not discussed explicitly within the 
policy literature, although it is noted that at the mesosystem level there is 
uncertainty around the extent senior NHS executives or clinicians should 
engage in the process of innovation or transformation (Castle-Clarke, et 
al. 2017). In the microsystems there is tangential evidence corroborating 
the importance of the team in creating ‘communities of practice’, which 
work together to problem solving and thus facilitate innovation (Swan, et 
al. 2002). Swan, et al. (2002) further elucidate, that although these 
communities of practice might be beneficial to the microsystems they 
support, they appear to have the opposite effect on organisational 
innovativeness, as when seeking solutions from within,  the free-flowing 
information across the microsystems then ceases. If radical innovation 
occurs at the intersection of established groups it is postulated that strong 
team innovation cultures might act as a barrier to organisational 
innovativeness (Swan, et al. 2002). In this way innovation leadership is 
intertwined with the organisations culture for innovation, explored in detail 
in the next section.   
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5.2 The Culture for Innovation (CfI)  
 
‘I’m always wary of the culture questions, [laughs] because I don’t 
think we have necessarily got a homogenous culture across the 
Trust’ (6K:SLT) 
 
The CfI was assessed quantitatively in two ways; the Collaborative 
Enquiry Workshop (CEW) which produced two data sets, individual scores 
(CEWi; n=90) and table groups (CEWg; n=22). Both data sets generated 
a single ‘mean Dimension Score’ (mDS) for each of the seven CfI 
dimensions (section 2.5.5). The Trust Survey (TS) (Appendix 1.0) was 
undertaken 3 months later, again a mean Dimension Score (mDS) was 
calculated for each of the seven CfI dimensions. Comparison was made 
across the three data sets (Table 5.2 and Figure 5.2).  
 
Table 5.2  




Resources Knowledge Goals Tools Rewards Relationships 
CEWi; n=91 0.30 0.00 1.34 1.77 0.91 1.07 1.70 
CEWg; n=22 0.41 -0.23 1.40 2.06 1.42 1.38 1.76 
TS; n=159 2.60 1.18 1.66 2.43 1.52 1.80 2.10 
 








The data representation in Figure 5.2 visually showed differences between 
data sets, compared in more detail during the transformation stage. 
Although CEWi scores appeared slightly lower than CEWg, the two data 
sets shared the same ‘organisational signature’ (Maher, et al. 2010) 
which, when compared statistically demonstrated no significant difference 
and were therefore considered to be from the same population.  
 
As the CEWg scores were negotiated amongst groups of individuals, the 
majority of which were senior leaders and managers, this was considered 
a proxy mesosystem CfI. This was recognised as being positive across the 
majority of dimensions, 5/7 dimensions scoring greater than +1. This was 
confirmed by calculating a grand mean, or overall Trust CfI score for the 
mesosystem of +1.17/+5.  
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The TS scores presented a broader cohort of individuals from within the 
Trust, and thus were considered a proxy for individuals within the 
microsystems. This was positive, with 7/7 dimensions scoring greater than 
+1, confirmed by the calculation of a grand mean, or overall Trust CfI 
score for the microsystem of +1.74/+5.  
 
Statistical comparison was carried out between these two data sets using 
the Kruskal-Wallis test, demonstrating a statistically significant difference 
between the CEWg and TS (p<.05), highlighting the variance between the 
proxy mesosystem and microsystem scores, with the microsystem 
obtaining the highest overall CfI score. 
 
The final analysis at this level was the comparison of overall CfI scores 
across four data sets; CEWi, CEWg, TS and the final TS item (TS Q29, ‘my 
department has an underlying culture that supports innovation’) for the 
Trust. The overall CfI scores were positive in all four datasets, the CEWi 
scoring the lowest (+1.02) and TS Q29 highest (+2.11) (Figure 5.3). An 
aggregation Trust CfI score was calculated using all data sets to give an 
aggregated Trust CfI score of 1.51 out of a maximum +5.  
 










CEW Individuals CEW Groups Survey SQ29
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This quantifies a positive CfI position for the Trust, corroborating the 
opinion provided in the CQC report in 2018 (TD4). As this was the first 
time this tool had been used within the Trust, no internal comparator was 
available. The only external comparator identified was in the original 
publication (Maher, et al. 2010 p50), which presented a portal graph from 
a trust, where the questionnaire had been sent to 200 staff, level 
unspecified, eliciting 47 responses (24% response) which was described 
as ‘having some of the highest scores amongst the Trusts in the pilot’. The 
numerical values for this survey were not given, so statistical comparison 
could not be made; however, visual comparison indicated the Trust scored 
higher than pilot. This positive overview of the Trust’s CfI is encouraging, 
but does not support the rich description and granular detail needed to 
assess where barriers to organisational innovation may lie (Swan, et al. 
2002) or where support might be required.  
 
In addition, although the majority of CfI dimensions appeared to share the 
same organisational footprint in the two data sets identified as 
representing the mesosystem (CEWg) and microsystem (TS), visually 
there were two exceptions; risk-taking, and resources. The differences 
between the mDS for these two data sets were explored statistically using 
the Kruskal-Wallis test. This confirmed that in five CfI dimensions there 
was no statistically significant differences between groups, the exception 
was risk-taking and resources, which both demonstrated highly statically 
significant differences (p<.001). This was explored in further detail, 
triangulating this data with that of the individual TS Questions (TS Q) and 
qualitative data drawn from the staff interviews (SI). 
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5.2.1 The complexity of ‘risk-taking 
 










(Maher, et al. 2010) 
 
‘the majority of the people who work in [Trust] are clinicians and 
there are different aspects to risk, certainly, you um, er, certain 
services it’s about taking positive risk, um, but then there is also 
the balance of looking to minimise um risk too, so, and that really 
feeds in, I think, to innovation, because um, whenever something 
is new there are risks associated with the introduction of that’ 
(1B:SLT) 
 
The elements of risk-taking are defined by Maher, et al. (2010) as 
emotional support, balanced assessment, learning from failure rather than 




Learning from failure rather than punishment 
Try new things 
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the first 4 TS Qs8 which achieved the highest TS mDS across the seven 
dimensions (Figure 5.5). 
 
Figure 5.5 CfI Trust Survey mean Dimensions Scores (MDS)  
 
 
If the risk taking CEWg mDS (0.41) is considered a proxy for an 
organisational or mesosystem score, and the TS mDS (2,60) a proxy for 
the individuals in the microsystem, it appeared that the mesosystem was 
more risk adverse than individuals within the microsystem. This risk 
aversion was recognised by some SLT interviewees, several of whom 
commented on the risk adverse nature of the NHS, although counter to 
this, one SLT member articulated their disappointment with this score, 








8 Trust Survey Questions (TS Q) 1-4 Risk-taking 
TS Q1: My direct supervisor supports me if I want to try something new. 
TS Q2: If I suggest a new idea and it fails, I know I will not be made to feel humiliated. 
TS Q3: In my department the general tendency is to try new things rather than hold onto 
the status quo. 
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‘NHS organisations are a little bit risk adverse, on the whole, um, I 
think that we as an organisation are more open to that, and in fact 
as a board, we set our risk appetite, one of the thing we are asked 
to do as a board is to set our risk appetite for different aspects and 
we set our risk appetite higher for innovation then we’d, then I 
think, traditionally organisations do, in the NHS, and I think that 
sends a signal about our preparedness to try different things’ 
(7X:SLT) 
 
This statement can be directly corroborated by a Trust Board document 
published in July 2018, ‘Risk Management Strategy’, (TD7) which stated 
that the Trust’s ‘risk appetite’ for innovation had been agreed as level 5, 
the maximum level, articulating its strategic ambition. The document 
further stating:  
 
‘Innovation the priority – consistently ‘breaking the mould’ and 
challenging current working practices. Investment in new 
technologies as catalyst for operational delivery. Devolved 
authority – management by Trust rather than tight control is 
standard practice’ (TD7) 
 
All Trust Board papers are publically available, yet, this document was not 
known to the emic researcher at the time and possibly not to other 
interviewees. This highlights two different problems; the first is the 
difficulty in communicating strategic decisions effectively across large 
complex organisations to those that need the information. The second is 
the temporal impact of research undertaken in a real world dynamic 
context; the CEW was undertaken at the beginning of January 2018, the 
TS April 2018, the interviews between June and September 2018, with the 
Risk Management Strategy published in July 2018. 
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In exploring the four TS questions that contributed to this dimension in 
depth, each achieved mean TS Question Score (mTS QS) of over 2, 
including TS Q4, which pertained to management support (Figure 5.6). 
This indicated that individuals within their teams, felt empowered to 
innovate and supported by their managers.  
 




The mTS QS were positive, but more significantly, these could be 
corroborated with interview data where clinicians pointed out that they 
took positive risks as part of their clinical duties and acknowledged the 
need to mitigate the clinical risk of innovation within approved governance 
systems (section 4.5). There were also direct examples from SI data of 
positive risk-taking with teams, where FLS were empowered and 
supported by clinical leaders to take forward ideas after a balanced 
assessment had been made. Indeed, the risks were acknowledged, and 
where failure had occurred, accepted as the next two quotes demonstrate. 
 
‘I have [staff name], who just came in now, was our first 
apprentice, um, and we were a bit, you know, anxious about her 
coming because we weren’t really sure how it was going to work, 







SQ1 SQ2 SQ3 SQ4
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my door and said, she’d been tidying up the treatment room, just 
to familiarise herself with where things were, she’d printed out a 
piece of paper, she said to me, can you look at this please, and it 
was, um, a charity, that collected out of date dressings and things 
for Syria, well my jaw just dropped, because she was this young 
girl, with no nursing background at all, who was 2 weeks in role, 
who was already looking at stuff like this, and it was just like, wow, 
I think we’ve aced out here’ (12S:FLS) 
 
‘There’s a few things that I’ve tried, but they haven’t really worked, 
when I first started I noticed that there was a lot of waste, I still 
notice that there’s a lot of waste, but it’s just trying to find out how 
to fix that problem, I did originally email, a charity, that were 
looking for medical supplies in, I think it was Syria, but they wasn’t 
interested, in what we’d got, so back to square one.’ (14Z:LFLS) 
 
Risk-taking, tolerance of failure, willingness to experiment and 
psychological safety are described as essential to innovation (West et al. 
2017), however, propositions from the literature identify NHS 
organisations are risk-averse (Albury, 2005). At organisational level this 
appeared to be the case within the Trust, although there appeared to be a 
desire to change this, this had yet to become established within the CfI. 
There was evidence that this was different however, within the 
microsystem, where clinical staff, within safe communities of practice 
undertook risky clinical procedures, including innovation, managed within 
their everyday roles. This juxtaposed position is evident in the 
quantitative data and recognised by staff, creating the most debate within 
the SI conversation, with the tension around getting this right 
acknowledged.  
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5.2.2 The exceptional case of medical staff (doctors and dentists) 
This was not the whole story, when the mTS QS for Risk-taking was 
explored by staff groups, the majority scored above 2, across all 4 
questions. There were two exceptions to this, doctors and dentists 
(collectively identified as medical staff) (n=5) and support staff (n=3). It 
was unclear who identified themselves as support staff, and therefore 
difficult to corroborate this directly with any other data; however, medical 
staff are easier to isolate from the data for separate analysis. Medical staff 
formed 3.1% of the TS sample (5/159), when compared with 2018 Trust 
workforce data, they also made up 3% of the Trust permanent staff 
(96/3183). In addition 4 medical staff took part in the interviews, 
although this cohort is too small for any statistical analysis, it is 
interesting to explore qualitatively.  
 
In the TS medical staff scored 3/4 Risk-taking questions8 highly (TS Q. 1, 
2 and 3), but scored TS Q4, senior leadership support lower than any 
other staff group (Figure 5.7).  
 
























The interview data corroborates some of this disconnect in terms of 
recognition, reward and career prospects.   
 
‘You know the doctor who did the [innovation project], he is a very 
good doctor, he genuinely feels that he did something over and 
above, neither reward and recognition and he can’t do it any 
longer, it is not, rewarded, it is not part of his core business’ 
(3T:SLT) 
 
If the mTS QS are extrapolated across all survey questions by staff group 
data, this disconnect between medical staff and the perceived CfI is 
further evidenced. Medical staff only achieved a positive score in the Risk-
taking dimension, all other MDS scored 0 or below. (Figure 5.8)  
 

























Several medical staff took part in the interviews, one explained: 
 
‘the average clinician needs to be convinced that what we are 
talking is for them, and, and, we can’t really force it, you can’t 
force anything on anyone, the moment that you say you need to do 
this and there is time in your job plan, then we will get into a 
discussion that ‘I have not time’, then we will lose the focus on 
innovation, because then the discussion will be time’ (3T:SLT) 
 
This opinion was not unanimous, as one member of the medical team 
(16B:FLS) postulated, innovation was actually restoring his own 
‘therapeutic optimism’. The barriers to engagement in research and 
innovation are documented within the literature (Greenhalgh, et al. 2005; 
Collins, 2018), time, skill and support are well recognised across all health 
and care staff; however, as the access to support for innovation within the 
Trust is open to all, why one professional group might feel disadvantaged 
over others, particularly a group that professionally is usually described as 
being more empowered than others is curious.  
 
As part of the analysis strategy, the researcher engaged with several Key 
Informants (section 3.4) to discuss findings and interpretations, one of 
which was a senior medical staff member. The difference in survey 
response and the comments from medical staff in the interviews were 
reflected on, the senior medic concurred with the predominate view, 
stating that they understood this response, that medical staff probably felt 
too pressured, didn’t know how or where to go for support to take 
innovative ideas forward, and identified that this was an area that needed 
developing within the Trust. This confirms suggestions from the literature 
around the way that doctors are trained and use knowledge as a 
profession is at odds with adoption of innovation (Williams, 2011; Castle-
Clarke, et al. 2017). 




5.2.3 The issue of resource 










(Maher, et al. 2010) 
 
‘I’m just curious as to why people feel that resources is low, um, 
[pause], and whether that is, that links to people feeling like, 
feeling that they’ve nowhere to turn, or, or, they would, yeah, or 
they wanted, if they wanted more information about something or 
they wanted support with something? They’d know where to go 
maybe? And I think that’s just always, challenging, it hard.’ 
(16B:FLS)  
 
If risk-taking created the most debate, the most discussed dimension was 
resources; this not only included funding and time, but authority to act 
(Figure 5.9) (Maher, et al. 2010). All of these elements are recognised 
within the literature as barriers to research, innovation, and organisational 
change, so this was not an unexpected finding (Greenhalgh, et al. 2004). 
Funding 
Time 
Authority to Act 
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In the CEWg ‘resources’ was the only mean Dimension Score to achieve a 
negative value, (-0.23) and in the TS was the lowest scoring of the seven 
dimensions (1.03). When exploring mean TS Question Scores across all 29 
items, TS Q69 and Q8, scored amongst the lowest across the data sets 
(Figure 5.10). 
 




This dimension also generated the most qualitative feedback from the 
CEW discussions, the trust survey, and staff interviews (98 codes in 
NVivo), although numbers alone do not equate to significance within 







9 Trust Survey Questions (TS Q) 5-8 Resources 
TS Q5: My direct supervisor supports me with the time to work on a promising new idea. 
TS Q6: In my department we seem to find the resources we need to find innovative 
ideas. 
TS Q7: I feel that I have reasonable authority to try out an innovative new idea 
TS Q8: Senior Leadership makes sure that there is both the availability of time and of 
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noted that the majority of these comments were coded as negatives. 
There appeared to be general agreement that resources were an issue 
within the Trust and the NHS in general. Amongst the SLT, some of the 
discussions were more reflective, the point was made that as a public 
sector healthcare provider, the core business was health delivery; 
therefore this was where funds were allocated. 
 
‘it certainly reflects the fact that we as an organisation have money 
to deliver care and treatment, that fundamentally where the 
resources are directed as a healthcare provider’ (1B:SLT) 
 
Other senior leaders reflected on what was available, rather than focusing 
on what was not available, with particular reference to the valuable 
resource of the staff themselves.  
 
‘I think the other one that’s important to reflect on is that, 
resources, is much more significant, I don’t know whether people 
would assume that you need overt resources, or whether you need 
people as resources and whether that influenced people’s minds 
sets in relations to that’ (8E:SLT)  
 
At present within the Trust, innovation funding is ad hoc and time within 
clinical services is limited, even with a supportive culture and engaged 
staff, one SLT member commented  
 
 ‘I understand from the corporate point of view, from the board 
point of view, but truly speaking we are not going to be getting 
very far with the innovation if there isn’t some kind of resource 
behind it, even if it’s just to evaluate’ (2P:SLT) 
 
At an operational level there was an acceptance that this was just how it 
was; it was the same for everybody and even a feeling that there were 
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work arounds that might be implemented. This might account for the 
significant difference in scores between the CEWg and TS data for 
resources.   
 
‘I think definitely resources is a, I would have guess that this would 
score low, I think sometimes there is blame, that’s the wrong 
word, but can always talk about lack of resources or we don’t have 
enough time we don’t have enough staff, we don’t have enough 
money, but, it isn’t always, that isn’t always the main barrier and 
actually if you got knowledge or goals or the tools we’ll find a way 
around the resource issue’ (10F:SLT)  
 
Yet, despite some more positive reflections, the lack of time and capacity 
within the services was clearly articulated, there was genuine anguish 
about the day-to-day pressures frontline clinical staff faced, and the 
impact that this had on them personally and indeed, ability to think or 
engage with any innovation, regardless of their desire.   
 
‘ok as a nurse, it’s, it’s kind of, ‘cause, obviously, you’re faced with 
daily challenges and its quite stressful and having to work in that 
kind of environment, sometime you don’t have much time, to really 
think about, other things, you’re basically putting all your energies 
and resources into working as a nurse, to get by, just to get by on 
a daily basis’ (13I:FLS) 
 
This lack of time is not just a ‘feeling’, it is corroborated through data 
captured by the Trust Corporate Performance System (TD12). ‘Headroom’ 
refers to a calculation made by organisations for managing staff 
unavailability (Hurst, 2003). It is the allowance within a Trust’s budget 
that covers staff absence through annual leave, sickness, parenting, study 
and leave. The Trust’s software provider supports comparisons to other 
NHS trusts; it demonstrated average headroom within NHS trusts of 21%, 
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with 63% of trusts operating above this threshold. The Trust’s headroom 
at this time was only 19%, without the inclusion of any parenting leave. 
This confirms both the ‘culture of busyness’ (Nevalainena, et al. 2018) 
within the trust and the challenging environment of care delivery (section 
2.1.3).  
 
If the effort was made to create the headroom, support across a team 
garnered, then the introduction of an innovation could provide a solution 
to this problem, creating capacity and releasing time to care, something 
that was much valued. A set of interviews took place with FLS within one 
team; all interviewees independently discussed the same initiative. The 
team leader talked about the team being at breaking point, the imperative 
to change and the challenge of leading that change. Although she had 
been given time to plan, implement and evaluate the transformation, she 
also described the feeling that this time allocation was not valued by the 
rest of the team and the frustration of having her ‘project days pulled’ due 
to ‘workload pressures’; conversely other team members commented that 
these project day’s ‘took her away from the work’ that needed doing, 
although they stated they understood the necessity of this. The initiative 
was successfully implemented, change had happened, and all had 
benefited from and valued the impact.  
 
‘it’s worked out that we’ve saved a lot of, nursing hours, um, I did 
a presentation, with all the information on that, and also with the 
[innovation] we’ve saved, I think like, in a month, we saved 9½ 
nursing hours, so it’s a big impact on, the girls, as well, because 
they are generally timed visits. (7N:FLS) 
 
In summary, the Trust position on resources corroborated the propositions 
from the literature (Maher, et al. 2010). There was however, some 
difference between the SLT perspectives, where there was a reflection on 
the resource that Trust had invested and the resource that the Trust staff 
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themselves provided, possibly confirming propositions that this provided 
organisational slack (Walker, 2014). SLT actors also recognised the need 
to identify and invest in an innovation if it was to succeed (Pisano, 2019). 
Amongst FLS actors, it appeared staff felt empowered to innovate within 
their teams, but, a lack of funding and in particular, time, were as very 
real barriers again confirming propositions from within the literature 
(Greenhalgh, et al. 2004). Despite this, there was evidence of positive 
deviant cases of innovation (Sheard, et al. 2017) with individual staff 
members, willing to take forward, or support the development of an idea 
or adopt ideas from outside the Trust and implement them for the benefit 
of their patients, and their teams, acknowledging the risks within this 
process. Another barrier given in the interviews however, was limited 
knowledge of how to evaluate innovation, this finding is presented next.  
 
5.2.4 What we know about knowledge  
 










(Maher, et al. 2010) 
 
‘I think we need more good news stories, whatever level they are, 
because I think that’s a classic, somehow we need to be much 
more aware of things that are going on in our own organisation, 
erm, and that’s always difficult to do, I know, but I think once you 
Wide Scope Search 
Uncensored, Unfiltered, Un-
summarised 
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hear something or see something that then start a spark for your 
own ideas or then you can think ok, how can we do that?’ 
(10F:SLT) 
 
Maher, et al. (2010) identify a broad knowledge base as the ‘fuel’ of 
innovation, including within their description, the need for knowledge to 
be  a wide scope search, uncensored, unfiltered, unsummarised, and free 
flowing (Figure 5.11). Although the mDS for knowledge was the most 
consistent across all data sets, it only scored +1.66/+5 in the TS, with 
further analysis of the dimension’s TS Qs (9-12)10, demonstrating the 







10 Survey questions (SQ) 9-12 Knowledge  
SQ9: If I don’t have the information I need, I feel comfortable asking my direct 
supervisor for it. 
SQ10: We are generally kept informed of activities in other departments that affect out 
work. 
SQ11: There is a lot of information available to me about what other organisations are 
doing to meet the same sort of changes we face. 
SQ12: Senior Leadership openly shares information that is important to me and the work 
I do. 









This dimension had limited attention within the interviews, however, when 
staff were asked directly where they went for support with ideas, FLS 
spoke in detail about the support of their immediate supervisors, with 
even very junior staff expressing how they felt comfortable taking ideas. 
In addition, the importance of the role of teams was emphasized, with the 
role of the team meeting highlighted as a place to discuss ideas. Clinical 
Leaders spoke about specialist support they could access from within the 
trust and from their service managers, corroborating the high value given 
to TS Q9. 
 
‘if it was something specific that I wanted to query, I would go to 
someone specific, if it was something general that I just thought 
erm, I’m not sure about this or are there issues there that I’m not 
sure about then I would got to [managers name] , she’s my 





















































































Figure 5.12 Mean Trust Survey Questions 
Scores highlighting Knowledge
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In the same way, when staff were asked what they would like in order to 
develop innovation, a common theme emerged around the need for the 
visibility of innovations within the Trust, supporting a low score of TS Q11.   
 
‘I think sometimes you get a little bit, sort of, almost, cocooned in 
your own role don’t you, and I obviously know what in our team is, 
is, you know, what’s there that’s changing and moving forward, but 
I think probably for the whole, um, organisation, maybe a little bit 
more vision of what’s there.’ (6M:FLS) 
 
Doctors also scored TS Q9 positively (mTS QS=+2.60); but, scored 
negatively on all of the other 3 questions in this section, this was 
commented on within the interview  
 
‘I would score probably a little lower on knowledge for innovate 
within the Trust, it’s not a huge score in any case, but I’m looking 
at average jobbing medic, but I’m also talking of nurses, with 
whom we all work very closely, an average clinician, clinicians’ 
awareness, knowledge about innovate, strategy or innovations in 
the Trust, out of 5 would be less than 1 point I think.’ (3T:SLT) 
 
This appears to concur with the other findings (section 4.4) of teams 
working in silos and not sharing what they are doing (Castle-Clarke, et al. 
2017). It also starts to highlight steps that can be taken to ensure that 
teams at the microsystem level are able to develop more open 
communication networks (Cohen, et al. 1990), the opportunity to make 
internal case studies available to staff, and develop sharing forums 
working across groups, spreading innovation (Williams, 2011). 
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5.2.5 We need the tools to innovate 
Figure 5.13 Tools 
 
 
(Maher, et al. 2010) 
 
‘I certainly think we’ve got the tools, I don’t know that people, 
clinicians or staff on the ground necessarily think that we’ve got 
the tools? Maybe they are reflecting on their tools, so have they 
got the tools rather than this, the Trust got the tools’ (2P:SLT) 
 
Innovating is a deliberate act, requiring both process and method; to 
believe that just because the culture is there that it will happen would not 
only be a fallacy, but creates chaos (Pisano, 2019). Maher, et al. (2010) 
concur, identifying the tools of innovation as flexibility, deliberate process, 
training, and encouragement for skills development (Figure 5.13), they 
note in their research that 46% of NHS staff said they require more tools 
for innovation. At the Trust Leadership Matters Event in January 2018 a 
workshop was presented around the accompanying publication ‘Thinking 
Differently’ (Maher, et al. 2010a). This resource was also available on the 
Trust intranet site, in addition, this and other tools for innovation are 
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taught in the one-day Foundation Level course ‘Quality performance and 
innovation’.  
 
TS Q23, explored the generation of ideas, scored amongst the highest in 
the data set, (2.97) corroborating the literature review preposition that 
individuals themselves did not feel there was an ideas problem (Adner, 
2006) (Figure 5.14 and Figure 5.15). Despite this, TS Q21 and TS Q2211 
both scored less than 1, confirming that FLS did not believe they had been 
trained or had a systematic approach to thinking differently. When this 
was extrapolated, and explored across staff groups, it showed that doctors 
felt the least trained and prepared in thinking creativity, again 
corroborating propositions from the literature regarding the impact of 








11 Trust Survey questions (SQ) 21-24 Knowledge  
TS Q21: My organisation has trained me in methods to support creative, new ways of 
thinking. 
TS Q22: My department uses specific methods to generate creative ideas around the 
challenges we face. 
TS Q23: I am capable of generative creative ideas. 
TS Q24: Senior Leadership actively demonstrates innovative new thing in tis our work. 
The Case to Innovate: understanding organisational innovativeness in one NHS Trust 
147 
 









The interview data generated only a few comments regarding tools, 
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5.3 Chapter summary  
This chapter presents an overview of the Trust’s receptive context for 
innovation, particularly focusing on the soft antecedent of innovation of 
leadership, and culture for innovation (CfI) (Robert, et al. 2009). These 
were explored within both the mesosystem and microsystem, with 
differences found across these levels for both antecedents.  
 
The SLT accepted their role in leading strategically, however the strategy 
itself was less explicitly described by FLS. The Trust leadership model has 
been described as devolved, and within the teams there was evidence that 
FLS were empowered to innovation, embracing change was part of 
everyone’s business (West, et al. 2017). Although high-level strategic 
leadership of innovation is noted within the literature, (Castel-Clarke, et 
al. 2018), this difference in leadership is little explored, identifying it as an 
area requiring further exploration. 
 
The organisations culture is recognised to be complex, difficult to measure 
and hard to change (Hogan, et al. 2014), nevertheless the CfI CEW format 
and TS provided a useful measurement tool (Maher, et al. 2010).  The 
data from the CEWg was considered a proxy for the mesosystem’s CfI and 
the TS a proxy for individual actors and the CfI within the microsystem; 
this was triangulated to give a rich descriptor of the Trust as the subject 
of this study. Overall the CfI was assessed as slightly positive, although 
potentially stronger within the microsystem then the mesosystem, and 
with some significant differences identified between the two around risk-
taking and resources dimension. This has only been partially explained 
within the rich description. 
 
The data confirms many of the propositions within the literature, but also 
presents several rival propositions (Yin, 2014) regarding how CfI was 
perceived within the Trust. The conceptualisation of changes in CfI over 
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the last year with the introduction of the Trust’s Innovation Strategy 
elicited contradictory responses across both SLT and FLS. Some felt there 
had been a very real positive shift, and that had a previous survey been 
undertaken, this difference would have been clearly demonstrated. Others 
felt that there really had been no change at all. Some staff referred to the 
positive changes in the Trust’s overall culture, but felt any impact this 
might have on innovation required much longer term investigation. Some 
appeared to feel empowered by innovation, for others it engendered a 
sense of fear. These contradictions clearly demonstrate that the CfI was 
not consistent across the organisation, or even within staff groups, 
thereby confirming the difficulties of measurement of the CfI (Hogan, et 
al. 2014; Maher, et al. 2010; Greenhalgh, et al. 2005). Perhaps one 
insightful reflection summarised this best. 
  
‘I’m not being critical but I still think it’s a bit embryonic, [laughter] 
I think everything’s there to make it something really special for 
the Trust, but it’s not quite launched, in the, and I’m not just 
talking about the usual razzmatazz type launch, I’m talking about 
making it much more in everybody’s consciousness, and I don’t 
think we’re there yet.’ (4A:SLT)  
 
This is accepted as a description of the Trust as it was, developing the 
understanding of what we know by reflecting, analysing, diagnosing, and 
describing, as the first stage of the design science model (Bevan, et al. 
2007). Chapter six builds on this by exploring what the value of engaging 
in innovation might be to the organisation and how it might then be 
developed.  
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Chapter 6.  Organisational Readiness for Change  
This chapter presents the findings from RQ412 around the shared beliefs, 
values, and behaviours around innovation. Although these findings have 
been transformed through triangulation and provide a rich description of 
the Trust, this stage of the analysis moves from the descriptive, ‘where 
are we now’, the first stage of the design science model, to the second 
stage of imagining and visualising the future (Bevan, et al, 2007). In this 
way the level of analysis changes, and starts the process of abduction of 
the findings, to theory development (section 3.3.3). This chapter explores 
three themes: the NHS climate of change; the value proposition; where 
do we go from here. 
 
6.1 The NHS climate of change 
The last decade has seen some of the most radical changes within the 
macrosystem in the NHS’s 70-year history, driven by the Health and 
Social Care Act (DH 2012), and ever increasing financial restraints. The 
macro level changes have reverberated to the meso-level; many NHS 
organisations have undergone significant and repeated organisational 
restructures. The Trust is no exception, undergoing a major restructure in 
2016, with significant impact on many positions in the Trust. Several 
interviewees from both cohorts referred to the constant climate of change 
within the NHS, and the Trust. There were numerous references to both 







12 RQ4: What were the shared belief, values, and behaviours around innovation? 
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within the microsystem, with recognition that memories were long and 
change was not necessarily seen as a positive.   
 
‘I mean transformation in terms of restructure and jobs, you know 
people, just 2 years ago we were seeing change as a threat, and 
we need to see it as something very different, so it’s not about 
your job, it’s about doing things differently and better, making your 
job better and making it better for your patients, ……. Erm, but I do 
think we’re almost, peoples’ memories are quite long and 
sometimes, yes, some of the anxiety and the hurt that went along 
side that exercise, people haven’t forgotten’ (4A:SLT) 
 
This particular thread resonated with the researcher, who, as an employee 
within the Trust at the time, and a long career in the NHS, could readily 
identify with the pain organisational change caused, reflecting in her 
journal that she ‘had never associated the negative impact this might 
have on innovation’ (PO:25/06/18).  
 
Although, there is a large body of healthcare literature on organisational 
change, how it should be managed, and on the wellbeing of healthcare 
staff, few authors recognise the impact that continual change within the 
healthcare ecosystem has on the innovation environment (Williams, 2011; 
Castle-Clarke, et al. 2017). Yet, organisational stability is powerfully 
associated with an organisations absorptive capacity (Williams, 2011) and 
psychological safety (Mueller, et al. 2012). The need for individuals to feel 
secure in order to innovate has been recognised in the business literature, 
where empirical evidence shows that uncertainty has a negative impact on 
creativity (Mueller, et al. 2012).  
 
Here, the Trust has two advantages, as a foundation trust it has some 
autonomy over decision making, including management and financial 
affairs, and as a CQC rated ‘outstanding’ organisation, it is less likely to be 
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subject to external pressures. This optimism was apparent within some of 
the SLT interviews, indeed, it might be hypothesised that this positioning 
might be the very reason why the Trust was able to develop its focus on 
its innovation strategy. If this focus is to be properly understood, then 
there is a need to understand how innovation is valued within the 
organisation.   
 
6.2 The value proposition 
Prior to the Trust’s innovation strategy being launched, the researcher had 
met with one of the Trust’s directors and been challenged to articulate 
what value innovation brought to the organisation and why they [the 
director], should support it. Despite years of experience and a 
fundamental personal belief in the value innovation and research brought 
to the NHS, providing a succinct response to a direct challenge around 
innovation was problematic (PO:11/06/18). National healthcare policy 
states that innovation is critical to the NHS (NHS, 2019). If the policy aims 
are understood to be those of quality improvement and cost efficiencies 
(Farchi, et al. 2016; Osborne, et al. 2011), then the findings from Chapter 
4.  suggests that this aim has been directly assimilated into the Trust 
strategy (section 4.2).  
 
Organisational Readiness for Change (ORC) (section 2.5.7) has been 
identified as the psychological state where the organisations members 
collectively value and commit to delivering change. This is however 
complex, not everyone shares the same motivation (Weiner, 2009). This 
was highlighted by other SLT members within in the interviews. 
 
‘I think there’s something about us quantifying the value they’re 
[innovations] bringing to the organisation, I don’t think we’re 
touching that yet, that’s what I’d look for us to do, is its benefit 
realisation.’ (2P:SLT) 




If NHS organisations are to become innovative organisations, then 
understanding the value to the organisation from the differing 
perspectives from within the system is essential. This elicited a lot of 
discussion within the interviews; the results are presented in five broad 
themes. (section 3.2.4). 
 
6.2.1  Value to customers; ‘for you, with you’  
The Trust’s strategic plan ‘for you, with you’ is a public document, 
available on the Trust website (TD8), within this the Trust outlines its 
strategic approach, ‘to develop a public and patient involvement model’, a 
concept that links through to the innovation strategy articulated through 
the ‘Involvement in Innovation (I3) plan (TD9). This reflects the impact of 
the outer context on organisational innovativeness, (section 2.5.1). 
Patients, carers, and the public were discussed at some stage within most 
of the interviews, across all staff levels. Interviewees stated they felt there 
was a clear commitment within the Trust to involve patients and the public 
in service improvement, re-design and innovation. This was particularly 
apparent at SLT level. 
 
‘if you can’t innovate then there’s no point in going and asking 
service users what they need from a Trust or organisation, because 
you’re just going to come back and say well we can’t do it, erm, so, 
so innovation should be a standard agenda item, because it’s about 
being responsive to, your population’ (9H:SLT) 
 
Clinical staff also identified their professional responsibility to keep up to 
date with new clinical developments, stating that if a proven clinical 
intervention was available, they wanted to be able to offer this to their 
patients. This appeared to be internally motivated and connected with the 
moral responsibilities of being a healthcare professional. This was 
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associated with offering treatment choice, improved therapeutic 
outcomes, and also linked with improving safety, particularly how the 
adoption of innovative technology could improve safety. A specific 
example given was ‘e-prescribing’, identifying that poor handwritten 
prescriptions were not only time consuming to decipher, but inherently 
dangerous.  
 
Most importantly there was recognition that doing things differently and 
doing different things to create a step change could release time to care. 
One ward leader summed this up when discussing the impact of a novel 
individualised drug administration routine recently initiated on their ward.   
 
‘….which sort of, avoided a lot of mistakes with them having the big 
trolley, with everyone’s medication in it, then you have to look for 
it, as well, so it saves time, improves 1:1 time with patient and 
then not making mistakes and omissions ‘cause you’re just 
concentrating on what’s in front of you’ (10V:FLS) 
 
The therapeutic advantages of patient choice, therapeutic outcomes and 
safety improvement innovation can bring to the NHS is a strong theme 
within the healthcare innovation literature, (NHS England, 2017). As the 
Trust is a healthcare organisation it is not surprising that this was 
explicitly stated within the findings. However, the benefit of customer 
engagement in delivering innovation are less well evidenced, only recently  
recognised as valuable to making sure that services meet the needs of the 
population they serve (West, et al. 2017).  
 
6.2.2 Value to the actors: energising the staff 
‘it’s about getting ideas, it’s about getting um, new concepts, it’s 
about bringing things together it’s about problem solving it’s about 
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creating energy in an organisation. Erm and for me it’s part of our 
culture’ (8E:SLT) 
 
SLT interviewees recognised the energy innovation could create within the 
organisation. They understood that healthcare was a constantly changing 
environment, that the Trust needed to change with it, but acknowledged 
this as challenging. Bringing people together to develop innovative 
solutions helped not only to solve these problems, but took staff along the 
journey with the Trust, one clinical leader stated that this was the part of 
the role they enjoyed the most, possibility even the one thing that kept 
them in their role.  
 
‘if you’re a nurse and you’re in an environment where there isn’t 
any change and you can’t respond to challenges and the, the 
progress that needs to be made, then that’s actually where some 
of your burn outs and stress and some of your difficulties with 
coming into work day to day is, because you just up against that 
wall all the time, whereas, if you’re innovating you spending a lot 
more time working out how to get around that wall, rather than 
just banging your head against it, erm, and it’s, it’s a bit addictive 
in a way’ (8E:SLT) 
 
At an individual level, clinical staff understood their professional duties 
regarding innovation and research, linking this to their professional 
training, where innovation and research is being taught as part of the 
educational curriculum, stating newly qualified staff were embracing this 
as part of their role. They acknowledged the impact this could have on 
their teams, even small innovations impacting on patient care, save staff 
time, and deliver a morale boost. Innovation, in this sense, was discussed 
as restoring belief in the future and engendering a sense of ‘therapeutic 
optimism’ that some staff had lost.  
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‘to do something more, to go beyond, um, what we’re doing 
already, or what we’re required to do, um, and that’s exciting, 
that’s, that make me feel, you know, enthused with some energy 
and some optimism for the future, and, you know, so, for example, 
um, my energy for um, for work and my sort of therapeutic 
optimism’ (16B:FLS) 
 
Workplace stress within the services is high, with an urgent call for NHS 
employers to address this (Wilkinson, 2015; George, 2016). Although 
there are recognised links to skill mix, workforce training and care quality 
(Addicott, et al. 2015) there is little in the healthcare literature about how 
engaging staff in innovation might energise them, potentially preventing 
stress or burn out. In the private sector it is recognised that people work 
for more than the financial reward, with innovative organisations that 
engage and motivate staff in problem-solving recognised to be good 
places to work, attracting, and retaining the most dynamic people (Pisano, 
2019). This appeared to be articulated by the interviewees who stated 
that they felt excited by innovation and were starting to believe in the 
future again. 
 
6.2.3 Value to the actors: join our team 
‘I saw the [Trust] were up for a national award with um, the 
[project], weren’t they, and you just think wow that’s phenomenal, 
you know, it’s those little titbits, isn’t it that you think, I, that’s, I 
work for these people, that’s wonderful’ (12S:FLS) 
 
The Trust, like many others, struggles to attract, recruit, and retain 
outstanding staff. The modern NHS is a highly competitive and challenging 
workplace (Addicott, et al. 2015). To address this the Trust has focused 
on becoming an employer of choice within the county, offering the living 
wage and career development opportunities (TD10). Staff at all levels 
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spoke of their pride to be working for an organisation that was looking to 
the future, taking things forward and offering patients treatment choice. 
They recognised the Trust had been nominated for several national 
awards and interviewees stated that they were pleased that they were 
working for the Trust, and the opportunity that this afforded them.  
 
There is little recognition in the NHS literature of this effect that an 
innovative organisation might have on recruitment and retention of staff. 
The business literature recognises that people are motivated by more than 
money and recognised the psychological rewards that work brings as 
significant. Companies that can offer challenging and interesting solution 
focused work places are known to attract talent (Pisano 2019). This was 
discussed with one key informant, who concurred, sharing an experience 
that had occurred in a recent interview they had conducted. When they 
had asked a candidate why they were applying for the position, the 
response was linked to an innovation that the Trust was known for 
nationally and the candidate’s therapeutic interest in that area of care. A 
reputation for innovation might therefore have the potential to attract 
talented staff. 
 
In these three themes the value proposition that innovation and 
innovating might bring to the patients, as the customers of the system, 
and to the staff, as the actors within the microsystems is presented. 
Although the potential impacts for patients are frequently cited in 
healthcare literature, the other two themes identified as energising staff, 
and supporting the recruitment and retention for trusts are not identified. 
There is however, a theoretical link to ORC, (section 2.5.7) identified as 
where ‘members share a collective determination to implement a change 
and a belief in their collective capacity to deliver’ (Weiner, 2009). This also 
connects to the aims associated with social innovation (Vickers, et al. 
2017) (section 2.6.1), where working together in new and different ways 
with multiple partners to solve problems can create something new and 
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exciting. These themes explored the value proposition from the customer 
and actor’s perspectives, the next sections explores the value proposition 
in the broader terms, within the constraints of environment, and 
transformation more closely associated with the system’s owners and the 
mesosystem perspective. 
 
6.2.4 Value to system owners: the on the front foot  
‘I think that embracing change is really important to us because 
everything we do be it internally or externally is about that, um, 
and if we’re going to remain, you know, front foot around the best 
quality of care and the best outcome for people than its essential 
that our teams can do that, it doesn’t matter where you sit in the 
organisation’ (8E:SLT) 
 
This desire to be and remain outstanding was not viewed as static; this 
was seen as a dynamic continuation across all interviewees. They 
understood that change was inevitable in healthcare, other organisations 
were innovating, and the Trust needed to keep moving forward, 
continually seeking out what was new and bring it into the Trust to remain 
contemporary. This was tempered with a note of caution that adoption 
was not a question of lifting and dropping into place, but needed to be 
carefully considered, trialled and evaluated to demonstrate real value 
within the specific context of the Trust. This was referred to as exploring 
the ‘art of the possible’, identifying problems, and finding solutions.  
 
Some SLT interviewees extended this concept beyond the Trust working 
alone as a single unit, linking innovation to large scale system change 
within the countywide healthcare ecosystem. There was an appreciation of 
the importance of the relationships the Trust had with other partners and 
providers and acknowledgement that synthesis of ideas within the system 
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and a desire to make these happen would not only benefit the Trust, but 
the population it served as well.  
 
6.2.5 Value to the system owners: survival of the fittest  
 ‘what do we need to focus the organisation on in order to remain, 
able to deliver services and to remain viable in an NHS 
environment, that’s getting increasingly financially restrictive and 
difficult to operate within. And innovate is one of the areas where 
looking to the future, without innovation now, we will are not going 
to be fit for purpose for the future’ (2P:SLT) 
 
The limited resource available within the NHS has already been identified 
(section 5.2.3); it was therefore unsurprising that association was made 
to the financial (Farchi, et al. 2016), and cost improvement argument 
(Osborne, et al. 2011). All were presented as important reasons why the 
Trust, as an organisation, needed to innovate. SLT members made 
connections from this to another concept, the need for NHS trusts to 
explore opportunities for business development. Here, there was 
acknowledgment that the context in which NHS trusts operated was 
changing and leaders needed to look outside their comfort zones for new 
business. 
 
‘the issue we sometimes face is that the NHS tries against all odds 
to innovate and then you get private providers who come in and 
basically, they take your innovation and they cut your costs, so 
they’re coming in and they nab the, nab the work away, so I don’t 
think we’ve got, I don’t think people here should see innovation as 
a threat, from within, but there will always be a threat from 
without unless we do, do things differently’ (4A:SLT) 
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Innovating was presented as an opportunity to win new funding, to 
develop and test ideas or grow the business. There was recognition for the 
need to promote success, take advantage of the kudos this would bring, 
and the suggestion that to be known as an innovative organisation would 
bring a competitive edge when putting in tenders, with the organisation 
recognised for keeping costs low and provide value for money, essential if 
the Trust not only wanted to survive but thrive.  
 
There was a hard business imperative to these conversations, in keeping 
with the business aims Baregheh, et al. (2009) definition of innovation 
(section 2.3). These value propositions, explored from the system owners 
perspective, were very different to the perception of the customers and 
actors in the first section where the conversations reflected on mobilising 
resources creatively for mutual benefit more associated with social 
innovation, (section 2.6.1). If these advantages are realised those within 
the organisation must collectively recognise them, how then to make 
innovation accessible is covered in the final section of this chapter. 
 
6.3 The accessibility problem 
‘innovation to an extent is like an orchid, it needs a lot of care and 
attention, it needs nurturing, it’s not just a seed that grows by the 
wayside, you got to put a lot of effort into it and if you don’t, it just 
won’t work, it’s not just something that germinates by itself’ 
(2P:SLT) 
 
The Trust can be demonstrated to have many of the building blocks of an 
innovative organisation in place; a strategy (section 994.2), systems 
(section 4.5), embedded leadership (section 5.1) and a developing culture 
for innovation (section 5.2), all essential for organisational innovativeness 
(Pisano, 2019). There are however, rival propositions within the evidence 
of the barriers to innovation, the nature of professionalism (section 5.2.2), 
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poor communication (section 4.5), the impact of organisational change 
(section 6.1) and differing values of innovation across staff levels (section 
6.2). All of these might impact on the Trust’s development as an  
innovative organisation, perhaps resulting in the overall Trust CfI score of 
only +1.51/+5, with the culture for innovation being described as 
‘embryonic’ and ‘patchy’ (section 5.3).  
 
Organisation Readiness for Change (ORC) has been identified as an 
important antecedent of organisation innovativeness, a psychological state 
where staff collectively value and share a belief in their ability to deliver 
transformation (section 2.5.7). Therefore unless there is collective 
awareness, understanding and engagement in innovation across the 
organisation, it is hard to envisage how ORC can develop. This led to what 
one senior leader called an ‘accessibility problem’, identifying the need to 
socialise the concept beyond a central hub. 
 
‘How does it feel accessible to the cleaner who works at [hospital] 
who may have a good idea about something? That’s the battle 
they’re up against as they don’t see it as innovation, they see it as 
just a good idea for their job, erm, unless it reaches that person 
who I see on a Wednesday I don’t know that we’re socialised it 
properly.’ (12N:SLT) 
 
ORC works across many elements of the social attribute required for 
innovation (section 2.5) and can be explored through the inter-relation of 
the seven dimensions of the CfI model (section 2.5.5). Several elements 
of this model have already been described in depth in Chapter 5. Three 
dimensions however, have not been explored and might further support 
development of this issue (Table 6.1).  
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Table 6.1 CfI mean Dimensions Scores 
 
Data Source Goals  Rewards  Relationships  
CEWi 1.79 1.08 1.70 
CEWg 2.06 1.38 1.76 
TD 2.32 1.64 1.79 
Overall mDS 2.01 1.23 1.75 
 
 
6.3.1 Psychological safety  
The quantitative data indicated that although the goals appeared to be 
understood, achieving the highest mDS across the CEWg (+2.06) and a 
high TS mDS (+2.32), the qualitative data highlights a disconnect. One 
discussion point from the CEWg stated ‘corporate goals and operational 
goals needed to be clearly aligned and easy to understand’, a point also 
recognised by interviewees.  
 
‘trust has identified this [innovation] as a significant area, my 
feeling is, this is all, corporate, or at the most at the managerial 
level as yet, it hasn’t gone anywhere significantly because it hasn’t 
percolated down to the people who will come up with these ideas 
and who will need input, the clinicians, ……. they’re probably saying 
because they [corporate] want to save some money, I’m not 
saying that is the reason, but it’s how it is perceived.’ (3T:SLT)  
 
Maher, et al. (2010) suggests that leaders need to not only set the goals 
for the organisation, but to then communicate them clearly to the rest of 
the organisation. Of the 16 FLS interviewed, 14 had either not heard of 
the Trust strategy or were unclear about it. In addition, very junior staff 
did not understand the term innovation and beyond gaining support from 
their immediate teams did not know how any idea might be developed, 
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linking ‘goals’ to either targets, their team goals, or confirmed their lack of 
clarity on the matter.  
 
Engagement across all levels of an organisation in innovation is recognised 
as important within the literature (Edmondson, 2018), this is not easy to 
affect though, particularly within a resource limited, culture of busyness 
(section 5.2.3). Some interviewees felt the innovation exemplars being 
promoted within the Trust were too complex to be accessible across all 
levels of staff, feeling simple examples that everyone might be able to 
comprehend or examples of continuous innovation taking place 
operationally, might give clarity of definition and purpose, making it part 
of everyday business for FLS.  
 
In these environments having the courage to present a new and maybe 
challenging idea can be an issue, particularly for junior staff (Edmondson, 
2018). Maher, et al. (2010) emphasises the need for leaders to support 
this process by framing the goals in a way that focuses on the ‘what’ 
needs to change and ‘why’, before then stretching these by asking 
individuals ‘how might we…….’ address these and thus expand creative 
thought. To implement this however, Maher, et al. (2010) highlights the 
need for managers and staff to feel both empowered and safe, barriers 
that have already been discussed in leadership (section 5.1) and risks 
(section 5.2.1).  
 
The ‘emotional support’ required to take risks has been described 
previously, but this can be strengthened by relationships developed 
between actors. Promoting open trusting environments, valuing 
everyone’s inputs, embracing diversity and working as a team have been 
identified as having an important impact (Maher, et al. 2010). The 
relationship dimension scored consistently across the quantitative data. 
The TS qualitative feedback elicited several comments in this area, which 
perhaps due to anonymity, allowed for some brutal honesty. Several 
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stated that ideas were dismissed out of hand by target driven managers, 
or that there was a need for face-to-face/team meetings where open and 
honest conversations could be encouraged and supported. Indeed, it 
seemed if new ideas were to happen then there was a need for more 
engagement and collaborative working. This was corroborated by the 
qualitative data, where examples although less direct, still presented a 
mixed perspective regarding relationships, perhaps one reason the mDS 
for relationships was only +1.79/+5.  
 
‘Managers meeting their staff face to face and being open and 
honest with them. Encouraging and engaging rather than sending 
constant text messages with capital letters.’ TS: 6842431804 
 
‘Staff need the confidence to block out time to discuss new ideas 
without worrying about waiting lists and other priorities.’ TS: 
6846037411 
 
It was also noted by the researcher that all examples pertained directly to 
the Trust or the local health economy, there was no acknowledgement of 
the NIS (section 2.2.2) or the support this could offer the Trust. There 
was however, some positive indication that the Trust recognised that 
relationships might require improvement, both internally and externally.  
 
‘some of the challenges are those relationships, that, so I would 
score higher because in the sense that I believe that people are 
working very, very hard to make those right’ (4A:SLT) 
 
Reward was identified as crucial to staff feeling engaged in innovation 
(Maher, et al. 2010), this dimension again scored consistently within the 
quantitative data, although overall it was positive, scoring highest in the 
TS mDS it still only achieved +1.64/5. Rewards received little attention at 
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the CEW discussion and only received 6 comments from the TS, although 
again these were honest. 
 
‘Rewards- Scored neutral, but would like to have scored higher, but 
we felt recognition is dependent on positive outcome or success, 
rewards are based on external outward facing success rather than 
internal attempts as day-to-day innovation’ CEW:8votes 
 
Edmondson (2018) links innovation and learning with organisational 
growth, but describes how the actors within the organisation need to have 
a collective belief in the ‘psychological safety’ to deliver this. It is only 
through psychological safety that individuals are able to share ideas and 
thoughts in the belief that they will be supported and without fear of 
personal reprisals (Edmondson, 2018). Psychological safety triangulates 
across other key texts; Maher, et al., (2010 p85) commentary on goals, 
relationship and rewards and West, et al.’s (2017) compassionate 
leadership model. This might then provide an explanation for the rival 
proposition of how organisational instability negatively impacts on 
innovation, as this destroys the psychological safety of employees.  
 
This might also go some way to explaining the variance of data between 
professional groups, if some professional groups such as doctors retain a 
more hierarchical model of knowledge development and structure (section 
5.2.2), then psychological safety might be harder to achieve. It might be 
hypothesised that perhaps one reason the Trust can now engage in the 
dialog around innovation, is that some level of organisational stability has 
been achieved due to its outstanding CQC rating.  
 
6.3.2 Contagious communication   
‘I think communications is one of the most positive things you can 
have, because if you have open communications that when as a 
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team you are sharing your ideas, that’s when you’re adapting 
ideas, pushing ideas forwards, erm, the knowledge again, that’s 
very important’ (4L:FLS) 
 
If psychological safety is to be achieved and impact on the ORC then this 
message must be communicated to all Trust members. The Knowledge 
dimension, particularly in relation to TS Q11 has already been discussed 
(section 5.2.4). The TS qualitative comments (n=24) were analysed into 
two themes; better communication and sharing examples, this was 
echoed throughout the SI data.  
 
There was recognition by SLT members of the Trust’s strategic decision to 
put a few high profile innovations forward for national recognition; award 
winning innovations were also discussed by FLS, with both groups 
associating success in this area with a sense of pride. There was a 
reflection by staff across all levels that small innovations were also being 
taken forward within teams, but often remaining unrecognised, not 
celebrated and most importantly not shared, which worried some FLS as 
these perhaps could add value elsewhere.  
 
‘I always think that there’s a risk that we do something really, 
really, good in one place and how do we capture and share that? 
So actually that becomes then, that innovation becomes good 
practice or best practice or becomes engrained within a protocol of 
actually that’s the way we all do it now? Because it’s such a good 
idea and it’s made such a difference.’ (5G:FLS) 
 
Several innovation examples were given from frontline staff (Table 4.2), 
yet when probed about plans to share these more widely, there was an 
acknowledgement that they hadn’t considered this, and agreed maybe 
they should, but didn’t know how. Although the Trust has a feedback 
button for sharing innovation successes on the staff intranet site, this 
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mechanism has remained unutilised and was not known to the 
interviewees. 
 
Clinical staff acknowledged that they were not very good at ‘selling 
themselves’, they appeared to feel that smaller changes were of no real 
significance and larger ideas, if not robustly evidenced through proper 
research, would not be seen as valuable by other clinic staff. One clinical 
leader spoke about an evaluation that they had been involved in with a 
colleague, although they were enthusiastically sharing with other teams 
within the Trust; they explained they lacked the knowledge of how to 
write this for external presentation or publication.  
 
‘we’ve done an evaluation, we’re um, myself and my colleague 
that’s, that’s been doing this, er, um hoping to publish, um, 
eventually, not really sure how to do that? So we’re, we’re trying to 
work our head around that at the moment’ (7H:FLS) 
 
It seemed that each interviewee had their preferred method of 
communication; notice boards, team meetings, electronic newsletter, the 
intranet, email updates and social media to name a few. The only method 
that most people agreed on was face-to-face presentation and support 
from the Trust’s Innovation and Research Team. They also felt that to be 
effective this should be away from the day-to-day environment, at team 
meetings, away days and conferences, although they recognised the 
resource intensive nature of this method. 
 
The importance of communication is generally cited within healthcare and 
is a key element of the Trust’s Innovate theme delivery plan (TD5). 
Despite this there is clear evidence that the Trust’s strategy is not 
penetrating across all staff groups (Chapter 4. ), that there are time 
delays in communicating strategic decision even across the SLT (section 
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5.2.1), and staff do not share innovative practices beyond their immediate 
teams.   
 
Maher, et al. (2010 p85) reiterates a ‘timeless principal in communication’ 
that ‘if they didn’t get it, you didn’t communicate it properly’. This 
certainly appears to be the case with innovation starting with the national 
policy documents that provide no clear message of how NHS trusts should 
understand innovation (section 2.2.5). This perhaps then has an effect on   
adoption and spread (Collins, 2018) or even on replication (Horton et al. 
2018). It appears systemically, with the ‘Weltanschauung’ (wider context 
of the macrosystem and exosystem), something is being lost in translation 
(Pope, et al. 2006).  
 
In this dynamic ecosystem even the traditional ‘gold standard’ ways of 
knowledge generation, the Randomised Controlled Trial (RCT) is being 
challenged as slow and out dated (Cornish, et al. 2009). Indeed, in a 
world increasingly dependent on rapid communication through technology, 
where communication threads go ‘viral’ overnight, traditional methods of 
transferring knowledge, conferences and publication, might be seen as 
slow and counterproductive. Finding a way to support contagious 
communications across complex networks that can support innovation is a 
key challenge.  
 
6.3.3 Demystification 
 ‘this whole thing’s about demystifying research and innovation, so, 
getting people to realise that doing research in their particular 
areas it doesn’t need to be this huge university sponsored piece of 
work, that actually so long as there’s some good governance and 
parameters and you’ve got some advice and you’ve got all the key 
components in place you can do that in your area’ (6K:SLT) 
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To support effective communication staff must have some understanding 
of the concepts being communicated. Tools and in particular TS Q21 and 
TS Q22 both obtained low scores; 33 TS qualitative feedback comments 
were coded to this dimension, specifically to the two elements; ‘deliberate 
process’ and ‘skills development’, (Maher et al. 2010) other data indicated 
that although very junior frontline staff saw the structure of their teams as 
providing all the support they required, clinical staff, and clinical leaders 
felt that they needed specific tools.  
 
Explicitly staff felt they needed a simple process to access resources that 
could support taking ideas forward including; funding, governance 
processes for innovation, and support evaluating impact. Simplifying the 
process may make access to support easier; it doesn’t solve the issue 
around the ambiguity of language identified (sections 2.2, 2.3.1, Chapter 
4. ). Addressing national policy concepts is beyond the scope of this 
research, however, within the mesosystem the lack of an agreed definition 
for innovation and how it is conceptualised is important, particularly as a 
lack of clarity and recognition might contribute to safety concerns 
(Osborne, et al. 2011).  
 
The different risks are associated with different innovation have been 
discussed, identifying the nature, type, and stage of innovation is 
therefore essential if the associated risks are to be considered both by the 
actors within the microsystem and supported and managed by the system 
owners and resources supplied. Capturing and classifying innovation is 
important to understanding both the resource commitment and support 
required, but another important reason for addressing this robustly is 
strategic; NHS trusts are increasingly being required to report the 
innovations within the CQC annual Partner Information Request (PIR).  
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6.3.4 Prioritisation  
 ‘It’s hard to be innovative, all I can say is time and resources, 
because if we, it’s a bit like you need to take time to ‘sharpen your 
sword’, it’s something that [executive] talks about lots, you carry 
on,  you’re run ragged, but if you take the time to ‘sharpen that 
sword’, it takes off so much of everybody’s time, because you  
stopped to think about it, what actually are we going to do, can we 
do that, you think it though, you come up with a proper solution, 
and you put it in place, whereas we all fire fight’ (11D:SLT) 
 
Resources have already been covered in a significant topic discussion 
(section 5.2.3); however, they are also important to how the Trust moves 
forward with its innovation strategy. Of the 48 CEW discussions 22 of the 
topics were coded as ‘resources, these discussions picked up 26% of the 
dot-democracy votes (n=90/351). In addition, the qualitative TS data had 
27 specific comments around being allowed time and making time.  
 
‘Protected time to discuss new ideas and ways to implement new 
ideas’ TS 
 
Time was a significant theme of the interviews, however, the focus was 
subtly different, this was not just about having time to undertake 
innovation projects it was also about time to think, recognising the 
associated value that this created. The Trust had initiated a monthly 
Senior Leadership Team meeting where SLT staff could come together to 
discuss pressing issues and sharing information. This was felt to be really 
positive as it brought together staff from across all services and 
directorates, creating the opportunity for ideas exchange that was much 
valued.  
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‘I think and I think having SLT has made a massive difference, 
having everybody together at SLT is hugely beneficial because you 
do get to understand what other people are doing within the 
organisation and what the risks might be’ (11D:SLT) 
 
There was acknowledgement by system owners that making time was 
never going to be easy, but if the Trust was serious about innovation, 
then there needed to be a systematic process allowing staff the time to 
stop and think about what could be done differently or better. Indeed, 
there was some recognition that there might be more risk associated with 
not stopping, thinking, and doing things differently to the organisation.  
 
‘if we, just continue to do what we have been doing, then it may 
not be enough, and so somewhere we’ve got to make room for 
innovation’ (4A:SLT) 
 
This coming together to share information and ideas was linked by FLS 
more generally to the Trust conferences. Several more junior FLS had 
recently attended a Trust conference on ‘Well-being’, they stated that this 
time away from their workplace, meeting other Trust staff was really 
useful and energising, one commented that she felt ready to take on new 
challenges as a result. One suggestion of how this could be replicated 
across the whole Trust was to have some protected ‘ideas time’ prioritised 
on the team meeting agendas within the Trust, so that regular discussions 
were encouraged.  
 
This concern about time has been raised within the wider context. An NHS 
Confederation blog in anticipation of the NHS Long Term Plan (2019) 
highlighted the opportunity this presented in ensuring that innovation and 
research was integrated as part of 21st century healthcare (Griffin, 2018). 
Although the blog commented on the huge potential for improvement and 
sustainability of the NHS, it also stated that ‘Batteries must be included’, 
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indicating that unless ring-fenced time was identified, innovation would 
just not be possible (Griffin, 2018).  
 
6.4 Chapter summary  
The chapter builds on the case descriptor and abducts what is known into 
theory using both design science and soft system methodology, to present 
three theories for how innovation might be developed within an NHS 
Trust. First, there is a need to achieve organisational stability, then 
conceptualisation of the value that innovation brings needs to be agreed, 
and finally how innovation should be strategically developed must be 
articulated. Critically to the success of the last concept are four elements: 
the need for staff to feel psychologically safe to innovate; the need to 
develop communication around innovation; the need to develop a clear 
conceptual understanding of innovation and the need to prioritise the type 
of innovation within an organisation so that resources, such as time and 
the funds required to deliver it, can be identified. The next step of this 
research takes this a stage further; seeking to develop a novel conceptual 
model of how this might work together to support the creation of an 
innovative organisation, as a prototype. This is presented in the discussion 
and conclusion that follows. 
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Chapter 7.  Discussion and conclusions 
The aim of this concluding chapter is to present how the purpose of the 
research has been addressed, the results delivered, and new theory 
developed (Murray 2002). Pulling the research together in this way 
creates the closure of the thesis, but also recognises the limitation of a 
particular piece of research and identifies further actions that still need to 
be undertaken (Murray 2002). This is discussed in six sections: addressing 
the study purpose; the essence of organisational innovativeness; 
contribution to knowledge; implications for practice; areas for further 
study and the limitations of the research. The chapter concludes with 
reflections of the researcher’s research journey.  
 
7.1 Addressing the study purpose 
Two aims were articulated at the outset of this research, the first was to 
develop theoretical knowledge by providing conceptual clarity on how an 
NHS Trust functions as an innovative organisation and the second was to 
provide a solution to the problems faced by those tasked with supporting 
and developing innovation and innovation strategy within these 
organisations. A review of the literature identified the use of the word 
innovation as widespread within macrosystem policy, and the exosystem 
of UK healthcare; yet, innovation as a concept was not clearly defined or 
conceptualised. Indeed, although the role of individual clinicians is 
acknowledged within this literature base (Farr, et al. 1990), there is 
limited recognition of the role of NHS trusts, the mesosystem, as partners 
in innovation. This has led to some identifying the NHS trust as a ‘hidden 
innovation system’ (Thune, et al. 2011) with others identifying the lack of 
theory available to support the leaders to support this agenda (Williams, 
2011).  
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This thesis acknowledges the complexity of this area and identified three 
useful theoretical models from the literature to support the structure and 
exploration of organisational innovativeness: a contextual definition of 
innovation as a six-stage process (Baregheh, et al. 2011)(section 2.3); a 
model of the ‘inner context’ in innovation technology adoption, describing 
an organisations hard and soft antecedents of innovation (Robert, et al. 
2009) (Table 2.4) and a framework for the measurement and 
development of organisational Culture for Innovation (Maher, et al. 2010) 
(Figure 2.4). The similarities between these three models was observed 
(Table 7.1)  
 
Table 7.1 Similarities between three conceptual models 
 
 Baregheh, et al. 2009 Robert, et al. 2009 Maher, et al. 2010 
Innovation as a 
creative process 
  x 
Means/hard 
antecedents 
  (resources) 
Social context    
Leadership  x   
Strategic vision   (goals) 
 
 
The complexity and inter-relational nature of these elements was 
identified and explored in the literature review (Chapter 2. ). Their 
importance, in terms of an organisation’s innovative performance was 
corroborated within the business community where Pisano (2019), notes  
 
‘Innovative performance is rooted in a combination of strategy, 
organisational systems, and culture, all of which are shaped by 
leadership.’ 
 
This then framed the three research objectives (Table 7.2). 
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Table 7.2 Research objectives 
 
1. How is innovation conceptualised? 
2. How are the antecedents of innovativeness understood? 
3. How can organisational innovativeness be developed?  
 
  
To explore these objectives the researcher chose a case study approach. 
As an academic methodology, the case study has been criticised as poorly 
developed, nevertheless, it was appealing because the healthcare 
ecosystem was described as a complex system with porous boundaries 
(Greenhalgh, et al. 2005). The case study provided a means to identify 
the bounds of the case, a single NHS Trust, and the specific time period of 
exploration (Thomas, 2016). To articulate this approach in a cogent 
format, Carolan, et al.’s (2014) ‘DESCARTE’ framework was applied and a 
detailed description of the research design given (section 3.2). The 
positionality of the researcher and the critical realist lens that the research 
was conducted through was made explicit from the outset (section 1.5).  
 
In keeping with the case study ethos, the research posed five questions 
for the research to answer (Yin, 2014) and used mixed-methods of data 
collection (Section 3.2.6). Two primary data sources were adapted from 
the Culture for Innovation (CfI) model presented by Maher, et al. (2010). 
This included quantitative measurement of the Trust’s CfI at a 
Collaborative Enquiry Workshop (CEW), and a Trust Survey (TS). The 
CEW provided a negotiated group score for the organisational CfI, 
accepted as a proxy for a mesosystem, and the TS allowed wider access 
to individual scores, identified as a proxy CfI score for the microsystems. 
The results of both data sets informed the qualitative data collection. 
 
The quantitative data was augmented by qualitative data from 28 Staff 
Interviews (SI) which included two embedded units, the Trust’s Senior 
Leadership Team (SLT; n=12) and Frontline Staff (FLS; n=16) (Plsek, et 
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al. 2007). These three primary data sources were supported by other 
secondary data sources including, Trust Documentation and Participant 
Observation (PO). This generated a lot of data; a significant challenge in 
terms of data management, presentation, and analysis. Data triangulation 
was undertaken using Onwuegbuzie, et al. (2006) seven-stage model, 
through a critical realist’s lens, informed by reflexive practice and key 
informant feedback.  
 
A case study is a holistic enquiry method that explores a contemporary 
phenomenon in-depth within its context (Thomas, 2016); the findings 
were presented as a case descriptor in chapters four, five, and six with 
each chapter structured to consecutively address the three research 
objectives through rich description. This started in Chapter four 
conceptualising innovation within the Trust; Chapter five addresses the 
antecedents of innovation through discussion of the social attributes of 
innovation within the receptive context; Chapter six concluded with how 
an innovative organisation can be developed through a review for 
organisational readiness for change. At the level of transformation and 
abduction the two aims of the research, how the Trust functions as an 
innovative organisation, and how the researcher, leading in this area can 
support innovation development within the Trust were met.  
 
7.2 The essence of innovativeness, a new theoretical model  
The research aims however, were more ambitious, stating the desire to 
develop theoretical knowledge by providing conceptual clarity on how NHS 
trusts function as innovative organisations. The final stage of analysis 
uses the process of retroduction, where the focus shifts from the empirical 
generalisation to possible causal mechanism and structures that operate 
within the real domain (Tsang, 2014). Bhaskar, (1979) considered this 
moving from:  
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‘the manifest phenomena of social life, as conceptualised in the 
experiences of the social agents concerned, to the essential 
relationship that necessitates them’. (Bhaskar, 1979 p32) 
 
The reasoning process behind this stage is by design, ‘fluid and recursive’; 
moving from the empirical evidence to theoretical model and back again 
to develop deeper levels of understanding (Fletcher, 2016). In this way, 
not only is the case able to describe how the findings work together as a 
whole system, but how in understanding this system, problems can be 
solved (Thomas, 2016). The third stage of the design science model puts 
this more simply as modelling, planning, and prototyping (Bevan, et al. 
2007). This then would be the research’s original contribution to theory.  
 
If innovativeness is understood as ‘the quality of being innovative’ (Table 
2.1), then NHS trusts seeking to develop as outstanding innovative 
organisations need to be able to articulate this ‘essence of organisational 
innovativeness’, and the possible casual mechanism and structures that 
operate within the real domain that contributes to this theory. The 
complexity of this task however, should not be underestimated, innovation 
has been identified as a nebulous concept, difficult to conceptualise within 
complex systems that do not function in predictable ways (section 3.2.4). 
Indeed, the findings presented (Chapters 4, 5, and 6) cover 27 broad 
themes and corroborated many of the propositions identified in the 
literature review (Table 7.3).  
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Chapter five The receptive context Chapter six Organisational readiness for change 
4.1 The Trust  5.1 
Leadership 
Matters 






6.2 The value 
proposition  
6.3 The accessibility 
problem 
 
4.2 The strategic position  5.1.1 
Articulating 
the Vision 
5.2.1 The complexity 
of risk-taking 
 
 6.2.1 value to 
customers; ‘for you, 









5.2.2 The exceptional 
case of medical staff  





4.4 Understanding the 





5.2.3 The issue of 
Resource 
 6.2.3 Value to the 





4.5 The hardware of 
innovation 
 5.2.4 What we know 
about Knowledge 
 6.2.4 Value to the 
system owners; on 
the front foot  
6.3.4 Prioritisation 
  5.2.5 We need the 
Tools to innovate 
 6.2.5 Value to the 
system owners; 









If these findings are described as a narrative, then Chapter four confirms the propositions that the definition of innovation in 
the healthcare macrosystem policy is poor with an umbrella conceptualisation directly assimilated into the mesosystem. In 
the complex environment of the mesosystem the pressure to innovate is accepted, however, the concept of innovation is 
taken to mean everything (section 4.2). In this situation, it could be hypothesised that the mesosystem suffers from a lack 
of innovation identity that must be addressed. 
 
In the microsystems, the culture of ‘busyness’ dominates, (section 4.3 and 4.4) the majority of healthcare staff implement 
ideas supported by strong multi-professional communities of practice. Innovation thrives at this level, good ideas, small 
micro-innovations survive, contributing to a general positive improvement, but may not spread beyond these small 
communities; other ideas, just wither. The lack of innovation identity appears to have limited significance. 
 
Acceptance of this status quo however, could have significant but hitherto unrecognised implications for the mesosystem. 
Communities of practice, which only look inwards for solutions by their very nature, impede the free communication across 
the whole organisation, identified as an important dimension in developing an organisational CfI (Maher, et al. 2010). In 
addition, although a large professional workforce is noted to be positively associated with innovation, a professional 
community, such as medical staff, who historically work more autonomously, may be isolated from these communities of 
practice, (section 5.2.2) disabling their ability to contribute (Ferlie, et al. 2005). In addition, there are risks associated with 
conflating quality improvements and innovations which need to be managed (section 2.3.1).  







Lastly, organisational change was identified as a particular obstacle to innovation, (section 6.1) and supported by the 
literature as having a negative and undermining impact on the innovation process (Mueller, et al. 2012). In the dynamic 
healthcare ecosystem, change is unavoidable. If these are conflated with the more overtly recognised barriers to innovation 
discussed within the data of ‘risk-taking’ (section 5.2.1), and the lack of specific ‘resources’, in particular, time, (section 
5.2.3), and the impact of organisational change (section 6.1), then the obstacles to developing innovation within the 
mesosystem can be understood. If these are not articulated and addressed, barriers to innovation will remain, (Collins, 
2018), with potentially disastrous consequences for the NHS. 
 
The literature review identified that NHS trusts need to start thinking more like businesses (Youth Health Parliament, 2016). 
A business’s survival is dependent on its understanding of its innovation strategy and supporting organisational innovation 
systems (Pisano, 2019). If the findings summarised in Table 7.3 are transformed through retroduction to describe the 
structures and mechanisms within the mesosystem then this might be identified for NHS trusts, with gaps and actions 
identified. 
 
The ‘Essence of Organisational Innovativeness’ model ( 
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) provides a diagrammatic representation of a model that might support 
theory development in this area. It demonstrates the complexity within 
different levels of the healthcare ecosystem; macrosystem, exosystem, 
mesosystem, and microsystem separated by dotted lines that represent 
the porous boundaries between. In the mesosystem, it is essential that 
innovation is clearly described and understood to ensure it fits with the 
business imperative. This strategic conceptualisation also ensures that 
risks are identified and can be managed with appropriate resources 
allocated. This is supported by four conceptual pillars identified as 
Leadership, the Culture for Innovation, the Value Proposition, and 
Accessibility. Each pillar has its own unique elements, but none works in 
isolation, all work together within the mesosystem, and the microsystem 
where the communities of practice are located. 
 
The first pillar of leadership needs to be understood at multiple levels 
across the organisation. Senior leaders and managers take the role 
articulating the innovation vision across the organisation with the 
devolved leadership whilst enacting this on the frontline, through a 
compassionate leadership model (West, et al. 2017). All individuals then 
play their role within their communities of practice.   
 
The second pillar is the Culture for Innovation, demonstrating the need for 
the seven separate but overlapping dimensions. Together these also 
capture knowledge and relationships, key elements of absorptive capacity 
(section 2.5.3). It is here that the impact of different professional groups 
needs to be understood. In this research the Trust was assessed as having 
a positive overall CfI, although described as embryonic, maybe even on 
the verge of development (section 5.3), but where the mesosystem 
barriers around ‘risk-taking’ (section 5.2.1), and ‘resources’ sit (section 
5.2.3) and need to be managed. An advantage of the CfI is that an 
existing theoretical framework (section 2.5.5) means this can be 




measured; annual audits undertaken and action plans developed to 
address specific issues identified. 
 
The third pillar has been articulated as the value that innovation brings to 
the system. This is viewed from the differing perspectives of the 
customers, actors, and system owners (Thomas, 2016). This is related to 
the motivation that sits behind an Organisations Readiness for Change 
(ORC) (section 2.5.7). This noticeably differs across the organisational 
hierarchy, senior leaders clearly identifying the value innovation could 
bring to the mesosystem, (sections 6.2.4 and 6.2.5). There was a shared 
understanding of what innovation brought to patients (section 6.2.1), but 
a new understanding emerged regarding the value innovation brought to 
staff (section 6.2.2 and 6.2.3). If this understanding is embraced by the 
mesosystem, this could deliver a real driver to mobilise ORC and engage 
individuals to work collectively to achieve a greater impact (Weiner, 
2009).  
 
The fourth pillar requires innovation to be conceptually accessible across 
all levels of the system, mitigating the barriers identified as organisational 
changes by making the organisation feel a psychologically safe place to 
innovate. There is a need to create a contagious conversation so that 
innovation is recognised, shared, and adoption supported. To achieve this, 
innovation must be demystifying, it must become real, tangible, and 
achievable. If an organisation is to engage in the thoughtful and careful 
construction of innovation, then clear priorities must be identified to 
ensure limited resources can be effectively targeted. 
 
These themes are not just descriptive; they represent a translation of 
data, distilled from an in-depth exploration of the case and through the 
process of retroduction encapsulated to address the first aim of the 
research to develop conceptual clarity and theoretical knowledge of how 




NHS trusts function as innovative organisations, and at a theoretical level 
responds directly to the three study objectives (Section 1.2). 
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7.3 Delivering Innovation Strategy in the NHS 
The second aim of this research was to provide a way forward for those 
with responsibility for leading innovation strategy within NHS trusts 
(section 1.2). In case study research, the research questions (section 
3.2.6) are posed as ‘tools’ that helps the researcher to define the evidence 
and address the study aims (Yin, 2014). The five research questions 
(Table 3.5) thus supported the researcher, an innovation leader within an 
NHS trust, to identify the specific areas of exploration required to address 
the second research aim, which focused on providing solutions for those 
leading innovation within an NHS trust.  
 
The macrosystem, although keen to establish the UK within a Global 
Innovation System and build the National Innovation System (Section 
2.2.2), has been reproached for confused polices, that do not readily 
translate to the mesosystem context (Youth Health Parliament, 2016). 
Conversely, although innovation can be seen to be thriving in the 
microsystem, the lack of strategic clarity within the mesosystem prevents 
these innovations spreading at pace and scale (Collins, 2018; Greenhalgh, 
et al. 2005). This lack of innovation strategy within the mesosystem could 
be considered a bottleneck in developing the National Innovation System 
pipeline. To address this NHS trusts need to develop from being mere 
‘contexts’ for innovation, to being true ‘partners’ of the innovation process 
(Thune, et al. 2016). This research begins to describe how NHS trusts 
might start to develop as partners in research, which might be described 
as three critical elements 
 
A primary principal for developing an NHS trust as an innovative 
organisation is how the organisation defines and conceptualises innovation 
(Baregheh, et al. 2009). If conceptually innovation within the mesosystem 
is not clearly defined and understood, conflating anything from quality 
improvement to disruptive technology under one label, then how can a 




message around what the organisation considers as innovation become 
accessible to the microsystems and the individuals within them? 
Identifying a definition of innovation and having an understanding of the 
nature, type, and stage of innovation that will be supported is essential. 
 
The second principal is to have a clear strategy for innovation within the 
organisation’s inner context (Robert, et al. 2009). Critical elements for a 
strategy are included within the Essence of Organisational Innovativeness 
model, including leadership, the culture for innovation, the value 
proposition and accessibility. These elements are the glue or theory 
(Thomas, 2015) through which organisations can develop and promote 
their innovation ambitions. If this strategy is well-defined, resources can 
be allocated and clear communications can be promoted through the 
organisation to the microsystems. 
 
The final principal is that if organisations want to develop their 
innovativeness they need to know their starting point, identify action 
plans of how to develop their organisational innovativeness journeys and 
to be able to measure success. The Culture for Innovation (CfI) framework 
developed by Maher, et al. (2010) has been demonstrated to provide an 
ease of use, evidence-based tool for this principal. The seven dimensions 
of the CfI tool collectively have been demonstrated to incorporate many of 
the other areas key to innovative organisations identified within this 
research; leadership, organisational readiness for change and goals. It is 
therefore able to provide baseline assessment, action plan development 
and impact measurement.  
 
7.4 Contribution to knowledge  
In summary this research presents as its product a novel model ‘The 
essence of organisational innovativeness’. This model for the first time 
conceptualises theoretically how NHS organisations, as complex systems, 




might function as innovative organisations, and in doing so identifies the 
NHS trust as a partner in innovation and not merely a context for 
innovation.  
 
The research also offers as an output a roadmap to a three-part evidence-
based strategy that can be utilised in NHS trusts. This roadmap identifies 
the need for organisational leaders to define and conceptualise what they 
understand innovation to mean, they then need to develop a strategy 
based on the four pillars of ‘the essence of organisational innovativeness’, 
acknowledging that this will vary across the differing levels of the 
organisation. Lastly, the organisation needs to measure the impact of 
what they are doing and review regularly. Here the evidence based 
Culture for Innovation model provides an easy to use tool.  
 
The staff in this case study have been both participants in the research 
and key informants, and in this sense they have become co-investigators 
in the translation, abduction, and retroduction of the findings, 
corroborating and developing them conceptually throughout the process. 
A test of the usefulness of a study is when a co-researcher confronted 
with an account of the case recognises it as being true, described in more 
interpretive methodologies as the ‘phenomenology nod’ (Van Manen, 
1990). When presenting these key themes to very senior managers, these 
findings have been recognised and acknowledged as true by these key 
informants (PO:18/07/19). This concept of conceptualising innovation, 
developing organisational strategy and measuring success using the 
model ‘the essence of organisational innovativeness’, could be used to 
shape health innovation understanding in academia, policy and practice 
and is this thesis’s original contribution to research, with the implications 
for practice described in the next section. 
 




7.5 Implications for practice  
The fourth and final stage of the design science approach is action and 
implementation (Bevan, et al. 2007). This research was undertaken within 
the Trust, as such it is directly relevant to the case and thus recognised as 
valuable in developing the organisation’s innovation journey. At this stage 
the implications for practice are targeted at the senior leadership level 
within this organisation. The findings have been shared with the Trust’s 
Executive board, including the director lead for innovation, and other 
strategic leaders, and will contribute to the strategic conversation within 
the Trust regarding how to develop its strategic theme to innovate. In 
addition, the findings will impact on the development of the Innovate 
theme annual plan, the staff within the Innovation and Research team in 
the Trust, and the conversations with services managers and Trust staff. 
 
The ambition is to develop the ‘essence of organisational innovativeness’ 
model into a workshop, to be targeted in the first instance at the senior 
leadership level. The aim of the workshop will be to develop a collective 
understanding of innovation in order to advance the corporate vision for 
the future. The workshop will focus on the creativity process, and 
developing the organisation’s vision for innovation, drawing out the 
barriers to achieving success, and present the understanding offered from 
the four supporting pillars as a means to overcome these. The outcome of 
this workshop will feed into the Trust corporate strategy and the Innovate 
theme development plan. The CfI survey has now been established as an 
annual audit, this will measure the impact of the actions and over time will 
allow trends to be analysed, making the implicit understanding of the 
culture for innovation explicit.  
 
As a single case study, this research makes no attempt at being 
generalisable. This research, however, will seek to present and publish the 
findings, and if other NHS trusts and the innovation leadership within 




them recognise and understand these, then the analytical theory may be 
generalisable. The researcher is a member of a regional Innovation and 
Research Leads group; the regional leaders within this group are aware of 
this research and have supported the researcher with their curiosity and 
their desire to know the findings, the results will, with the permission of 
the Trust, be shared with this group. The ambition would be to work 
collaboratively with other organisations within the region to build on this 
foundation of knowledge and support the development of innovation in the 
region and promote the value it brings to patients, staff, and the trusts 
themselves.  
 
At this stage there are no immediate policy implications for this work, 
however, the regional Academic Health Science Network, are aware that 
this is being undertaken. As the evidence base is established the 
opportunity to work with this body that supports innovation may develop.  
 
7.6 Areas for further study  
The ‘essences of organisational innovativeness’ model, is a prototype, 
untested within the real world setting and therefore its usefulness is not 
established. The usefulness of this model and thus the impact of this 
research is still to be established within the Trust. This will be done 
internally through feedback from the senior leadership and evaluation of 
the workshop as it develops, corroborated by annual CfI scores. 
Externally, feedback from the regional innovation leadership and 
collaborative work that may be taken forward will inform the next stage of 
development. 
 
In addition, the researcher has been in email discussions with Dr. Lynne 
Maher, one of the original authors of the CfI framework. It has been noted 
that there has been limited development in the area of organisational 
innovation in the NHS since the demise of the Institute of Innovation and 




Improvement, no published examples of the CfI framework being used 
have been identified, and no benchmarking exists. The framework, and in 
particular the questionnaire, provided a useful, easy to use, evidenced 
based tool for measuring an organisations’ culture for innovation. If NHS 
trusts are to be recognised as organisational innovation systems, 
promoting the use of this tool and developing some benchmarking for NHS 
trusts would be beneficial to innovation leadership. This would be an 
exciting area of work to develop. 
 
This research used innovative methodologies, such as the collaborative 
enquiry workshop (CEW) and dotmocracy scoring, where the evidence 
base within healthcare is not established. The CEW, although time 
intensive for the researcher to set up, worked well; the resultant data was 
used as a proxy for a mesosystem CfI score. However, the discussion 
element of the workshop elicited only broad aims from the senior leaders 
present, with limited actions that could be implemented. The highest 
ranked element from these discussions was a desire for more resources, 
but with no suggestions of where these would come from. This presented 
a challenge regarding how to manage this data within the research. Plsek, 
et al. (2007), identified similar issues with expert group discussions 
(section 3.2.4) and suggested augmentation of this data with more 
focused qualitative enquiry, where people had the opportunity to tell their 
stories. The data therefore informed the development of the interview 
schedules, and the CEWg portal chart was used as a physical artefact (Yin, 
2014) to aid the development of these discussions. 
 
7.7 Limitations of the research 
A thesis is an integrated argument that must stand up to critique, 
however, all research and all research methodologies have limitations; for 
each proposition it must be considered that opposing beliefs and 
perspectives may be held. It is the responsibility of the researcher to 




anticipate these and through transparent discussion, present the research 
limitations (Murray, 2002). This is understood and presented next. 
 
This study was undertaken by a single researcher, around a full-time 
senior post for an academic qualification. Out of necessity the research 
was limited in terms of its size and time frame, with data collection taking 
place over one year at a single site. In addition, the research was also 
limited by the regulations of the DProf. Prac. thesis module, which had a 
reduced word limit in comparison to a traditional PhD. This has been 
problematic for a subject matter as conceptually broad and diverse as 
‘innovation’ and has resulted in the adoption of a purposive writing 
method, acknowledging that certain aspects are beyond the scope of 
exploration or development within this research.   
 
The weaknesses of the single case study approach, the lack of 
comparators and the impact this has on theory development, is 
highlighted in the literature (Yin, 2014). In addition, the researcher was 
an emic researcher, a senior manager based within the case; the data 
used and the interviewees were purposively selected. Although every 
effort was made to ensure that all staff had the opportunity to participate, 
and that findings were fairly representative, the accusation of researcher 
bias is unavoidable. Careful attention has been given to the presentation 
of the methodology in Chapter 3.  and in addressing the quality of the 
research (section 3.4). In addition, the critical realist perspective (section 
Error! Reference source not found.) acknowledges this. Through this 
lens these findings are understood to be one interpretation of the data, 
based on the researcher’s critical knowledge and understanding, at a 
specific point in time. It is recognised that this is empirically messy and 
the findings contestable, (Gabb, et al. 2009; Edgley, et al. 2016). It is 
hoped in making this transparent, the quality of the research can be 
assessed. 





It was beyond the scope of this research to include the patient’s voice and 
this was not asked as a direct question within any of the data collection 
methods. Including this would have added a unique and different 
dimension to this research, however, this might have pulled the model in 
a very different direction. This is something that should be explored in 
future research. 
 
7.8 The research journey: a personal reflection 
All research studies develop as they proceed and this research is no 
exception. The original concept was conceived from a professional need 
and a personal interest, but the outcome has developed into something 
much more. Originally this research sought to explore the Trust culture for 
innovation, to understand if the implementation of the innovation strategy 
had indeed impacted on this. The initial data analysis identified the 
complexity of this area, in particular the lack of conceptualisation of 
innovation, the confusion with quality improvement, the potential 
differences between professional groups and the impact of organisational 
change. If the original proposal had been followed, this rival data might 
have been disregarded from the analysis, with the focus remaining on the 
dimensions of the CfI. This might have been a much easier and shorter 
process.   
 
The researcher however, chose instead to engage with these rival 
propositions, a process that necessitated a recursive re-immersion in a 
much broader literature field. This revealed the complexity of the 
healthcare ecosystem and the subject matter, innovation, itself. There is 
an acknowledged lack of healthcare innovation theory, but a lot of 
published material. The literature by necessity draws on a large number of 
models and theory, not all from within healthcare, the public sector, or the 
UK. The complexity of structuring a cogent literature review and using it 




to support the subsequent cycle of analysis proved demanding, with a real 
requirement for tenacity.  
 
The multi-method case study approach is not for the faint hearted, 
managing, and addressing the quantity of data, and its analysis became a 
personal challenge, which drew on years of NHS research experience. This 
could not be hurried, although with each stage of the recursive process, 
reading, thinking, analysis and writing the research became clearer, 
maturing into cogent thoughts, and structure, epitomised as the so called 
‘writing in layers’  (Murray, 2002).  
 
Although the researcher was immersed in the case and ‘an expert’ on 
subject matter, it became apparent that her knowledge was operational 
and not theoretical, presenting another personal challenge. A real 
personal reflexive journey was required to transcend this knowledge base 
and go beyond the known (Day, 2002). The anguish and frustrations of 
this process were clearly recorded in the reflective journal, and provides 
some interesting reading, one such entry simple read, ‘HELP! I don’t think 
I can do this’ (PO:23/02/19). If you read on, the layers of development 
are laid out, exemplified by entries such as ‘I think I am progressing in my 
comprehensions, I am feeling comfortable again with my position as a 
critical realist’ (PO:06/04/19). Essential to this process was the critical 
feedback and support from the academic supervisory team. These too 
were captured within diary entrees, with exclamations such as ‘oh no, 
more comments that are really challenging me to think’ (PO:06/07/19). In 
addition, the healthcare environment, and innovation are both dynamic 
and continually evolving areas, bringing this thesis to a conclusion 
presented the final challenge. 
 





NHS trusts are complex inter-related healthcare ecosystems, as such, 
using complex system theory presents a useful tool to understand how 
they work as an interrelated system. NHS trusts must respond to national 
policy documents; however, these documents present high-level 
communications with little operational detail that supports an NHS trust in 
either understanding or operationalizing these into cogent local strategies. 
In the climate where there are many competing priorities, certain 
questions therefore go unasked about what these policies mean 
operationally. This then means that knowledge gaps do not get identified 
or addressed. 
 
This research goes someway to identifying and thinking about the 
knowledge gap in relation to ‘innovation’ and ‘innovativeness’ within an 
NHS Trust, how it is perceived and understood, as well as why this is 
important to a trust and how it can be developed. To achieve this 
synthesis, theory has been borrowed from the business sector and applied 
within an outstanding NHS Trust, committed ‘to innovate’. The case study 
explores why NHS trusts might wish to engage in development of 
innovation with their organisation and how they may go about achieving 
this. Pisano (2019) encapsulated the complex and co-dependent 
relationship between strategy, process, culture, and leadership necessary 
for business to infuse innovation into their DNA, articulating that these 
elements do not happen by chance, but require focus, design, and 
identified resources.  
 
The final word is left to a participant  
 
‘if I think back to where we were 5 years ago, I am really 
encouraged with where we are going to now, it feels like a different 
organisation, and it feels like we’re just on the cusp of really 




grasping hold of the future. And I know there’s work still to do and 
I know there’s people we need to take along on that journey, but I 
get the sense that we have far more people now who are aware of 
and open to the possibility, of using this [innovation] as a vehicle, 
using this as a strategic tool’ (6K:SLT) 
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Title: A case study to investigate the innovation culture within one 
NHS trust following the introduction of an innovation strategy 
 
Introduction 
Innovation in health has in the last decade been driven forward through 
national policy and the development of a national infrastructure. Although 
an increasing number of National Health Service (NHS) trusts are making 
‘innovation’ part of their strategy, at an organisational level assimilation of 
innovation into core business, accepted by individual clinicians as part of 
their role has been ad hoc; understanding of relevance and impact 
appears poor.  
 
THE TRUST] developed the Trust’s five-year strategy in 2014, which 
included ‘Innovation’ as a key theme. A recognisable ‘Innovation Strategy’ 
was only developed within the Trust in 2017. It is beyond the scope of this 
study to evidence the impact of Trust’s Innovation Strategy; this research 
seeks to investigate the innovation culture of the organisation, how it is 




The National Context 
In 2008, the United Kingdom (UK), in common with much of the world, 
went into the deepest recession since data collection commenced (Allen, 
2010). The impact of this, coupled with demand outstripping resources, 
places the NHS under extreme pressure (Bienkowska-Gibbs, et al. 2016). 
It will not be possible in the future to continue to provide high quality care 
through existing mechanisms and fiscal envelope; change must happen 
(NHS, 2014; Sood, et al. 2014). 
 




At times of economic crisis, seeking novel solutions and problem solving 
approaches to facilitate economic growth and improved performance are 
common (Hogan, et al. 2014, Efrat, 2013, Martins, et al. 2003). 
Department of Health (DH) and NHS policy recognises this and presents 
‘innovation’ as the mechanism for delivering the change that must happen  
(NHS 2014; DH2013; DH2011; DH2015; DH2012). 
 
Economic theory suggests that development of ‘National Innovation 
Systems’ (NIS) as a stable platform necessary for supporting innovation 
(Efrat, 2013). NIS are networks of public bodies, academic institutions 
and commercial enterprise, that fund research, develop outputs into 
innovations, ready for market adoption (Efrat, 2013). It is no coincidence 
that the National Institute for Health Research (NIHR) and Academic 
Health Science Networks (AHSN) have been established (Young 
Foundation, 2011). At this  ‘macro level’ (Greenhalgh, et al. 2016, 
Warring, et al. 2014), there is increasing recognition by government, 
commissioners and academic institutions of these structures and 
acknowledgement of their potential to develop the UK into an 
internationally recognised health NIS (DH 2011; Bienkowska-Gibbs, et al. 
2016; AMRC2013; Hunn 2013).  
 
The Local context 
It is recognised that creative firms, with high levels of innovation and 
research, out-perform less innovative firms (Efrat, 2013), with direct links 
to productivity and efficiency (Duchek, 2013). This concept is now driving 
the local NHS innovation agenda, with individual organisation, the NHS 
trust, being made accountable for their contribution to innovation (DH, 
2011). This is reinforced through commissioning contracts, monitoring 
systems and partnership agreements with regional NIS organisations.  
 




Although many trusts are adding ‘innovation’ to their strategies (Maher, et 
al. 2010), modern healthcare is an increasingly complex and challenging 
environment, particularly at meso (trust) and micro (individual clinician) 
level (Greenhalgh, et al. 2016, Warring, et al. 2014), where the focus is 
on continuous delivery of high quality, value for money, patient care, 
often in very challenging circumstances (Shaw, et al. 2011). Add local 
history and transformational change to the mix and individual unexpected 
microsystems develop, at odds with national policy (Warring, et al. 2014, 
Bienkowska, et al. 2016). The resultant pace and scale of change at this 
level is dangerously slow with serious repercussions for NHS reforms 
(Bienkowska-Gibbs, et al. 2016; Dixon-Woods, et al. 2013). 
 
Empirical understanding of the barriers and enablers to innovation 
adoption are emerging (Greenhalgh, et al. 2004; Dixon-Woods, et al. 
2013; Moullins, et al. 2015); however, how NHS trusts should respond to 
this challenge is not clear. Indeed, confusion exists about the very term 
‘innovation’ in the NHS, let al.one how to develop and deliver an 
innovation strategy (Pisano, 2015; Page, 2014; De Vires, et al. 2016; 
Youth Health Parliament Report, 2016). , 
 
Innovation and Research in the NHS 
Innovation theory in the NHS is limited, drawn mainly from the 
commercial sector (Maher, et al. 2010), where products or processes are 
created for commercial gain (Hogan, et al. 2014). Idea generation and 
implementation are overlapping elements of the creativity process 
(Martins, et al. 2003) that can be described in three-phases Efrat, (2013).  
 
• Invention, idea generation, tested within research and development, 
which may or may not proceed.  
• Innovation, development of proven inventions for commercialisation, 
either internal or external to research and development. 




• Adoption, taking a novel innovation out to the market, which to be 
successful requires support from a wider network, NIS (Efrat, 2013).  
 
In this theoretical model innovation and research are implicitly connected. 
In medicine, clinical research has a long history (Bhatt, 2010), Evidenced 
Based Medicine (EBM) is well established (Wieringa, et al. 2017), and is 
currently being driven forward in the UK by the National Institute of 
Health Research. Research is considered to have high associated clinical 
risk; it is therefore clearly defined and managed through strict national 
governance processes (DH 2005; NHS, 2017), with responsibility usually 
sitting with a Medical Director.  
 
In comparison innovation is a relatively new concept, originating with the 
invention of the NHS itself, less well defined and understood (Young 
Foundation, 2011) with no specific governance framework. Recently 
innovation has been developed through the ‘Quality, Innovation, 
Productivity and Prevention’ (QIPP) agenda (DH, 2010), implicitly linked 
with quality improvement (Maher, et al. 2010) and integral efficiency 
savings (DH2011a). This placed innovation in many trusts under the 
Directors of Nursing and Finance, disassociated from clinical research.  
 
A recent national shift in 2017 brought innovation and research together 
under one directorate in NHS England (NHSE, 2017); correspondingly 
many NHS trusts are now publishing ‘Research and Innovation’ strategies. 
Yet, published trust Research and Innovation Strategies appear heavily 
focused on the research agenda, with little reference to the creativity 
process. Although national policy describes the connectivity between 
innovation and research (DH, 2011), at the meso level the system is 
confused and fragmented, causing barriers and delays (Youth Health 
Parliament, 2016).  
  




The Role of Culture 
Organisational culture has been described as powerful force that must be 
recognised and understood (Schein, 2004), having a greater impact on 
desired outcomes than both structure and strategy (Hogan, et al. 2014). 
First associated with scientific inquiry by Pettigrew, (1979), organisational 
culture is a popular concept within behavioural and management science 
(Hogan, et al. 2014). Emergent theory draws from psychology, sociology 
and anthropology (Scott, et al. 2003) and gives persuasive evidence that 
changing an organisation’s culture has the potential for dynamic impact 
(Mannion, et al. 2008).  
 
The link between organisational culture and creativity is well established 
(Efrat, 2014; Hogan, 2014; Martins, et al. 2003, Harrington, et al. 2005). 
Greenhalgh, et al. (2004) present organisational culture as one of the 
‘system antecedents’ which can influence the likelihood of successful 
assimilation of innovation in the NHS. The risk adverse nature of NHS 
culture does not lean itself to creativity (Albury, 2005) as Greenhalgh, et 
al. (2004) postulate, the why and how of creating a culture for innovation 
in the NHS is still to be identified.  
 
The Trust 
Although [THE TRUST] adopted ‘innovation’ into its Trust’s five-year 
strategy in 2014, there was little underpinning documentation as to why 
this was agreed. In 2016 after a period of extensive organisational 
change, [THE TRUST]’s executive reengaged Trust senior leaders with the 
five-year Strategy; feedback from the event criticised the lack of clarity 
around ‘innovation’. In January 2017, [THE TRUST] Research and 
Development was formally given the task of taking innovation forward 
within the organisation.  
 




The researcher is Head of Innovation and Research in [THE TRUST] and 
charged with the responsibility of developing [THE TRUST]’s Innovation 
Strategy. In undertaking a literature review to support this development, 
the tension between the macro level need for innovative NHS trusts and 
the meso and micro level ambiguity surrounding innovation became 
apparent; as did the lack of resources to address this challenge.  
 
In addition, the literature suggests that writing a strategy alone is not 
enough to create an innovative organisation, developing the organisations 
culture for innovation is fundamental to success (Greenhalgh, et al. 2004, 
Maher, et al. 2010) and in creating this culture, the behaviours of the 
organisational leaders is disproportionately influential (Maher, et al. 2010, 
West, et al. 2017). It is logical that ‘Creating an Innovation Culture’ is 
therefore the first of five objectives of [THE TRUST]’s Innovation Strategy, 
yet an understanding of what is the trusts innovation culture, or how one 
might be developed is currently unexplored within health service 
literature. 
 
This research is being undertaken to fulfil the requirements a Doctorate in 
Professional Practice thesis module. In keeping with the ethos of 
Professional Doctorates, the findings will have direct impact on the 
professional practice of the researcher; provide evidence regarding 
innovation culture in one NHS trust, how to develop this and contributing 





Definitions of innovation in the NHS are poorly defined and understood 
(Page, 2014), however, Maher, et al. (2010) suggest that there is little to 
be gained from debating this issue, for clarity for this research the 




definition of innovation below will used as it is straight forward and widely 
recognised within the NHS having been developed through the NHS 
Institute for Innovation and Improvement. 
 
 ‘Doing things differently, and doing different things, to create a 
step change in performance.’ 
 (Maher, et al. 2008) 
 
Organisational Culture 
The term ‘organisational culture’ is nebulous and complex; definitions 
range from ‘the way we do things around here’ (Scahill, et al. 2009, 
Davis, et al. 2000) to ‘an anthropological metaphor used to inform 
research and consultancy to explain organisational environments. 
(Parmelli, et al. 2011). 
 
A popular definition (Scahill, et al. 2009; Mannion, et al. 2008; Scott, et 
al. 2003, Parmelli, et al. 2011) appears to be the ‘essence of culture’ 
defined by Schein, (2004). As this is a widely cited definition, it will be 
used for this research.  
 
‘a pattern of shared basic assumptions that was learned by a group 
as it solved its problems of external adaption and internal 
integration, that has worked well enough to be considered valid 
and, therefore, to be taught to new members as the correct was to 
perceive, think, and feel in relation to those problems’  
(Schein, 2004 p17) 
Innovation Culture  
Maher, et al. (2010) undertook a comprehensive review of the dimensions 
of an innovation culture, defining them as: Risk taking; resources; 
knowledge; goals; rewards; tools; relationships. They further describe 
tools for measurement of innovation culture although no published 
information can be identified of this having been undertaken within NHS 








( Maher, et al. 2010 p9)  
Aims 
To understand how innovation culture within an NHS Trust is shaped at 




• To investigate Innovation Culture from a leadership perspective 
• To investigate Innovation Culture from staff within the trust  
• To synthesis a framework of innovation culture that merges 
leadership and staff perspectives. 
 
 





The methodological framework for the study will be a case study approach 
as described by Yin, (2014) 
 
‘A case study is an empirical enquiry that  
 
• investigates a contemporary phenomenon (the ‘’case’’) in depth and 
within its real-world context especially when 
• the boundaries between the phenomenon and the context many not 
be clearly evident  
(Yin 2014, P16) 
 
As the ‘case’ is a single NHS trust, the model will be a single case design; 
however, the complex, multi-level context of a trust (Waring, et al. 2014) 
will be acknowledged by investigation at both the meso (organisational) 
and micro (individual clinician) level. The overall methodological 
framework will therefore be a single case design with multiple embedded 
units of analysis (Yin, 2014). 
 
In case study methodology, unlike other methods, the research questions 
are posed to the researcher, as a tool to help define the evidence that is 
required to address the study aims. At the protocol stage Yin, (2014) 
identifies these questions as ‘level 2’ questions i.e. ‘questions asked of the 
individual case’, articulating the importance of keeping this in mind for all 
data collection. Each question should be accompanied by ‘likely’ sources of 
evidence; this is summarised in table 1. As analysis is dependent on 
convergence of evidence, case studies by their nature require multiple 
sources of evidence, triangulated to reach a conclusion (Yin, 2014).  
 
Data analysis theory in case study methodology is still emerging (Yin, 
2014), although a case study methodological framework will be used for 
this research, to ensure robust analysis of the embedded units, each unit 




will independently analysed using an appropriate method before 
triangulation.  
 
Qualitative data will be informed by ethnography. Ethnography’s 
disciplinary tradition stems from anthropology; as such its primary domain 
of enquiry is focused on the cultural perspective (Robson, 2015). It can be 
used to contextualise the behaviour, beliefs and feelings of people from 
the ‘emic’ (insider) perspective, whilst remaining removed from their 
behaviour, retaining an ‘anthropological strangeness’ (Hammersley and 
Atkinson, 1995; Hammersley, 2006), and is particularly suited to complex 
organisation study (Waring, et al. 2014). Although ethnography is not 
without challenges, it is a commonly used social science and health 
method (Hammersley, et al. 1995, Hammersley, 2006; Gray, 2013, 
Waring, et al. 2014; Reeves, et al. 2008; Coffey, et al. 1996), familiar to 
the researcher; it is believed it will provide a useful theoretical approach 
for analysis of the embedded units. 
  
Site Selection 
Selection of the site is a critical element of case study research, making a 
selection based on special arrangements and ease of access is an 
acceptable arrangement (Yin, 2014). This study will take place in one NHS 
trust, where the researcher is based, this has several advantages 
including an in-depth knowledge of the case and easy access (Silverman, 
1998) and the findings directly relevant.  
 
The place of the researcher 
In keeping with Yin’s philosophy for case study, a ‘realist’ perspective, 
assuming the existence of a single reality independent of any observer will 
be taken (Yin, 2014). This will be supported by a position taken by the 
researcher of ‘anthropological strangeness’, exploring with new and 




possibly alien gaze common in the anthropological roots of ethnography 
(Hamersley, et al. 1995; Hammersley, 2006).  
 
 
However, this also presents challenges, within data collection the power 
dynamic of relationships cannot be ignored (Pillow, 2003; Riley, et al. 
2003). As a senior manager situated within the organisation of study, the 
researcher position could be hierarchically inferiority to very senior 
leaders, executives and board members or superior to staff members. This 
presents ethical tensions that must be acknowledged and managed during 
data collection (Simmons, 2012). The researcher is familiar with data 
collection from both perspectives and these elements will remain 
continually under review and addressed throughout the development of 
the study with the support of the supervisory team. 
 
Data collection  
The researcher acknowledges this proposal draws on theory and literature 
from outside the familiar healthcare environment and that healthcare itself 
is a dynamic and evolving field. Development and interpretation of the 
literature will continue throughout this study, informing data collection, 
acknowledging the need to stay ‘adaptive’ and make changes to the 
design, if they can be appropriately justified (Yin, 2014). 
 
Table 1 Research Questions and method   
Research 
Question  
Data Collection Method Sample 
size 
Data Analysis  





Collaborative Enquiry Workshop 
(Parkes 2013)  
Dotmocracy approach 
www.dotmocracy.org/ 





How do Trust 
staff score their 
‘Innovation 
Culture’? 
questionnaire version of the 
seven dimensions of culture 

















has worked and 
why? 
 
A purposive sample of very 
senior leaders from within the 
organisation will be invited to 
be interviewed (Executives, 
Deputy Directors, Heads of 
Department and non-executive 
directors). 
6-8 Qualitative 
thematic analysis  







has worked and 
why? 
 
A purposive sample of staff that 
have developed ideas within 
the trust will be identified and 
interviewed to understand their 
experience of trust culture and 




How can learning 
from the 
introduction of 
the strategy be 




has worked and 
why  
 
The journey of the research will 
be captured in a reflective diary 
and analysed to produce an 
auto-ethnographical account 
(Taber, 2010; Pillow, 2003). 





All data will be captured electronically and managed using NVivo 10 
software or SPSS version 22.  
 
Statically analysis will be undertaken depending on the data collected 
which may include ANOVAS, cross-tabulations and or correlations as well 
as simple descriptive statistics. 
 
Each set of qualitative interviews will be analysed using an interpretative 
qualitative analysis framework. This will involve an iterative process of 
reading, coding, comparison, elaboration of emerging themes and re-




engaging with wider literature (Waring, et al. 2014) to develop an 
ethnographic account (Hammersley, et al. 1995). 
 
Eisenhardt. (1989) describes overlapping of data collection with data 
analysis, supported by reflexive field notes within and between each case, 
in a triangulation and comparative process to support theory generation. 
This constant comparison and triangulation of data in a non-hierarchical 
approach to examine phenomenon in several different settings and 
different points in time will be central to the analysis process (Yin, 2009; 
Reeves, et al. 2008; Scott, et al. 2003). 
 
Once the embedded units have been analysed, the five specific techniques 
of case study analysis will be applied of pattern matching, explanation 
building, time series-analysis, logic models and cross-case analysis to 
develop a case description (Yin, 2014) 
 
Report Writing and Dissemination 
A research report will be written and submitted for the Doctorate of 
Professional Practice thesis module and defended though oral 
examination.  
 
The lead researcher Sue Palmer Hill is a member of multiple Innovation 
and Research forums and will be presented findings to these groups. The 
national R&D Forum will be specifically targeted, as this will reach a large 
number of interested stakeholders.  
 
It is anticipated that papers will be written for publication in Qualitative 








Timetable and work plan  
The timetable for this has been set by the requirements of the 
Professional Doctorate programme at the University of Northampton. Data 
collection from staff will not commence until all permissions have been 
granted. This is anticipated to be early 2018. Data collection will take 
place over 1 year. (Appendix 2) 
 
Ethics and Governance 
All requirements of the Doctorate in Professional Practice programme will 
be satisfied. As the data collection does not involve any NHS patients an 
application to for NHS Research Ethics Committee review will not be 
necessary. As the research will take place in a single site, Health Research 
Authority permission will not be required. Permission to conduct the study 
will be formally sought from the host NHS trust prior to commencing. 
 
It is recognised that clinician time is valuable; it is therefore essential to 
ensure that any time spent on this research by the trust’s staff justifies 
the time away from clinical practice or management duties. The [THE 
TRUST] Innovation, Research and Clinical Effectiveness Committee will 
oversee this work within the trust providing an ongoing governance 
framework. 
The researcher works within the trust, Fraser (1997) considers the ethical 
dilemmas this throws up in 5 areas: 
 
1. Personal values and potential for bias 
2. The Researcher’s Role Within the Organisation 
3. Confidentiality and Anonymity 
4. Role Conflict Issues 
5. Time Constraints 
 
These are explored and addressed further in Appendix 2.  





This study seeks to gain understanding at an organisational level and 
professional level; it does not seek to elicit any sensitive personal 
information and not expected to cause any distress. All participants will be 
volunteers and have full informed consent taken. (Appendix 3, 4 and 5) 
Although data is not expected to contain any personal identifiers or 
sensitive information, it will be treated as confidential. Original data will 
be stored on password protected computers on a secure NHS service, only 
anonymised data will be shared by the researcher with supervisory staff.  
 
Resources required 
The main resource required is researcher’s time; this is given freely as 
part of her study commitment and as part of her paid employment.  
All qualitative data will be captured electronically and managed using 
NVivo 10 and SPSS software, available to the researcher as a student at 
the university. 
 
Travel commitment outside the researcher’s usual place of work is 
minimal. Recording equipment, printing facilities and IT equipment are 
available to the researcher through her employment at [THE TRUST].  
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II. University of Northampton ethics application 
Submitted 10 January 2018 
Ethical Considerations for Researcher’s for engaging with participants for interviews, questionnaires etc… 
Issues Strategies  
Preliminary papers 
and authority 
• The researcher should have documentation to 
identify him or herself 
• Criminal Records Bureau check must be carried 
out if dealing with children and/or young 
persons 
• Permissions from organisations and other 
authorities to conduct activity 
(interview/questionnaire/etc.) must be obtained 
e.g. Home Office for interviewing offenders,  
Government bodies, local officials as appropriate 
• Research has an NHS ID badge valid within the 
organisation of study, no letter of access will be 
required, for the purposes of this study the student will 
also carry her student ID badge 
• All DBS checks are current 
• Permission from the organisation is in place 
• No HRA/NHS REC required as a single site study not 
including NHS patients. 
Choice/recruitment 
of participants 
• Method by which participants are requested to 
join in the research must be addressed 
• Age of participants must be considered provision 
for elderly, young, disabled or special needs. 
• The most appropriate method of approaching 
participants must be used e.g. through 
associations, advertisement etc. 
• Will any incentives be offered to take part 
• All participants will be recruited by virtue of their 
professional roles and their willingness to participate. 
There will therefore be no issues regarding 
vulnerability, age or spoken language. 
• In line with the methodology, participants will be 
targeted as a purposive sample using professional 
communication routes. 
Training  and 
qualifications 
• Training and qualifications may be required to 
undertake certain types of activity 
• The individual proposing to undertake this research 
has been a qualified Nurse for 30 years and working in 
I&R for 20 years in the NHS. She is also trained in 
Good Clinical Practice, Informed Consent, ISEB Data 
Protection and follows the NMC Code of Conduct.   
• She has had the appropriate training to conduct this 




research through her professional practice and as part 
of the taught modules of the Professional Doctorate 
programme 
Involvement • Each participant must be given the opportunity 
to positively decide to be involved in the 
research 
• There must be no coercion and ample 
opportunity must be offered to first decide to 
take part and secondly to withdraw (see Section 
8 above) 
• A participant should be able to have a friend or 
relative present if he or she wishes and in 
certain circumstances this may be desirable for 
the safety of the researcher 
• It will be made clear to all individuals that the primary 
purpose of this study is for an academic qualification 
and their participation is entirely voluntary and if they 
choose not to take part in the interviews, this will not 
affect their future relationship within their clinical team 
or the Innovation and Research team. 
• All participants will receive written information 
pertaining to the aims of the study at least 24 hours in 
advance ensuring that they know what can be 
expected if they participate in the process.  
• It will be made explicit that their participation will be 
confidential throughout the data collection, analysis 
and dissemination process of the evaluation. 




An Assessment of risk to self and participants must 
be carried out in relation to: 
• Health and safety of premises in which activity 
takes place for researcher and participant 
• Health and safety of researcher e.g. interviewing 
in a penal institution 
• Health, safety and wellbeing of participant e.g. 
in relation to the questions asked and their 
psychological effect 
• The age mobility etc. of the participant must be 
considered  
• The interviewees as all health care professionals; the 
issues being explored are related to their professional 
practice and will not impact on their personal or 
professional lives. All interviews will take place in the 
normal workplace of participants, at a time and 
location convenient to them. 
• It will be made clear that should the participant wish 
to withdraw at any time they may do so and withdraw 
their data without any explanation. 











• If activity conducted on certain premises 
permission for researcher and participant to be 
on those premises must be obtained e.g. if in 
school permission of headmaster 
 
• Permission from the NHS host Trust has been secured 
Suitability of 
premises 
• Premises must be accessible 
• Position of furniture etc. to ensure appropriate 
relationship between interviewer and 
interviewee is maintained 
• The researcher is an employee within the host trust 
and has full access to the premises as part of this 
employment. 
Method of interview The most appropriate method interviewing from the 
participants point of view must be used: 
• Individual or group interview 
• Questionnaire 
• Open or closed questions etc. 
• Workshops will be run at planned events 
• Questionnaires will be completed on line via 
SurveyMonkey, an approved system within the trust 
• Individual interviews have been chosen to support the 
most flexibility for busy NHS staff 
Method of recording 
data 
The most appropriate method of data collection 
from the participants point of view must be used: 
• Photographs, video or audio recording 
• Written notes  
• Intellectual property rights in data 
• Audio recordings of interviews will be taken, with the 
permission of the interviewees 
• Captured recording will be via a password protected 
digital recorder 
• These will be uploaded to an NHS password protected 
computer as soon as possible by the researcher and 
stored on a secure section of the NHS server only the 
researcher can access. 




• Data protection 
 
The appropriate consent must be obtained. If the 
data is to be retained the participant must consent 
to this. An opportunity must be given to enable a 
participant to withdraw his or her material from the 
research (see section 8 above). 
  
• Once uploaded onto the computer the digital recorder 
data will be cleaned. 
• All other data will be stored on an NHS password 
protected computer in a secure section of the NHS 
server only the researcher can access. 
• Any paper documentation will be stored in a secure 
filing cabinet in a locked NHS room with limed access 
to NHS staff. 
Interviewers • Who will undertake the interviews? 
• Will they be paid? 
• The researcher will undertake the interviews as part of 
her paid NHS employment within the host site 
Transcribers • Are audio recordings to be transcribed? 
• Who is to transcribe them? 
• Are copies of the transcription to be shown to 
the participant for approval? 
• The researcher will transcribe all audio recordings as 
part of her immersion in the data 
• Only anonymised versions of the transcriptions will be 
shared with supervisory team, however as there are 
only a very small number of very senior leaders within 
the organisation people may be able to be identified 
from their roles. Every effort will be made to limit this, 
but as these people are used to being under this level 
of public scrutiny and the material is not of a sensitive 
nature, it is not expected to cause any significant issue 
Translators  • Are translators to be used if so are they 
professionally qualified ad compliant with the 
appropriate code of conduct? 
• How is the problem of interpretation and 
checking of information to be dealt with? 
• N/A 




Attendees • Who will be attending the interview e.g. care of 
disabled participant? 
• Consent for attendees must be obtained from 
participant 
• All interviewees are professional N/A 
Consent • Particular note should be made of the comments 
in the Institution’s code in relation to covert and 
deceptive research. 
• Informed consent must be obtained: the 
participant must receive information, 
understand it and be able to respond 
• The information should be written and it should 
be made clear precisely what the research is,  
what is being required of the participants 
whether the identity of the participants will be 
confidential and/or anonymous 
• Consents should be clear and unequivocal and 
also in writing 
• Consents form all those involved must be 
obtained e.g. parents as well as children where 
children involved. Employees as well as 
employers etc…  
• Participants must positively agree and must be 
given the opportunity to withdraw 
• Informed consent will be taken; the researcher is a 
nurse on the NMC registry, trained in Good Clinical 
Practice and an experience NHS researcher of 20 years 
experienced in taking informed consent.  
• Written information sheet will be given at least 24 
hours in advance 
• A consent form will be used, participants will be made 
aware that they are under no obligation to participate, 
that they can withdraw at any time and request that 
their data be removed; any request of this nature will 
be honoured if data is identifiable. 
Confidentiality and 
Anonymity 
• The researcher needs to be clear whether the 
participants wish to be identified in the research 
report or thesis. In any event identities need to 
be confidential until the research is complete in 
case a participant wishes to withdraw.  It must 
be made clear to participants who have agreed 
to be identified the point at which publication 
• The research is trained to ISEB standards for the Data 
Protection Act, undertake mandatory annual Data 
Protection and Information Governance training and as 
an NMC registrant and an NHS employee is bound 
professional and contractually to respect and protect 
all data. 
• No patient data will be accessed  




will take place and that it will no longer be 
possible to withdraw. 
• To ensure confidentiality participants should be 
allocated codes and their personal details kept 
separate and secure.  
• Personal contact details should be destroyed at 
the end of the research unless permission has 
been obtained to retain them for further 
research 
• Codes or pseudonyms should be used when 
writing the thesis or report and names of places 
may be changed or fictionalised to ensure 
anonymity 
• Time scales for the keeping of information need 
to be stated. 
• The data protection legislation must be followed. 
 
• Only professional data will be requested and used for 
the research, this will still be safeguarded to the 
highest standard. Quotes used will be anonymised to 
ensure confidentiality is maintained.   
• All information disclosed during interview will be used 
for the sole purpose of the research, however if the 
researcher believes a participant to have raised any 
safeguarding issues or significant risk to organisation, 
this will be discussed with the participant and reported 
to the appropriate Trust route.  
• All raw data will be held on NHS IT systems as this will 
contain professional, identifiable data pertaining to 
that organisation. Only anonymised data will be shared 
outside of the organisation 
• All data, hard copy and electronic, related to the 
project will be destroyed 3 years after the conclusion 
of the project by secure shredding or electronic 
deletion. 
Issues arising from 
the activity 
• What provision is in place for participants who 
may be adversely affected by the activity?  
• Do medical practitioners, counsellors or others 
need to be present? 
• Might the research uncover matters that are of 
wider concern? (e.g. participant’s involvement in 
criminal offences, illness or condition in respect 
of which the participant may not have been 
aware) 
• No issue of this kind is expected, however as an 
employee of the Trust, should any participant feel that 
there are issues they need to raise against the 
research they will be able to report these through the 
Whistleblowing Policy or the Trust Freedom to Speak 
Up Champion or any appropriate route within the trust. 
• It will be made clear that if participants do not wish to 
answer any questions they may defer these questions 
• If any safeguarding issue or issues of malpractice be 
highlighted these will be discussed with supervisors 
and/or managed according to NHS trust policy. 




• The position of the research as a senior member of the 
trust staff and ethical issues this raises are 
acknowledged and explored in more detail in Appendix 
3, p30 
Feedback • Each Participant must receive a summary of the 
research together with contact details of the 
researcher should any subsequent issues arise.  
If there are likely to be matters raised which 
may trouble the participant sources of advice 
and assistance must be given. 
• A draft version of the report will be shared with 
participants for feedback.  
• The final written report Will be submitted as the thesis 
for the Doctorate in Professional Practice, UoN 
Note This template is not exhaustive. There may be 
other issues in relation to interviews appropriate to 
a particular area of research that should be 
addressed. 
• Ethical considerations remain ongoing through the 
whole of a research study, should any new issues be 
identified, these will be discussed with the supervisory 








University of Northampton ethics committee decision 23 January 
2018 
Action required 
Resubmit application to future REC meeting 
Decision 
Not approved, candidate is invited to resubmit 
Notes 
The Committee enjoyed reading this application for full approval – you 
have developed a good project, have good knowledge of research ethics 
and have provided lots of detail. The Committee highlighted some areas 
that needed further consideration before full approval can be given: 
1) You refer to dissemination of the research to national forums but the 
ethics application currently does not cover dissemination beyond thesis 
write up. 
2) It was felt that some issues might arise from the research setting and 
dual role of the researcher/professional. The blurring of identity and issues 
of positionality should be covered in more depth and the participants need 
to be clear about your role as a postgraduate researcher and as a senior 
colleague. (e.g. carrying your NHS card and the use of NHS headed paper 
arguably does not make this distinction clear)  
3) UoN policy recommends storing data on University systems: storage of 
data on an NHS computer may not be compliant. You propose using SPSS 
and/or NVivo and this may require storage on UoN PCs anyway, which is 
not covered in the application. You should give information about data 
storage and security in relation to SurveyMonkey as your chosen survey 
tool. Issues of data destruction and participant withdrawal need more 
careful thought in practical terms. 
4) The application says there will be interviews but the consent forms 
concentrate on focus groups. You need to provide details and 
documentation in relation to each method.  
5) Questionnaires should be submitted for full approval. 
The Committee looks forward to your resubmission. 
  




Response to University REC Review submitted 21 February 2018 
This application was reviewed by the University Ethics Committee on 23 
January 2018, the following comments were raised for clarification and a 
request to resubmit was made prior to approval. 
 
1. You refer to dissemination of the research to national forums but the 
ethics application currently does not cover dissemination beyond thesis 
write up.  
 
Reference to dissemination has been removed from the ethics template 
and Participant Information Sheet, Appendix 3 and 4 
 
2. It was felt that some issues might arise from the research setting and 
dual role of the researcher/professional. The blurring of identity and 
issues of positionality should be covered in more depth and the 
participants need to be clear about your role as a postgraduate 
researcher and as a senior colleague. (e.g. carrying your NHS card and 
the use of NHS headed paper arguably does not make this distinction 
clear).  
 
This was covered in part within the original protocol ‘Place of the 
Research’ p13. Further reference is now included in the main body of the 
proposal in Ethics and Governance section p17. A more detailed 
exploration is submitted as Appendix 3 p 31. ‘The Insider Research: a 
discussion on ethical dilemmas’;  
 
University Headed note paper will now be used, this has been amended in 
the Ethics Template Appendix 4 p34 and Participant Information Sheet 
Appendix 5 p40 and consent for Appendix 6 p42.  
 




Student ID will be worn in addition to the NHS ID for all interviews this 
has been amended in the Ethics Template Appendix 4 p34 and Participant 
Information Sheet Appendix 5 p40 and consent for Appendix 6 p42.  
 
3. UoN policy recommends storing data on University systems: storage of 
data on an NHS computer may not be compliant. You propose using 
SPSS and/or NVivo and this may require storage on UoN PCs anyway, 
which is not covered in the application. You should give information 
about data storage and security in relation to SurveyMonkey as your 
chosen survey tool. Issues of data destruction and participant 
withdrawal need more careful thought in practical terms.  
 
The student does not have a university laptop and as a mature student in 
full time employment within the NHS, visits the university sites 
infrequently, making access to onsite university systems difficult.  
 
Professionally the researcher uses the NHS IT equipment and systems, 
undertaking annual mandatory training in data protection/information 
governance; NHS hardware and the software are fully compliant with data 
security measures required by the Data Protection Act 1998 and will 
migrate to the General Data Protection Regulation (GDPR) May 2018. All 
research undertaken within the NHS needs to be fully compliant with the 
latest guidance from the HRA https://www.hra.nhs.uk/about-us/news-
updates/gdpr-guidance-researchers/ , the researcher is responsible for 
this compliance within [THE TRUST].  
 
The data will contain profession identifies that the researcher has access 
to via her employment, keeping this data on the system where it is 
normally held will minimise breaches of confidentiality through transfer.   
All Professional Doctorate study to date has been undertaken on NHS 
computers, there is no issue with downloading programmes such as 




student SPSS from UoN onto NHS laptop with the support of NHS IT 
services.  SurveyMonkey is a commonly used survey tool in the NHS and 
has been approved by the HRA for used within the host trust for several 
NIHR pieces of research and approved for a number of student research 
projects. [THE TRUST] holds a platinum licence which allows multiple 
surveys to be undertaken. The researcher has the support of the trust for 
this survey. In this case the survey will go our only to NHS staff with all 
data collected being anonymous, all data returned will be held on a secure 
server. Approval from the trusts DPA/IG specialists has been sought with 
no security issues have been identified.   
 
The NHS systems are continually backed up to a secure server.  
Information gathered for the purposes of the project will be used within 
the parameters of this project only. Only processed anonymised data will 
be shared outside of the organisation where it will be collected.   
All data collected as part of this project will be destroyed 3 years after the 
conclusion of the evaluation.   
 
4. The application says there will be interviews but the consent forms 
concentrate on focus groups. You need to provide details and 
documentation in relation to each method.  
 
This is amended on the Participant Information Sheet and the Consent 
Form Appendix 5 and Appendix 6  
 
5. Questionnaires should be submitted for full approval.  
 
The Questionnaire to be used are previously validated and published tools 
for NHS (Maher et al. 2010) and have now been included as Appendix 7 p. 
 
  





Response from University of Northampton ethics committee 13 
March 2018 
Action required  
Resubmit application to future REC meeting 
Decision 
Not approved, candidate is invited to resubmit 
Notes 
The Committee received your response but didn’t think that you had 
engaged fully with all of the issues raised. 
Comments back from the committee 
‘On the matter of data storage, you still wish to hold the data on NHS 
servers and whilst that is not insurmountable in terms of ethics and data 
management, the university is responsible for the data and must have 
appropriate assurances in place. The pertinent issues are of access, use 
and security and propriety of the data both during and after the research 
project. It is stated that data will be held at the NHS and will be destroyed 
but there is no rationale given for this. Issues of intellectual property and 
practical issues if the NHS take ownership of the data you collect should 
also be explored if the data are to be held in the organisation. 
You refer to gaining access to data through NHS systems and you should 
show that you have permission to use the data and assurance that the 
data can be used for research purposes.  
Clear guidance on this is required  
A permission letter or written agreement with the NHS might cover this.  
You say you will not share data outside organisation but the consent forms 
only seek consent for use of the data in the thesis. The consent should be 
extended to dissemination in professional and academic outputs.  
The power dynamic and separation of researcher and manger roles issue 
isn’t yet fully explored. For example, Participants are asked to discuss 
their participation with their managers but the research is about the 
relationship with the manager and this could be problematic. Telling 




potential participants, you have been approached “as part of your 
professional role” is coercive” whereas “due to your professional role” is 
less so. 
 
The right to withdraw at any time should be re-addressed considering the 
practicalities of extracting data once it has been anonymised and 
analysed. A cut-off for the withdrawal of data from the study might be 
more appropriate. 
The participant information sheet needs further proof reading and 
formatting. 
The committee wished to offer you and your team an opportunity to 
discuss the issues and seek a resolution to them. Please contact the Chair, 
[xx] if you would like to organise a meeting. A further response should be 
made via Gateway for approval in due course.’ 




Response to the UoN ethics committee submitted 21 March 2018 
1 use of NHS servers and 
computers to manage data 
during the project (pp.29-
30): please confirm that the 
approval sought from the 
NHS Trust’s Data Protection 
/ Information Governance 
specialists (p.30) has been 
obtained. For the record, 
please confirm terms and 
conditions of this approval. 
Please confirm measures 
that will be in place to 
password-protect, encrypt 
and/or limit access to 
project data 
See attached letter of support from Sarah Ratcliffe, Head of Clinical Systems and 
Governance, LGSS on behalf of the Trust which confirms the legal basis under 
which the data is being carried out and the expectation of the trust in terms of 
data management and security.  
 
[THE TRUST] IT policy expects all people’s access NHS data to use [THE TRUST] 
IT equipment to support this as it is complaint with N3 standard required for NHS 
data security.  
 
For this reason all data will be managed through a password protected encrypted 
NHS lap top. The data will be stored on a ring fenced section of the [THE TRUST] 
server, compliant to N3 standards for data security. All members of NHS staff 
have a personal section on the server, only the named person can access this 
ring fenced section of the server.  The server is backed up regularly so can 
ensure prevention of loss. 
2 Please provide a rationale 
for the destruction of data 
after three years. If this a 
requirement or expectation 
of the NHS Trust, please 
clarify this. 
This has been revised to 5 years after careful consideration of NHS guidance 
 
In accordance with the Data Protection Act, all data must be held for only as 
longer as required, then destroyed appropriately. Research data in line with this 
requirement must only be held for sufficient time to allow any questions about 
the research to be answered. It is acknowledged that research is a complex 
activity, every project unique, thus a of records for an individual research project 
is involves detailed assessment.  
 
Although some research sponsors specify requirements for retention of specific 




categories of records, which must be respected, this is not always the case.  The 
Principal Investigator (PI) is, by default, responsible for the accuracy, 
completeness and security of all the records produced during a research project, 
this includes being responsible for their destruction. Where there are no external 
requirements for retention of records for a research project, or when such 
requirements have already been met, the PI should apply the institution’s own 
records retention policy to the project records.  
 
 
All institutions should establish a policy for managing research records to ensure 
a consistent approach across all disciplines and all types of research. This policy 
should be supported by detailed procedures to guide and support staff in fulfilling 
their responsibilities for managing the records associated with, and arising from, 
their research activities. 
 
NHS organisations have guidance on this matter through Records Management 
Code of Practice for Health and Social Care 2016, Information Governance 
Alliance  (July 2016),  Appendix 3 section 8.  HEI guidance is found in HEI 
Records Management, Guidance on Managing Research Records, JISC / JISC 
infoNet (January 2007).   
 
Depending on the type of research the data may not need to be kept once the 
purpose has expired.  Research data used for passing an academic exam may be 
destroyed once the exam has been passed and there is no further academic need 
to hold the data. However, if dissemination through publication is to take place 
then retention of data for a minimum period of 5 years is recommended.  An 
amendment to this effect will now be included in [THE TRUST] policy CLP 001: 
Management and Governance of Innovation Research and Clinical  Effectiveness 




3 Please clarify the statement 
that ‘The data will contain 
profession identifies that the 
researcher has access to via 
her employment’. If this 
infers the accessing of 
information from the NHS 
Trust systems, please 
provide evidence that you 
have permission to use the 
data and assurance that the 
data can be used for 
research purposes. 
This will be names of [THE TRUST] staff members names, their [THE TRUST] 
email address and phone numbers 
4 Please amend the consent 
form to include 
dissemination in 
professional and academic 
outputs, including any 
dissemination activities 
within the NHS Trust. 
See amended consent form V3.March 2018 
5 In the participant 
information sheet (p.41), 
please amend “you are 
being invited to take part in 
this evaluation as part of 
your professional role” to 
“you are being invited to 
take part in this evaluation 
See amended PIS V3 March 18 




because of your professional 
role” 
7 The right to withdraw their 
data ‘at any time’ should be 
re-addressed considering 
the practicalities of 
extracting data once it has 
been anonymised and 
analysed. A cut-off for the 
withdrawal of data from the 
study might be more 
appropriate 
See amended PIS V3 March 18 
  




The Insider Research: a discussion on ethical dilemmas 
 
The researcher is undertaking this study as a student to gain a personal 
qualification, but also works within the research site as a senior member 
of staff and has a vested interest in the outcome of the study. This also 
presents ethical challenges, which require thoughtful consideration prior to 
the study commencement (Fraser, 1997; Rooney, 2005). Potentially, 
utilising only an anonymous survey, yielding quantitative data could 
mitigate this issue? However, this would give only a snapshot in time of 
the situation and learning from the richness of qualitative data and 
insights it can yield (Hammersley, et al. 1995) would be lost. It is 
important to therefore acknowledge the issue and develop strategies for 
sensitively managed, Fraser, (1995) summaries these into 5 areas. 
 
• Personal values and potential for bias 
As the senior manager within responsibility for the design and 
implementation of the innovation strategy, a bias towards ascertaining or 
reporting a positive impact of the strategy might be argued. Fraser 
(1997), in similar circumstances acknowledges the potential for a 
‘powerful insider evaluator’ to act as gatekeeper, focus on aspects that 
support personal interpretations or ignore problem areas. She suggests 
several mitigations, including professional duty, accountability and 
responsibilities of her substantive post and the value of the external 
supervisor team to challenge predominate personal biases. 
  
• The Researcher’s Role within the Organisation 
There is hierarchical relationship between the researcher and participants 
within this study; some will be more senior other more junior and 
potentially even in a line management relationship. The insider researcher 
must be mindful of these relationships, careful not to exceed the rights 
afforded by her position, seeking to ensure mutual respect is maintained 




between professional within the work place (Fraser, 1997). This is 
supported by the process of free giving of information about participation 
and informed consent to participate. 
 
• Confidentiality and Anonymity 
Although data collected is not expected to contain any personal identifiers 
or sensitive information and will be treated as confidential, this needs to 
be realistic from the outset. In any organisation there is only one chief 
executive, a pseudonym would have no power to protect identity. Fraser, 
(1997) suggests a policy of ‘honest from the outset’ acknowledging that 
although the principals will be upheld, in some situations only reporting in 
general terms will be appropriate, in others where anonymity would not 
be possible, respectful acceptance is  acknowledged.  
 
• Role Conflict Issues 
Fraser, (1997) states she naïvely expected to be able to separate her 
research role from her professional role, but found unexpected conflicts in 
this area, which proved challenging. She found the process of continued 
reflection invaluable to the actions taken. As part of this research 
methodology a reflective journal is being used, this will capture any 
challenges as they arise and will also allow supportive discussions with 
supervisory team.    
 
• Time Constraints 
The final area Fraser, (1997) highlights is that of time constraints of the 
full time employed, undertaking research, sighting the impact on personal 
life as the result. This is acknowledged as a risk of any person in full time 
employment undertaking additional work. A bigger issue in this study is 
possible the business of other staff and the commitment of their time, this 
will need to be carefully negotiated with them and their manager. 




Although many of these issues can be anticipated and addressed in 
advance, there will be some unexpected issues that arise; these will be 
managed through personal reflection and the support of the supervisory 
team as they arise. 
  





University of Northampton Ethics approval 17 April 2019 
Ethics committee decision 
Action required 




Thank you for providing these clarifications and the very helpful covering 
letter (‘Response to Ethics 21-March-2018.V3’) and additional supporting 
documentation. We are happy to confirm that all of the Committee’s 
queries have been addressed. The application is therefore approved.  
Congratulations on reaching this stage. We wish you all the best for your 
project. 
Please update the Committee via Gateway if you need to make substantial 
changes or additions to the approved project. 
The Committee also noted the concern raised in the supporting letter from 
the  
The Trust Head of Clinical Systems and Governance/Data Protection 
Officer regarding information governance and security control 
requirements for University of Northampton projects. The Chair of the 
University’s Research Ethics Committee has replied directly to this letter to 
request further information. 
 
  




Medical Director: XXXXXXXXXX 
Address: xx 















Date: 19 March 2018 
Dear Sue 
 
RE: Professional Doctorate Thesis: A case study to understand how innovation culture within an 
NHS Trust is shaped at the institutional and individual levels by the introduction of an Innovation 
Strategy 
 
Thank you for submitting this proposal to the Ideas Forum for review and approval. This was 
reviewed at the meeting on 27 February in your absence. I am happy to confirm as the director with 
research responsibility the trust has offered this study its full support. 
 
In supporting this study we acknowledging that not only will this achieve your study ambitions as 
identified as part of your Personal Development Plan, but also the value to this study will bring to the 






Dr XXXXX XXXXXXXXX 
Medical Director and Caldicott Guardian 
 
  
Sue Palmer Hill 
Head of Innovation and Research 


















I write to confirm my approval of the approach that Sue Palmer-Hill is using to collect and 
secure data generated during her professional doctorate. A Data Privacy Impact Assessment 
has been completed to ensure that information governance and information security risks 
have been considered and mitigated. 
 
Trust laptops are encrypted to 256bit meeting the NHS standard and are more secure than 
data being held on unencrypted personal devices. The Trust policy IGIS01 clearly states that 
all information must only be held on Trust equipment/Network. 
 
I would like to raise concerns in regards to other projects reviewed by your Ethics Committee 
and would like to request that the information governance and security control requirements 
for University of Northampton projects are reviewed by your organisation to ensure that 









Head of Clinical Systems and Governance/Data Protection Officer 
 
  






















25 September 2019 
 
To:  The University of Northampton 
Via Sue Palmer-Hill 
 
Re:  The Case to Innovate: understanding organisational innovativeness in one 
NHS Trust, submitted for the Degree of Doctor of Professional Practice at the 
University of Northampton  
 
I am writing to confirm that having read this draft thesis (version 3 September 9, 
2019). I am content that sufficient redactions and other changes have been made 
that protect the anonymity of the Trust as so as far as is reasonable, given the role 
that Sue Palmer-Hill holds within our organisation.  
 
Sue will discuss with yourselves how we redact some of the information in the 
appendices which shows evidence of approvals by our organisation, but clearly 
includes our address, logos and senior executive signatures that instantly identifies 
our organisation. 
 
Should this letter also be included in the appendices, this will also require redaction. 
 
Assuming those redactions are made, on behalf of the organisation I am very content 
to sign up to this thesis and believe it will make a very useful contribution to our work, 





xxxx xxxxxxx  
 





































VI. Participant Information Sheet 
V3.March2018 (PIS to be on UoN headed note paper) 
 
Participant Information Sheet 
 
Title: case study to understand how innovation culture within an 
NHS Trust is shaped at the institutional and individual levels by 
the introduction of an innovation strategy 
 
Interviewer:    
Sue Palmer Hill, RGN, MSc, 
 
Invitation to take part: 
You are being invited to take part in an evaluation study. Before you 
decide to take part, it is important that you understand why this is being 
done and what it will involve. Please take time to read the following 
information. If you require further information or are unclear about any 
aspect related to this project please feel free to speak directly to the 
interviewer or your manager. 
 
Why is this being done? 
This study is being carried out as the thesis module of a Doctorate in 
Professional Practice at the University of Northampton. The project aims 
to investigate the innovation culture within one NHS trust following the 
introduction of an innovation strategy 
 
What will I be asked to do if I agree to take part? 
This study will involve taking part in an individual interview to explore 
your opinion of the innovation culture. The interviewer Sue Palmer Hill will 
be undertaking these interviews as a student on the Professional 
Doctorate course at the University of Northampton.  The interviewer will 




ask the questions attached to this information sheet to help focus the 
discussion. 
 
The interview will take approximately one hour and probably a lot less 
time than this and will be at a time and location convenient to you, so as 
not to interfere with your duties or your personal time. 
 
You will be asked to sign the attached consent form. This confirms that 
you understand the project and what’s involved. This form will remain at 
the trust and we would like to reassure you that no personal data will 
leave the site. In addition only first names will be used throughout the 
interview and any information used in any reports or publication this will 
be completely anonymised. 
 
For accuracy and ease it would be most beneficial to record the interview 
with a digital recorder. This is a secure recorder and the digital data will 
be uploaded into secure IT systems before being transcribed and 
analysed. All recordings and any notes made during the interview will be 
securely stored by the interviewer and destroyed when the final evaluation 
report has been first reviewed by you and then made public.  
 
Are there any risks? 
There are no physical risks to you as a person; however you may find that 
as a result of the discussions that you feel uncomfortable. You will not be 
expected to answer any questions that you feel uncomfortable with, and if 
you wish to leave the interview you may without having to justify this to 
the interviewer and request for your data to be withdrawn. 
 
Will information collected be kept confidential? 




All information collected during the process will be anonymised, data will 
be stored in a secure place, and protected by password if stored on 
computer.  
 
Am I obliged to take part? 
No, you are being invited to take part in this evaluation because of your 
professional role, but if after reading this you do not want to participate 
then you do not have to. If you do decide to take part, but then change 
your mind, you can request you’re your data is withdraw. Every effort will 
be made to identify and remove your data from the study, however this 
will only be possible before data is anonymised and analysed occurs.  
 
If there are further questions that you wish to ask please contact the 
Interviewer or your manager/. Only when you feel happy to proceed you 
will be asked to sign the consent form, even then if you wish to leave at 
any time you may without having to give a reason. 
 
What will happen to the results? 
The draft version of the results of the study will be shared with you.  The 
final report will be submitted as the thesis module for the Doctorate of 
Professional Practice at the University of Northampton.   
 
Thank you for taking the time to read this information sheet. 
 
Sue Palmer Hill, RGN, MSc 
Head of Innovation & Research 
Sue.palmer-hill@[the Trust].nhs.uk  
VII. Consent form 
 
V3.March2018 (Form to be on UoN headed paper) 
 




Title: A case study to understand how innovation culture within an 
NHS Trust is shaped at the institutional and individual levels by 
the introduction of an innovation strategy 
 
Interviewer:   
Sue Palmer Hill, RGN, MSc, 
Head of Innovation and Research 
 
Please initial box 
1. I confirm that I have read and understand the information sheet 
dated  ………. (version......) for the above study. I have had the 
opportunity to consider the information, ask questions and have had these 
answered satisfactorily.  
□ 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my legal rights 
being affected.  
□ 
3. I understand that information discussed at the interview will be kept  
confidential  
□ 
4. I understand that the interview is being recorded and that some of 
that I say may appear in an anonymised form within written reports from 
this project. 
□ 
5. I understand that the results of this study will be dissemination in 
professional and academic outputs, including dissemination activities 
within the NHS Trust 
□ 
 
6. I agree to take part in the above study. 
□ 
 
Name of Participant 
_____________________________________________ 
 
















When completed: 1 for participant; 1 for site file  
 
  




VIII. Interview Schedule  
Confirm reading of the PIS  
Discuss and take informed consent 
Confirm confidentiality 




1. Can you briefly introduce yourself and your role in [THE TRUST]  
• Can you just explain your duties and responsibilities 
•  
Micro Level investigation 
2. Can you define what innovation means to you 
• You just described your role, why is innovation important to this? 
• Tell me a little more ….?  
•  
Meso level investigation 
3. The trust has identified Innovate as a key strategic theme, what do you 
believe is the value of this to the organisation? 
4. If culture is the shared beliefs/values and behaviours, how would you 
describe the trust’s innovation culture? 
5. I am showing you a ‘portal chart’ created by staff in this trust who 
rated our innovation culture, the more open the portal the more 
enabled the culture; resources were seen as a slight barrier and risk 
taking was a weak element. In your opinion, do you feel this is a fair 
representation? 
• From your perspective what if anything would you rate differently?  
• Why? 
6. Have you seen any change over the last year? 
• What would you like to see change? 
7. How do you think the organisation can support you to be more 
innovative in your work? 
 
Leadership 
8. Our trust Leadership Behaviours makes embracing change everyone’s 
business, how do you see your role in supporting the development of 
the innovation culture? 
 
Conclusion 
• Are there any other comments you would like to make around our 
innovation culture? 
Thank you for your time 
Turn off recorder  




Appendix 3 Database of evidence  
I. List of evidence sources 
Data source Referencing key in text 
Trust Documents TD (number) 
Collaborative Enquiry Workshop CEW 
CEW group scores CEWg 
CEW individual  CEWi 
Trust survey TS (unique identifier code) 
Staff Interviews SI (unique identifier code) 
Participant Observation/reflective journal PO(date) 
Sli.do poll Sli.do 
Key Informant Feedback  KIF 
 
II. Chronology of events 
Dates in 2018 Event 
8 January  Collaborative Enquiry Workshop  
8 January  Sli.do poll 
26 March– 30 April Trust Survey  
April- September Staff interviews 
  




III. Trust Document list 
Reference  
in Text 
Trust document name 
TD1 Corporate Strategy (2016) 
TD2 OUR COMMUNICATIONS STRATEGY (2016-2018) 
TD3 Leadership Matter’s Strategy (2017) 
TD4 CQC report (2018) 
TD5 Innovate Theme: annual plan (2018) 
TD6 Framework for the management and governance of the innovation 
pathway (2018) 
TD7 Risk Management Strategy – CRM001 (July 2018) 
TD8 DELIVERING OUR STRATEGY: FOR YOU, WITH YOU. OUR STRATEGIC 
PLAN: (2018 – 2023) 
TD9 Involvement in Innovation plan (2018) 
TD10 Workforce strategy (2017-2019) 
TD11 OUR LEADERSHIP BEHAVIOURS: leaflet V2. 
TD12 Trust Corporate Performance review, headroom discussion (July 2018)  
  










Yes / no  x 
Management 
Responsibilities 




1B SLT X    White 
2P SLT   White 
3T SLT   BME 
4A SLT   White 
5G SLT X   BME 
6K SLT X   White 
7X SLT    White 
8E SLT    White 
9H SLT    White 
10F SLT   White 
11D SLT X   White 
12N SLT   White 
1U FLS  X BME 
2O FLS  X BME 
3Y FLS  X White 
4L FLS  X White 
5W FLS  X White 
6M FLS  X White 
7N FLS   White 
8R FLS  X  BME 
9C FLS   White 
10V FLS   BME 
11J FLS  X  White 
12S FLS   White 
13I FLS  X  BME 
14Z FLS  X  White 
15Q FLS  X  BME 
16B FLS   White 
  




Appendix 4 Chain of evidence  
I. Second stage literature review search strategy 
 










II. Collaborative Enquiry Workshop Data 
90 individual and 22 group response were collected. Mean dimensions 









Comments recorded verbatim  Count 
Risk Taking No longer blame culture: staff need to feel supported 
when it goes wrong. It needs to be shared widely that it’s 
ok not to be ok 
52 
Resources Inspire all levels to have confidence and room/time to 
generate ideas 
40 
relationships Introduce interviews with new starters after 6 months and 
learn from their perspective 
26 
Risk taking Feedback: for bids that are not accepted, or there is no 
learning 
24 
Risk taking Mind set (challenging) challenging negativity, over-
estimating the risk. Action: open questioning, be honest 
with the patient, quality improvement project 
18 
Resources We have the resources and encouragement to innovate, 
not often the opportunity to do- time for innovation within 
teams. - team meeting – - supervision ...........move up 
the agendas 
17 


















and organisation, e.g. suicide strategy, challenge the 
status quo, use our knowledge 
Risk taking Change of culture and language- associated with risk to a 
positive, positive risk taking, encourage learning  rather 
than blame, need to encourage more risk taking + 
cascading learning + way we talk about this 
15 
Risk Taking Neutral Innovation Panel: ideas are presented and 
challenged, committee decides (instead of finance and 1 
or 2 people). How do we take this forward, make it safe 
for people to share, ensure the right support is in place 
14 
Resources  Start-up funds for innovation 14 
Resources  Simplify the process 14 
Risk Taking From action i learn not failure 9 
Resources Share our limited resources across directorates  9 
Resources Support services to appoint a named person to work with 
different services to speed up allocation of resources   
9 
Resources Protected time for innovation 8 
 Involve service users and other stakeholders  8 
Rewards Scored neutral but would like to have scored higher, but 
we felt recognition is dependent on positive outcome or 
success, rewards are based on external outward facing 
success rather than internal attempts as day-to-day 
innovation 
8 
Resources When there is funding staff should be consulted for ideas, 
all professional groups should get the change to innovate, 
working together to make better use of funding (across 
professional groups i.e. OT, nurses 
6 
Resources Retention of staff 5 
Knowledge  More forums to share knowledge 5 
Rewards When it’s don’t it is done well... when its missed..... 
-more feedback on a daily basis (small recognition – big 
impact) 
- everyone feeling part of a process of recognition- 
everyone can give recognition, not just from the top 
- personal touch in rewards – not generic  
5 
Resources  Eliminate waste, stop doing things that don’t need to be 
done, give + take, authority to act, enhancing skills to 
increase output, business development – seek new 
funding opportunities  
5 
Knowledge Need more input from all levels of staff 4 
Risk taking Create a safe test bed to test ideas 4 
Resources Collaborating on knowledge and resources in the trust i.e. 
Sharing effectiveness before investment; different uses of 
SystmOne 
4 
Resources More space and time to implement ideas 3 
Goals Operational and corporate goals to be clearly aligned and 
easy to understand  
3 
Resources Being able to access resources available  3 
Tools Integrated working across teams- MH, CAMHS, 
community nursing, OAMH, iAPT etc. 
2 




Risk taking Whilst the board has moved risk towards more risk taking 
this does not seem to have translated to the ward 
2 
Risk taking Create a culture where it is safe to fail  2 
Resources Support of leaders to allow ideas to be put into practice  2 
Resources Improve communication platform  1 
Resources More space and protected time  1 
Resources Encourage discussions within team 1 
Resources Encourage networking both internally and externally  1 
Resources Financial resources identified that would help drive 
forward the innovation 
1 
Risk Taking Supportive culture 1 
Tools  Communication- sharing knowledge and skills to improve 
learning and development in the trust 
1 
Tools  Focus on induction and orientation to all services across 
the trust  
1 
Resources Create environments  1 
Risk taking Promote autonomy 1 
Resource Create clear easier channels to access resources 1 
Knowledge More sharing of knowledge, more time to talk to people 
and look onto the wider world e-brief  
1 
Resources Skill attraction and retention and development  1 
Relationships Sharing knowledge and innovation of practice - internally 
and externally- services and trust- should loud and shout 
proud 
1 
Risk taking Making accountability clear within the trust workforce 1 
Resources Publicise more on the innovation space on the staffroom 1 
 
Synthesised into themes 
 
Element Count Themes  
Risk taking 11 Promote autonomy 
Create safe test beds 
Use our knowledge to promote positive risk taking 
Clear accountability 
Challenge negativity  
No blame culture 
Neutral innovation panel 
Give feedback on ideas 
Understand and manage risk x2 
Supportive culture x2 
Ok to fail 
Resources  16 Inspire all levels  
Start-up funds for ideas x2 
Simplify process 
Communication – innovation space x2 
Protected time x4 
Share resources across departments x2 
Discussions within teams x4 
Retention of staff x2 
Leadership  





Clarity on how to access resources x2 
Stop think act differently  
Named person to lead 
Knowledge 3 Share more, talk more, include all levels look wider 
x3 
Goals  1 Operational and corporate goals clearly aligned and 
easy to understand x1 
Rewards 2 Feedback and recognition internally as well as 
externally, small recognition=big impact x2 
Tools 3 Sharing knowledge 
Integrated working 
Induction  
Relationships  2 Sharing knowledge; internally and externally  
Talk to new starters, learn from their perspectives 
Involve service users and other stakeholders 
 
  




III. CEW summary feedback presented to the Trust at conference  
 
(physical artefact used in Staff Interviews) 
 




IV. Trust Survey Results 
The Culture for Innovation measurement tool provided an easy to use 29-item 
survey. These were put into Survey Monkey and promoted with an introduction 
and an electronic link to the form.  
 
Promotion route 
Exec team Presented at monthly meeting 
Senior Leadership Team Presented at monthly meeting 
Governors Presented at monthly meeting 
Innovation office Out of office response to message and 
link 
 Promoted through email footer 
 Promoted at events 
Manager need to know – monthly 
electronic brief to all managers 
Promoted month before and during 
e-brief – weekly communication to all 
staff 
message and link to survey 
Intranet site- promotion on Innovation 
page 
Link to message and survey 
 
Number of permanent staff in the trust 3169 (Trust workforce data 2018); 159 
compete responses which represented 5% response rate. Although a 
disappointing response rate this was still assessed as viable for analysis. 
Responses were received from 9 different staff groups, although difficult to 
assess the representative professional, due to wording of this question on the 
survey. Some groups represented were also identified as too small to support 
statistical analysis  
 
Staff group declared Count  
Admin and Clerical 31 
Allied Health 
Professional  25 
Doctors 5 
Not declared 37 
Health care Assistants 4 
Managers 16 
nurses 38 
Support staff 3 
 159 
 
The minimum and maximum range, median, and mean for each individual 
survey item and mean Dimension Scores (mDS) were calculated. 












MEAN SCORES BY QUESTION





Points noted when comparing survey data with CEW groups and 
individuals risk and resources scored significantly higher and all other 
elements were higher. 
 
When the overall data is broken down by question, all questions received 
a positive score, even all the risk-taking and resources. All items in ‘risk-
taking’ section scored above 2. 5. Questions which scored low. 
• SQ6. In my department we seem to find the resources we need to fund innovative ideas 
• SQ8. Senior leaders makes sure that there is both the availability of time and money to 
support innovation 
• SQ11. There is a lot of information available to me about what other organisations are doing 
to meet the same sort of challenges 
• SQ21. My organisation has trained me in methods to support creativity, new ways of thinking 
• SQ22. My department uses specific methods to generate creative ideas around the challenges 
we face 
 
When explored by staff group, the exception to this were medical staff 
(n=5) and support staff (n=3). Although medical staff scored ‘risk-taking’ 
only slightly lower than other staff groups, all other areas were 
significantly lower; 4 sections in the negative areas. Support staff also 
responses scored very low in all areas except risk. However who were 





























































NVivo code book for Trust Survey comments-  82 comments returned 
Name Description References 
positive Comments that exhibited and overall positive response 1 
Negative comments that exhibited an overall negative response 14 
Tools Flexibility, Deliberate process, Training, Encouragement for skill 
development 
33 
Training  6 
Flexibility  2 
Encouragement for skills development  14 
Deliberate process  10 
Risk-taking Emotional Support, Balanced Assessment, Learning from Failure rather 
than punishing, Trying New Things 
24 
Trying new things  2 
Learning from failure rather than punishment  5 
Emotional support  15 
Balanced assessment  2 
Rewards Aligned with Organisational goals, Recognition, Intrinsic motivation, 
Individualised 
12 
Recognition  6 
Intrinsic motivation  1 
Individualised  0 
Aligned with organisational goals  5 
Resources Funding, Time, Authority To Act 51 
Time  27 
Funding  9 
Authority to act  8 
Relationships Honoring everyone’s input, Diversity, Trusting, open environment, Team 
based work 
30 
Trusting open environment  9 
Team based working  12 
Honoring everyone's input  6 
Diversity  1 
Knowledge Wide scope search, Uncensored, unfiltered, unsummarised, Free-flowing 24 
Wide scope search  2 
Uncensored, unfiltered, unsummarised  4 
Free-flowing  15 
Goals What, but not how, Specific call for innovation, Tie to strategic plan, 
‘Stretch’, Clear case for need 
0 




V. NVivo code book for Staff Interview Data  
Name Description References 
Differences between staff Groups  32 
staff  0 
management  1 
front line staff  4 
doctors  12 
Where do we go from here What participants feel would support the development of innovation within the organisation 181 
Demystify Process  46 
measurement of impact  1 
funding  3 
evaluation and support  15 
Time to sharpen your sword  19 
Team Agendas  8 
Tell us about it  70 
Personal Responsibility  7 
Grow it like an orchid  36 
trust and belief  14 
Strategic development  2 
stability  6 
Involved  8 
The Value Proposition How participants described the value innovation brings 699 
Strategy unrecognized  16 
Team  137 
Team Work  17 
Service Specific  2 
Professional Responsibility  32 
Part of the day job  12 
Making a difference  18 
impact  33 
i care  5 
Everybody's business  6 




Energize  136 
Value to staff  33 
proud  7 
optimism  1 
motivation  5 
good  8 
Excitement  21 
Empowerment  27 
courage  2 
Believe in the art of the 
possible 
 9 
The business imperative  306 
Vision  4 
Knock on effect  7 
Ahead of the game time to think and change, problem solving, business development, not just doing the minimum to survive as an 
organisation 
173 
Trying it ourselves  12 
transformation  12 
Thinking differently  29 
Problem Solving  39 
Improvement Service Improvement, improvement in patient care, improvement to staff, general improvement 5 
Service  2 
Patient Care  5 
Forward thinking not standing still, not stagnating 44 
Fit for the future  7 
Can’t keep doing the same 
thing 
 9 
Survival of the Fittest/business 
need 
External Treats, seen to be better, seen to be innovating, transformation of business models 119 
staff retention  22 
Political, seen to be 
innovative 
 28 
Grow the business  28 
Financial imperative  32 




For you, with you  84 
better for staff  10 
Invested in the Trust  5 
adapting from others  4 
Better for patients  57 
time to care  11 
Quality and safety  20 
reduction of errors  4 
PPI  7 
Patient Choice  1 
Dimensions of Innovation 
Culture 
Descriptions of the Culture for Innovation. Categorized using the seven dimensions of an Innovation Culture, 
Maher et al 2010, with all sub-dimensions included as sub-nodes 
329 
Recognition and examples  12 
sharing and adoption  4 
Not Recognised  13 
Disruptive Innovation  11 
Continuous Innovation  20 
Not Invented Here  12 
business model  9 
How do you feel about our IC  24 
Relationships Honoring everyone’s input, Diversity, Trusting, open environment, Team Based work 40 
Trusting, open environment  4 
Team Based work  5 
Honoring Everybody's input  4 
Diversity  9 
Rewards Aligned with organizational goals, Recognition, Intrinsic Motivation, Individualized 23 
Recognition  4 
Intrinsic Motivation  62 
don’t know we're doing it  32 
Individualized  5 
Aligned with organizational 
goals 
 0 
Goals What, but not how, Specific call for innovation, Tie to strategic plan, ‘Stretch’, Clear case for need 18 
What, but not how  0 




Tie to the strategic plan  0 
'Stretch'  0 
Specific call for innovation  1 
Clear Case for Need  0 
Tools Flexibility, Deliberate Process, Training, Encouragement of skills development 12 
Training  0 
Flexibility  0 
Encouragement for skills 
development 
 1 
Deliberate process  1 
Knowledge Wide scope search, Uncensored, Unfiltered, Unsummarised, Free-flowing 33 




Free-flowing  5 
Resources Funding, Tim, Authority to act 98 
Time  19 
Funding  9 
Authority to Act  5 
Risk taking Emotional Support, Balanced Assessment, Learning from Failure rather than punishing, Trying new things  53 
Trying new things  6 
Learning from failure rather 
than punishment 
 3 
Emotional Support  2 
Balanced Assessment  9 
safe  11 
Strategy & leadership General overview of innovation, how it is perceived and understood and how this starts to interplay with the  
Innovation Culture within the organisation 
533 
Attitudes  157 
positive  78 
negative  64 
Targets  3 
fear  23 
Technology  3 




risk  1 
academic  3 
corporate not clinical  6 
Change as a threat  9 
challenge and barriers  22 
it’s hard  14 
The place of Leadership  208 
Devolved Leadership to all 
levels 
 83 
Support  28 
Team & Peer Support  32 
Sharing what we are doing  5 
passion  2 
creating the environment  19 
socializing concept  14 
Celebrating  1 
Changes through staffing 
levels 
 23 
leading from the front  12 




Senior leadership and vision  83 
working together  2 
Well led  2 
Visibility  1 
Risk Appetite and safety   18 
Grow innovation  5 
External Partnerships  6 
Champions  17 
Celebrating  3 
Ambition  20 
Everyone's responsibility  11 
Leadership Matter Leadership Matter document and events 17 




Leadership Behaviors  1 
Conferences  3 
Changes over time  63 
Threat  1 
temporal element  12 
not changing  14 
NHS Context  21 
don’t stop to think about it  2 
Understanding Innovation  44 
quality improvement  50 
links to research  15 
    Strategy  16 
 




VI. Sli.do poll Word clouds 




Appendix 5 Ontological and epistemological frame 
A case study has no prescribed philosophical position; different seminal 
authors adopt differing stances (Harrison, et al. 2017). There are long 
established differences between research philosophies, with purists 
fundamentally disagreeing on many underpinning principles, thus the 
particular perspective of a researcher must be articulated (Maxwell, et al. 
2010). Positivism is popular in the natural sciences and embraces 
experiment; individual concepts singled out as variables, manipulated and 
controlled, developed into predictive models, which establish laws 
(Thomas, 2016). In complex social systems however, experiments may 
not be ethical or even feasible (Carolan, et al. 2015). In social sciences 
the alternative world view of the interpretivists acknowledges the 
complexity of the social world, where human actors and their behaviour 
are unpredictable, interacting with each other in a unique social 
environment, in a time-bound context that must be interpreted 
subjectively by the researcher (Burke, et al. 2004). If one believes that an 
ontological position infers epistemological commitment, then quantitative 
methods are associated with positivism and qualitative methods, 
interpretivism (Maxwell, et al. 2010). Case studies, commonly accepted to 
utilise mixed-methods approaches, are therefore confounders. This 
methodological eclecticism requires a fundamentally different ontological 
perspective (Carolan, et al. 2015).  
 
Some believe the case study to be a methodology in its own right (Yin, 
2014); others believe it is a method that focuses on research choice 
(Stake, 1995). There is, however, agreement on the purpose of a case 
study; to explore the case in its wholeness, in depth, from multiple 
different perspectives, so as to create a unique understanding (Yin, 2014; 
Thomas, 2016; Stake, 1995; Carolan, et al. 2015). If this is coupled with 
an epistemological belief that in order to know and understand this 
moment in time, then philosophical arguments can be disregarded and 




methods combined on the basis of their practical application, the 
philosophical concept of ‘pragmatism’ can be understood (Maxwell, et al. 
2010).  
 
Pragmatism is a popular stance from within mixed-methods research 
(Maxwell, et al. 2010) within case study methodology described as a 
philosophical bridge across the qualitative and quantitative epistemologies 
(Harrison, et al. 2017). Maxwell, et al. (2010) describes this bridge as 
‘realism’, a philosophical perspective that Yin, (2014) identifies within his 
methodology, promoting the need for objectivity and methodological 
rigour in order that resultant theories can be generalisable. Although 
useful in the practical application of knowledge creation (Morgan, 2014), 
Easton (2010) reflects, that for the novice researcher this approach lacks 
justification for valid interpretation.  
 
If the nature of reality is dynamic, constantly negotiated, based on what is 
known at any specific time point, then the nature of being is also transient 
(Morgan, 2014). Others agree with this, suggesting that pragmatism, 
which merely discounts philosophical differences, undervalues the role 
ontological positioning plays as the lens through which the research is 
conducted, suggesting value is increased through combining these world 
views (Maxwell, et al. 2010). In this perspective the position of the ‘naïve’ 
realist is contested as failing to recognise the role diversity plays within 
the social world (Maxwell, et al. 2010). The concept of diversity is 
important to both the complex healthcare context and innovation 
(Greenhalgh, et al. 2005) and is therefore an important construct in this 
research. If diversity is accepted, then knowledge must be partial, 
incomplete, and fallible, if new understandings are to emerge, an 
interpretative approach is required (Maxwell, et al. 2010).  
 




Critical realism is an ontological approach originating from the 
philosophical arguments presented by Bhaskar (1978) which, while 
retaining the ontological perspective of realism, also accepts an 
epistemology of interpretivism (Maxwell, et al. 2010). The critical realist 
believes the world is ‘theory-laden’, but not ‘theory-determined’ (Fletcher, 
2016); where a ‘real’ domain generates patterns of events, these events 
may or may not be observed in the ‘actual’ domain, whilst in the 
‘empirical’ domain events can be studied (Tsang, 2014). Theoretical 
inferences from the empirical to the real domains can be made through 
retroduction, thus getting close to reality and identifying causal 
mechanisms of social phenomena (Fletcher, 2016).  
 
This research acknowledged both the complex world of the NHS 
ecosystems and diversity as a real phenomenon; in addition, innovation 
has been identified as having a lack of theoretical underpinning in this 
environment. If this research is to be useful, then empirical findings will 
need to be interpreted to create new theories regarding what might occur 
in the real domain. Although Yin’s (2014) definition of case study is useful, 
his proposition of conducting the case study through the lens of the naïve 
realist is rejected, in favour of a critical realist approach, acknowledging 
the impact that this decision has on the conduct of the study, in particular 
the situation of the researcher. 
 
Edgley, et al. (2016) explores the relationship between this researcher-
self and new knowledge creation from within the paradigm of critical 
realism, articulating that from this perspective the researcher-self 
becomes a tool that can challenge the value of the current knowledge 
base, then through interpretation of literature and results in a recursive 
process, marshal ideas to create new theories to advance knowledge 
(Edgley, et al. 2016). Crowe, et al. (2011 p103) concur, identifying the 
‘critical’ position as questioning previous held assumptions and 




‘interpretivists’ position as understanding social meaning. This creativity 
process however, infers ‘empirical messiness’ with findings subjectively 
created by the researcher themselves, at the expense of objectivity 
(Gabb, et al. 2009), thus findings are always contestable (Edgley, et al. 
2016). This conceptualisation is coterminous with the belief stated, that 
the world is theory-laden, where empirical observation of the actual 
domain allows inferences to be made in the real world (Fletcher, 2016) 
and embraced within this research. 
 
